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ABSTRACT
The α, ω-dicarboxylic acids HOOC-(CH2)n-COOH (where n = 1-11) reacted smoothly
with [Ag(CH3COO)] to yield 11 novel silver dicarboxylate complexes. These silver
dicarboxylates were reacted with triphenylphosphine (PPh3) in 1:2.5, 1:4 and 1:6 molar
ratios resulting in the isolation of 30 novel silver dicarboxylate triphenylphosphine
derivatives. X-ray crystal structures for nine of these complexes were determined
showing a variation in the structural motifs across the series with mononuclear,
dinuclear, polynuclear and polymeric species being generated. When the 11 novel silver
dicarboxylate complexes were reacted with bis-(diphenylphosphino)methane (dppm) in
a 1:2 molar ratio 11 novel complexes were isolated. The complexes were isolated as
powders and 8 of them formulated as [Ag2(dicarboxylate)(dppm)4] with the remainder
having just three dppm ligands in their formulae. The only crystals isolated from this
series

precipitated

from

the

mother

liquor

of

the

reaction

involving

dodecanedicarboxylic acid (dddaH2), which formulated as {Ag2(dppm)2(ddda)(H2O)}n
and whose structure comprises a linear polymer in which centrosymmetric Ag2(dppm)2
units are linked by diacid anions.
The

11

novel

silver

dicarboxylate

complexes

were

reacted

with

bis-

(diphenylphosphino)ethane (dppe) in a 1:2 molar ratio using the same procedure
employed for the dppm reactions to yield 11 novel complexes which again were isolated
as

powders

and

formulated

as

either

[Ag2(dicarboxylate)(dppe)4]

or

[Ag2(dicarboxylate)(dppe)3]. All of the complexes were found to have limited
solubilities and the phosphine derivatives were all relatively light stable compared to
simple silver salts such as AgNO3.
The metal free dicarboxylic acids and phosphine based ligands are relatively poor
antifungals and display no antibacterial activity. The 11 silver dicarboxylate complexes
are potent in-vitro anti-Candida agents but only five of them displayed good
antibacterial activity, although it was significantly less than that of AgNO3.
Furthermore, unlike the activity of AgNO3 these five complexes displayed some
discrimination towards the Grampositive (S. aureus /MRSA) and Gramnegative (E.coli)
bacteria suggesting that these complexes do not act on microbial cells in the same way
as AgNO3. All of the PPh3 complexes exhibited significant antifungal activity against

the Candida albicans cells although their activity is, on average, over ten times less than
that of the equivalent silver dicarboxylate. Only 5 of these complexes are active against
the bacterial cells tested. Three of these complexes display higher antibacterial activity
(comparable to that of AgNO3) than antifungal activity, a trend not previously observed.
The dppm and dppe derivatives all exhibited significant antifungal activity against the
Candida albicans cells. However, most of their activities are again significantly less
than that of the equivalent silver dicarboxylate. Only three of these complexes display
any activity against the bacterial cells tested and one of them exhibits good activity
against the Grampositive MRSA but it is inactive against the Gramnegative E.coli.
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I General Introduction
During the last two decades the frequency and types of life-threatening fungal and
bacterial infections has increased dramatically. This has been as a result of changes in
both medical practice and in the diseases to which humans are exposed. The yeast
Candida albicans, is considered to be the most opportunistic fungal pathogen as it
presents itself in immunocompromised patients, and over 75% of women suffer from
vaginal candidosis at some stage in their lifetime. Candida infections are diverse in
their manifestations, varying from superficial skin problems, chronic infection of the
nails, mouth, throat or vagina to frequently fatal systemic diseases that involve the
lungs, heart, gastrointestinal tract, central nervous system and other organs. These
infections are considered to be opportunistic in nature since some aspect of the host's
defence system is impaired in some way. C. albicans is a dimorphic yeast, existing in a
yeast phase (blastospore) and having the ability to form germ tubes that elongate into
hyphae (hyphal phase). The definitions of the two phases are given below.
A blastospore is defined as the unicellular form of the fungus, the yeast cell.It is
distinguished by a specific process of mitotic cell division known as budding (Figure 1).
Budding involves the growth of new cellular material from selected sites on the
blastospore surface. The new bud grows for a period of time until it is one third the size
of the parent blastospore, and then stops. Nuclear division follows and a septum is laid
down between the parent and the daughter cell. The two cell units separate and form
two blastospores. 1
Figure 1: A yeast cell budding2
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In mycology, germination refers to a process in which a hardy dominant spore
undergoes a complex set of metabolic rearrangements and cell wall alterations to
generate a new hyphal cell. This cell emerges through a pore in the wall of the spore as
a germ tube of different molecular architecture from the spore. This nomenclature is
being used in all studies of C. albicans to define a process where a novel hypha emerges
by a simple evagination of the cell wall. Septae are laid down along the extending
hyphae. The term "germ tube" is used to refer to newly evaginating hypha up to the
time that the first septum is laid down.
Figure 2: Yeast cells, pseudohyphal cells and true hyphal cells3

Candida albicans can exist in three forms that have distinct shapes: yeast cells (also
known as blastospores), pseudohyphal cells and true hyphal cells (Figure 2). Yeast cells
are round to ovoid in shape and separate readily from each other. Pseudohyphae
resemble elongated, ellipsoid yeast cells that remain attached to one another at the
constricted septation site and usually grow in a branching pattern that is thought to
facilitate foraging for nutrients away from the parental cell and colony. True hyphal
cells are long and highly polarized, with parallel sides and no obvious constrictions
3

between cells. All three cell types have a single nucleus per cell before mitosis.
Important differences between yeast, pseudohyphal and true hyphal cells include the
degree of polarized growth, the positioning of the septin ring (green in Figure 2 and
micrographs, and black in light microscope images) and of the true septum relative to
the mother cell, the movement of the nucleus (blue line in Figure 2 and in micrographs)
relative to the mother cell and the degree to which daughter cells are able to separate
into individuals.
Many of the current antifungal agents that are used in therapy are generating resistance
or have adverse side effects. For example, the anti-Candida agent, fluconazole can
cause nausea, headache or provoke liver damage. As a result of this increase in
resistance, infections caused by other Candida species such as Candida glabrata,
Candida kreusi and Candida dublineinsis are becoming more common.
Antibacterial drug discovery reached its apex in the 1950’s and of the majority of these
compound classes are still in use today.4 After the introduction of streptogramins and
quinolones in the early 1960’s, no novel class of antibacterial agent was introduced into
clinical practice until linezolid was launched in 2000. Due to the diversity of bacterial
structures, drug discovery in this area requires agents with specific biomolecular targets
or pathways. Bacterial microorganisms have made use of antibacterial xenobiotics and
selective pressure to evolve an elaborate arsenal of defences to protect themselves from
attack. As a result, some researchers suggest the superior role of natural products, due to
evolutionary conditions, in producing an array of antibiotic producing microorganism,
compared with synthetic libraries.5 However, these antibiotics function by targeting
specific biomolecular pathways and as a result have a propensity for the development of
resistance to prophylactic treatment.
The major types of bacterial organisms which cause community and hospital acquired
infections are (i) Methicillin-resistant Staphylococcus aureus (MRSA), (ii) Clostridiumdifficile (C.difficile) and (iii) Escherichia-coli (E-Coli).
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Methicillin-resistant Staphylococcus aureus (MRSA)
MRSA has been pandemic for over a decade and is causing a major increase in serious
staphylococcal infections.6 It is a variety of Staphylococcus aureus (SA) which exists
on the skin and nose of about 30% of the population without causing any serious health
effects but can cause wound infections and severe bloodstream infections.7 Penicillin
was introduced in 1940 to fight against these infections but within a short period of time
nearly all strains of SA became resistant to it. Methicillin was then introduced to
overcome this resisitance but about 60% of SA strains have now become resistant to it.
The antibiotic drug vancomycin, is currently used to treat these infections but it is not
effective and resistance to this drug is also beginning to emerge.8

Clostridium-difficile (C.difficile)
Clostridium difficile (C.difficile) is an anaerobic bacterium which is usually found in the
large intestine and it can be found in a small portion of healthy adult population. It is
traditionally a nosocomial pathogen and is one of the leading causes of diarrhoea. It
usually occurs in patients that have had their natural intestinal bacteria destroyed by
antibiotics. In the absence of normal bacteria it multiplies and produces toxins that
damage the lining of the intestine resulting in diarrhoea.9 C.difficile spores can persist in
dust or on surfaces for months and can be transmitted to other patients or to healthcare
workers. The spores cannot be destroyed by usual detergents and survive hand
disinfections with alcoholic preparations. Therefore it is important to try and establish
an effective strategy for controlling the spread of this infection.10

Escherichia-coli (E-Coli)
Escherichia-coli (E-Coli) is an anaerobic Gramnegative bacterium that is found in the
intestinal tracts of healthy animals.11 It can adhere to the mucus overlying the large
intestine and once established it can persist there for months or years. It becomes
problematic for a patient if the natural flora in the gut is disturbed particularly after a
course of antimicrobial chemotherapy.12 It is one of the leading causes of urinary tract
infections and can form biofilms on catheters.
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I.1 GENERAL CHEMISTRY OF SILVER
Silver is a white metal, more malleable and ductile than other metal except gold.
Silver, one of the “coinage metals” was almost certainly one of the first three metals
known to man along with the other “coinage metals”, gold and copper. It has been
known and valued as an ornamental and coinage metal since ancient times and silver
mines in Asia Minor were probably worked before 2500 BC. The alchemists called
the metal Luna or Diana after the goddess of the moon and ascribed to it the symbol
of a crescent moon. It’s principle ore is argentite or “horn Silver”. Silver has the
electron configuration [Kr] 4d10 5s1. Its hardness ranges between 2.5 and 2.7; it is
harder than gold but softer than copper. Silver melts at about 962 °C, boils at about
2212° C and has a specific gravity of 10.5. The atomic weight of silver is 107.868 g
mol-1.
I.1.1 The silver(I) oxidation state
Ag(I) is by far the most important oxidation state and is the most commonly known,
with the electron configuration [Kr] 4d10. Ag+ forms a large variety of complexes. Most
simple ligands have a coordination number of two e.g. the silverdiammine complex
[Ag(NH3)2]+, [Ag(CN)2]- and [Ag(S2O3)2]3- and are therefore linear in shape. However
complexes of coordination number three, four and six are also found, with trigonal,
planar, square planar, tetrahedral and octahedral structures commonly seen. Ligands
capable of  bonding, such as phosphine derivatives, may form both two- and fourcoordinate complexes. A few silver(I) complexes with colourless anions are coloured.
AgI, Ag2CO3 and Ag3PO4 are yellow and Ag2S is black. This is due to the small and
highly polarising silver(I) ion and the anion, eg. I, being large and highly polarisable.
This leads to some covalent character.
I.1.2 The silver(II) oxidation state
The silver(II) ion has the electron configuration [Kr] 4d9. Numerous complexes of
Ag(II) are known, and are usually prepared by oxidizing a solution of silver(I)
containing the complexing ligand with potassium persulphate. These complexes are
usually square planar and paramagnetic. With neutral ligands cationic species such as
[Ag(pyridine)4]2+,

[Ag(bipyridine)2]2+ and

[Ag(ortho-

phenanthroline)2]2+

form

crystalline salts. The magnetic moments of Ag(II) complexes range from eff =1.75 to
2.2 BM, consistent with a d9 configuration.
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I.1.3 The silver(III) oxidation state
The silver(III) oxidation state is very uncommon. The flourination of a fused mixture of
alkali metal halide and silver halide will give M+[AgIIIF4]-, and the electrolytic oxidation
of silver(I) can give impure Ag2O3. Oxidation of alkaline Ag2O with persulphate gives
mixed oxide AgIAgIIO2. Persulphate in the presence of periodate or tellurate ions gives
compounds such as K6H[AgIII(IO6)2] and Na6H[AgIII(TeO6)2]. These compounds are all
unstable and are strong oxidising agents.
I.1.4 Complexes of silver(I)
I.1.4.1 Silver(I) and its coordination modes
Silver(I) has an outer electron configuration of [Kr]d10 and is diamagnetic. It forms
good complexes with nitrogen, sulphur and halogen donor ligands. Silver(I) has a low
affinity for oxygen donors although complexes containing carboxylate ions and crown
ethers are known. Numerous phosphine complexes of silver(I) are also known. There
are a number of coordination modes and geometries of silver(I) complexes. The most
common are linear (coordination number 2), trigonal planar (coordination number 3),
tetrahedral (coordination number 4) and octahedral (coordination number 6).13
Examples of these are shown in Figure 3.
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Figure 3: Structures of the most common coordination modes and geometries of
silver(I): (i) linear, (ii) trigonal planar, (iii) tetrahedral and (iv) octahederal13
I.1.4.2 Complexes with Nitrogen Ligands
Many of the silver complexes with nitrogen ligands readily form in aqueous solution. 13
NH3 is most important of the nitrogen ligands. There is a preference for linear
coordination, the linear [H3N-Ag-NH3]+ ion has been observed crystallographically in
several compounds. Formation of this ion is dependent on [Ag+] and [NH3], it can be
used for the separation of silverhalides.The solubility of AgCl gives [Ag(NH3)2]Cl on
treatment with aqueous ammonium carbonate, while AgBr dissolves only in aqueous
ammonia, in which AgI is poorly soluble.
Aqueous pyridine and substituted pyridines form [Ag(py)2]+ and [Ag(py)2]+ ions, but in
non-aqueous conditions tetrahedral complexes, such as [Ag(py)4]ClO4, may be
obtained. The tetrahedral acetonitrile adduct [Ag(NCMe)4]+ is also known and is quite
stable. There are a number of argentite(I) complexes such as [Ag(NCO)2]- and
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[Ag(ONO2)2]-; they are linear, with 2-coordinate Ag+. Linear coordination is also found
in the tetrameric silver amide [Ag{N(SiMe3)2}]4.
I.1.4.3 Complexes with Halogen Ligands
The halides AgX react with halide anions X- (where X is I- > Br- > Cl-) to give a series
of anionic complexes [AgKXl](l-K)-, with relative stabilities I- > Br- > Cl-.13 The type of
complex anion formed is strongly influenced by the counterion and the nature of the
halide, and there is considerable structural diversity. The ions [X-Ag-X]- (X = Cl, Br)
are linear, where as [Ag2X4]2-(X = Cl, Br, I) and [AgI3]- contain 3-coordinate silver.
Examples of anionic iodo complexes are shown in Figure 4. Cationic species such as
Ag2X+ and Ag3X2+ are formed when the silver halides are dissolved in aqueous solution
of AgNO3 and AgClO4.

Figure 4: Structures of the anionic iodoargentate complexes (a) [AgI3]2-; (b) [Ag2I4]2-;
(c)-(e) isomers of [Ag4I8]4- 13
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I.1.4.4 Complexes with Phosphine Ligands
With monophosphines these are mainly of the type (R3P)n AgX, with n=1-4.14 The 1:1
complexes are tetrameric, with either cubane figure or chair figure structures depending
on the steric requirements of both X and R3P; Ag4I4(PPh3)4 undergoes cube-chair
isomerisation, and the two structural types may be obtained by crystallization from
different solvents (Figure 5).

Figure 5: The Cube and Chain structures of [Ag4I4(PPh3)4]14
The complexes (AgXR3)2 are generally dimeric with bridging X. Triphenylphosphine
forms four coordinate [Ag(PPh3)4]+. Slightly larger phosphines, such as PCyPh2 and
PCy2Ph give 3-coordinate [AgL3]+, while bulky phosphines such as PBut3 or P(mes)3
form linear cations[L-Ag-L]+.
Complexes with bridging bidentate phosphines tend to be dimers or tetramers with
bridging phosphines, as in Figure 6. Phosphines with a large bite angle, (Figure 6), may
however form mononuclear chelates.
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Figure 6: Bridging and Chelating diphosphine derivatives of Silver14
I.1.4.5 Complexes with other ligands
Silver(I) has a relatively low affinity for oxygen donors, although compounds and
complexes containing carboxylate ions, DMSO, DMF, and crown ethers are known. 15 It
forms numerous complexes with the donor atoms S, Se, P and As. With sulfur the
thiosulphate complexes, [Ag(S2O3)]- and [Ag(S2O3)2]3- are quite stable. Other important
sulfur ligands for Ag+ are thiolate anions, which give oligomers, (AgSR)n,
dithiocarbamate ions, SCN-, thioureas and thioethers. Silver(I) binds to peptides and
proteins, with a preference for –SR and imidazole nitrogen functionalities.
The dithiocarbamate ion Pr2NCS2- forms a hexanuclear complex with a trigonal
antiprismatic array of silver ions. Similar anionic clusters are also formed with the
related (NC)2C=CS22- ligand, e.g. [Ag6L6]6- and [Ag8L6]4-. Four-, five-, and sixcoordination is found in Ag+ complexes with sulphur macrocycles. For e.g.,in
[Ag(16s6)]ClO4 only four of the six S atoms coordinate to give tetrahedral geometry
(16S6= hexathiacylohexadecane), while [Ag(18S6)]+ and [Ag(9S3)2]+ are octahedral.
The latter complex can be oxidized to silver (II) compound. The reaction of Ag+ with
tetrathiometallates MS42- gives polymers [Ag(MS4)]nn-(M=Mo,W).In [NH4]n[Ag(WS4)]n
this polyanion consists of a chain of S-bridged eight membered rings (Figure 7).
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Figure 7: Structure of [NH4]n[Ag(WS4)]n 15

I.2 THE SILVER ION AS AN ANTIMICROBIAL AGENT
Elemental silver and silver salts have been used for decades as antimicrobial agents in
curative and preventive healthcare.16 Silver and its simple salts have found important
applications in the treatment of chronic ulcers, extensive burns, and difficult-to-heal
wounds. The silver ion (Ag+) is the active ingredient in these simple systems and is well
known as an excellent antimicrobial with high efficacy against Grampositive and Gram
negative bacteria as well as a wide array of fungal microbes, but low toxicity against
non target organisms.17 Furthermore Ag+ ions also exhibit virucidal properties.18
Silver salts and compounds that release silver ions have also found applications in
materials used in medical devices such as intravascular catheters where they prevent the
growth of pathogens that cause catheter-related bloodstream infections which account
for a significant proportion of nosocomial infections in intensive care units.19 More
recently wound dressings containing fabrics impregnated with silver (FIS’s - a new
silver technology), which have antimicrobial efficacy, have been developed with the
potential to provide a protective barrier against infection in severe burn wounds. Such
FIS’s owe their efficacy to the inclusion of discrete silver complexes which have the
ability to release silver ions in a slow controlled manner.
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I.3 THE ANTIMICROBIAL MECHANISM OF ACTION OF SILVER ION
It is believed (but not yet fully understood) that the silver ions interfere with cell growth
by 1. inhibition of transport functions in the cell wall (respiration), 2. interruption of cell
metabolism (changing enzyme structures) and 3. inhibition of cell division (interaction
with DNA) (Figure 8).20 This multimodal efficacy, which occurs at very low
concentrations, is unique to silver ion antimicrobials and reduces the possibility of
developing resistant organisms.21

Figure 8: The antimicrobial mechanism of action of silver ions20
In 2000 Feng et al.22 reported a mechanistic study of inhibition of silver ions against
two different bacterial species, S. aureus and E. coli. For the experiment, both bacteria
were inoculated into liquid Luria Bertoni (LB) medium and incubated at 37 °C on a
rotary shaker (200 rpm) for 16 h. After that 10 µg/ml of silver nitrate was added to the
liquid culture and allowed to incubate for 4–12 h. Five milliliters of the above culture
was removed, centrifuged and the subsequent biomass obtained was further studied by
transmission electron microscopy (TEM) and X-ray micro-analysis to find out the
morphological changes occurred in the cells after treatment with silver ions. In the case
of E. coli significant morphological changes were noticed after the treatment of silver
ions. An electron-light region was observed in the center of E. coli cells containing
some tightly condensed substance twisted together. A big gap was observed between the
cytoplasm membrane and the cell wall. Presence of some electron dense granules
around the cell wall was also noticed. The X-ray microanalysis of these electron dense
13

granules demonstrated the presence of silver and sulfur assuming that the silver ions
after entering the bacterial cell might have combined with the cell components
containing sulfur. Similarly, in the case of S.aureus the presence of condensed
substance in the electron-light region was observed. The cytoplasm membrane was
shrunken and detached from the cell wall. In the condensed region of S. aureus cells, a
large amount of phosphorus was found. There were also, slight differences observed
related to the effect of silver ions on S.aureus when compared with E.coli. The electrondense granules observed in S.aureus and the electron-light region was darker than E.
coli cells. S. aureus has a much stronger defense system compared to E.coli. S.aureus is
Grampositive bacteria with a thicker peptidoglycan cell wall than Ecoli and there is
presence of a clearly visible nuclear region in the center of cells where DNA molecules
are distributed randomly. Thus, this thicker cell wall protects the cell from the
penetration of silver ions in the cytoplasm.23 By the comparative evaluation of the
effects of silver ions on both the test organisms, the authors suggested the possible
mechanism of action of silver ions. The silver ions enter into the bacterial cells by
penetrating through the cell wall and consequently turn the DNA into condensed form
which reacts with the thiol group proteins and result in cell death. The silver ions also
interfere with the replication process. To the 0.05 M aqueous histidine and tryptophan
solution, 0.05 M silver nitrate was added which resulted in the formation of a white
precipitate. This precipitate was centrifuged, dried and used for the evaluation of
antimicrobial activity by double serial dilution method. The toxicity of silver complexes
of tryptophan and histidine was tested on a group of white mongrel mice. The histidine
complex with silver compound showed good antimicrobial activity against
Gramnegative bacteria while, the tryptophan complex with silver compound showed
higher antimicrobial activity and broad spectrum of action. In the toxicity study, both
the complexes of histidine and tryptophan show low toxicity. From the above
experimental work it was found that the tryptophan complex with silver depicted a
better antimicrobial activity than the histidine silver complex.
Bromberg et al24 demonstrated the use of silver nitrate for the treatment of periodontal
pathogens. They found silver nitrate more efficient than antibiotics for the treatment of
oral cavity of periodontal infections.
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The mechanism of action of silver is linked with its interaction with thiol group
compounds found in the respiratory enzymes of bacterial cells. Silver binds to the
bacterial cell wall and cell membrane and inhibits the respiration process. In the case of
E.coli, silver acts by inhibiting the uptake of phosphate and releasing phosphate,
mannitol, succinate, proline and glutamine from E. coli cells. Bactericidal actions of a
silver ion solution on E.coli, is studied by energy-filtering transmission electron
microscopy and proteomic analysis.
The mechanism for the antimicrobial action of silver ions is not properly understood
however, the effect of silver ions on bacteria can be observed by the structural and
morphological changes. It is suggested that when DNA molecules are in a relaxed state
the replication of DNA can be effectively conducted. But when the DNA is in a
condensed form it loses its replication ability hence, when the silver ions penetrate
inside the bacterial cell the DNA molecule turns into the condensed form and loses its
replication ability leading to cell death. Also, it has been reported that heavy metals
react with proteins by getting attached with the thiol group and the proteins get
inactivated.
Simple biocides such as Ag+ ions generally exhibit indiscriminate microbial activity due
to their multimodal nature and their ability to penetrate the outer cell layers of a range of
microorganisms.
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Table 1: Compositions of outer cell layers of different microorganisms25
Organism

Outer cell layers

Example(s)

Grampositive cocci

Cell wall: predominantly

Staphylococci

Peptidoglycan
Gramnegative bacteria
Mycobacteria

Outer membrane: phospholipids,

P.aeruginosa,

Lipopolysaccharide

E.coli

Cell wall: mycolate of a arabinogalactan

Mycobacterium
tuberculosis

Bacterial spores

Outer spore coat: alkali-resistant (S-S

Bacillus spp

bonds)
Inner spore coat: alkali-soluble (acidic
polypeptides)
Cortex: peptidoglycan, including spore
specific
Yeasts and moulds

Cell wall: chitin + chitosan

Mucor rouxii

Cell wall: chitin + glucan

A.niger

Cell wall: glucan + mannan

S.cerevisiae,
C.albicans

Intestinal protozoa

Cysts have thick outer coverings

C.parvum

Other protozoa

Double-walled cysts containing

A.Castellanii

cellulose (during encystation)
Algae

Cell wall: cellulose + other

green

polysaccharides + other constituents

(Chlorophyta),
brown(Phaeopphyta) and red
(Rhodophyta)
algae
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1.4 MICROBIAL RESISTANCE TO SILVER
Silver resistance has been reported in bacteria isolated from both clinical and
environmental settings. The genetic basis of silver resistance was first reported by
McHuge et al,26 demonstrating that silver resistance was plasmid encoded and has been
confirmed by others. The physiological, biochemical, genetic and structural studies of
the silver resisitance determinant plasmid pMG 101 established the molecular basis of
silver resisitance. Plasmid pMG 101 is a 182 kb, transferable plasmid encoding
resistance to silver, mercury, tellurite, ampicillin, chloramphenicol, tetracylin,
streptomycin and sulphonamide. The silver resistance cassette of genes encodes two
silver efflux pumps and two periplasmic Ag+ binding proteins.
I.5 SILVER COMPLEXES AS ANTIMICROBIAL AGENTS
In addition to simple silver salts a number of complexes have also been used
clinically.27 Such silver complexes are particularly interesting since the antimicrobial
activity and other desirable properties can be changed by varying the the number and
type of ligands coordinated to the silver ion. Important factors to consider when
designing novel silver based antimicrobial complexes are:
1. The type of atoms bound to the Ag+ ion (O>N & S>>P)
2. The ease of ligand replacement and control of Ag+ ion release.
3. Chemical and Photo-Stability (Blackening)
4. Cost
The search for new complexes and materials allowing biocidal Ag+ ions to be delivered
with increased efficiency is currently an active research area in inorganic medicinal and
material chemistry. Silver has been described as ‘oligodynamic’ because of its ability
to exert a bactericidal effect at minute concentrations28. In a complex biological system
such as wound fluid, the maximum level of free (available) Ag+ is approximately 1
µg/ml. Above this level, Ag+ complexes with anions such as chloride to form minimally
soluble and inactive salts resulting in costly loss of efficacy. However developing
formulations which allow for the application of optimum low concentrations of simple
silver salts and labile silver complexes under biological conditions can be difficult
because of problems associated with the photosensitivity of the free Ag+ ion. The rate of
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metal ion release and the relative stability of any silver-complexes can be controlled
using variations in the ligand architecture and the overall structural motif of the
compound.
Silver sulphadiazine
Silver-sulphadiazine(AgSD)29 (Figure 9) (which is available commercially in products
such as Flammazine®) a compound that has been very successfully applied in the clinic.
Upon application AgSD releases the two antibacterial agents, free Ag+ ion and the
sulphonamide antibiotic sulphadiazine which in the drug are combined together in a
polymeric structure composed of 6 silver atoms bonding to 6 sulphadiazine molecules
via labile Ag-Nitrogen linkages. The sulphadiazine also reduces the photosensitivity of
the Ag+ in the complex.
NH2

O
N

S
O
N

N

Ag

Figure 9: Structure of one unit of Silver-Sulfadiazine29
Silver sulfadiazine is used as a 1% water-soluble cream. AgSD works as a broadspectrum antibiotic. It is used especially for the treatment of burn wounds. AgSD serves
as a reservoir of silver in the wound and slowly liberates silver ions. All kinds of sulfadrugs have been tested in combination with silver but sulphadiazine was found to be
most effective. AgSD binds to cell components including DNA and cause membrane
damage. It achieves bacterial inhibition by binding to the base pairs in the DNA helix
and thus inhibits transcription. In a similar way it also binds to phage DNA.
In deep dermal and full-thickness burns, antiseptic agents, which can penetrate into
deeper layers, such as silver-sulfadiazine should be applied. The released silver ions
bind to the microbial genes (DNA) and inhibit the reproduction of bacteria and fungi.
Sulfadiazine inhibits the production of folic acid which is necessary for the reproduction
of bacteria. In case of later surgical debridement an unfavourable effect of silver18

sulfadiazine is that it softens the necrosis thus complicating a tangential excision. If
applied broadly, the systemic resorption of silver ions may cause an impaired acid-base
balance, leukopenia as well as liver and kidney damage.
A number of groups in various labs around the world are synthesizing silver complexes
and testing for biological activity. A number of silver complexes have been synthesized
that have been found to have chemotherapeutic potential as antimicrobial or cytotoxic
agents. The antimicrobial complexes are of interest to the pharmaceutical industry for
potential use as topical agents, oral antibiotics and antimicrobial coatings for medical
devices. With the emergence of ubiquitous antimicrobial resistance to antibiotics and
antiseptics Ag+ ion technologies have re-emerged as attractive biocides for medical and
industrial applications.
A number of silver complexes have also been shown to display significant cytotoxicity
against selected cancer cell30 lines and such complexes are of interest to medicinal
chemists. A selection of these biologically active complexes are discussed below.
1.6 SILVER BASED BIOCIDAL PRODUCTS
As mentioned, silver sulfadiazine cream is used for treating burns and this is available
commercially as a topical cream known as Silvadine.31 There are also a number of
antimicrobial wound dressings that contain silver such as ActicoatTM

32

, SilverIon33,

Contreet34 and Silvercel35. Several companies have manufactured silver antimicrobial
agents intended for use in many applications. For example Agion from Agion36, JMAC
from Johnson Matthey37 and Biomaster from Addmaster.38
AgIon
AgIon incorporates silver ions into a zeolite carrier and works by ion exchange. Silver
ions exchange with other positive ions present in the moisture in the atmosphere.
JMAC
This is silver chloride deposited on inert titanium dioxide and it is finding applications
as coatings on sutures, wound dressings, catheters and internal feeding tubes.
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Biomaster
Biosilver is a product from the Biomaster range and it consisits of titanium dioxide
coated with silver chloride and it is available in powder and liquid forms. It can be used
for incorporation into textiles, paints and coatings.
There are also some companies which have developed silver based paints. These
include Bioni Hygenic39 and Stershield40. Bioni Hygenic utilizes nanosilver as the
antimicrobial agent which is trapped inside a polymer matrix. This paint is currently
applied in severel hospitals in Germany. Stershield use Biosilver as the antimicrobial
additive in their paint and is marketed by Dulux. The use of an antimicrobial paint in
hospital wards may help reduce the spread of infection. There are also a number of
companies which market catheters impregnated with a form of silver.
I.7 SILVER COMPLEXES EXHIBITING BIOLOGICAL ACTIVITY
Despite the fact that silver has a low affinity for oxygen donor ligands, such complexes
are known. Silver complexes of oxygen donor ligands such as, [Ag(hino)]2 (where
hino = 4-isopropyltopolone) and water-soluble silver (I) complexes of (R)-(+)- and (S)(−)-2-pyrollidone-2-carboxylic acid displayed wide ranging and effective activities
against some bacteria, yeasts and moulds. It has been found that the silver–oxygen
bonding properties rather than the chiral helical or achiral polymer structure play a role
in exhibiting antimicrobial activities. The antimicrobial activities of Silver(I)–oxygen
bonding complexes are independent of whether the ligand itself possesses antimicrobial
activities. Examples of such complexes containing acetasalicyclic acid (Hasp) are;
{[Ag(L-Hasp)]2} and {[Ag(L-Hasp)]2}n, where the ligand showed no activity. Similarly,
salicylic acid (salH) did not prevent the growth of a fungal pathogen, while the silver
complexes, [Ag(salH)]2 and [Ag(NH3)(salH)]2 greatly inhibited cell reproduction. These
complexes also produced a cytotoxic response against human cancer cells.
The biological action of the silver (I) oxygen complexes comes from a weaker bonding
property of the Ag–O bond. In the biological system, the ease of ligand replacement of
the silver (I) complexes would result in further replacement with biological ligands. The
Ag–O bonding complexes can readily undergo ligand replacement with O-, N- or Sdonor atoms. The antimicrobial activities of silver (I)–oxygen bonded complexes are
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due to the silver (I) ion itself, i.e., due to a direct interaction between the silver (I) ion
and the biological ligands such as protein, enzymes and membrane. The coordinating
ligands of the silver (I) complexes play the role of carrier for the silver (I) ion to the
biological system. The magnitude of antimicrobial properties of silver complexes is
related to the ease with which they participate in ligand exchange reactions. For
example, it has been speculated that the weak Ag–O and Ag–N bond strengths might
play an important role in exhibiting a wider spectrum of antimicrobial and antifungal
activities and that the potential target sites for inhibition of bacterial and yeast growth
by silver complexes might be the sulfur containing residues of proteins. Generally, Ag–
S complexes have been shown to have a narrower spectrum of antibacterial activity than
Ag–N complexes but no antifungal activity. In contrast, the compounds with Ag–P
bonds have shown no activity against bacteria, yeast or moulds.
A sulfur coordinated, water soluble silver (I) complex of thiomalic acid showed
remarkable antimicrobial activity against some bacteria, yeast and moulds. Although
aqueous silver nitrate itself has similar activities for bacteria, the complexation of silver
(I) with thiomalate leads to appreciably high activities for some moulds. Antimicrobial
activities have been observed for sulfur bonded silver complexes of 2-mercaptonicotinic
acid,

[Ag(Hmna)]6 · 4H2O

and

2-mercaptobenzoic

acid,

[Ag(Hmba)]n

and

[Na{Ag(Hmba)} · H2O]n. The spectra of antimicrobial activities observed in Ag–S
bonded compounds have so far been narrower than those in the Ag–N bonded
compounds such as [Ag(im)]n (im = imidazole) and [Ag(triaz)]n (triaz = 1,2,4-triazole).
The key factor determining the spectrum of antimicrobial activity is the nature of atom
coordinated to the silver (I) atom and its bonding properties, (i.e., the ease of ligand
replacement), rather than the solid state structure, solubility, charge and degree of
polymerization of the complexes.
In

2003

McCann

et

al41

reported

reaction

of

(Z)-3-(1H-imidazol-l-yl)-

2phenylpropenenitrile (imppn) with AgClO4 producing the [Ag2(imppn)4(ClO4)2]
(Figure 10) complex. In the dimeric Ag(I) complex each metal is coordinated to the
imine nitrogens of two imppn ligands in an almost linear fashion and the two
[Ag(imppn)2]+ units are linked by an Ag-Ag bond, supported by two trans bridging
bidentate perchlorate groups and by π-π interactions between the ligands. In vitro tests
on the ability of compounds to inhibit the growth of pathogenic yeast Candida albicans
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showed that imppn and its metal complexes were markedly less effective than the
prescription drug, Ketoconazole.

Figure 10: Structure of [Ag2(imppn)4(ClO4)2] 41
In 2004 Coyle et al 42 synthesized [Ag2(NH3)2(SalH)2] from salicyclic acid and Ag2O in
concentrated aqueous NH3 and the dimeric Ag(I) complex was characterised using Xray crystallography (Figure 11). The complex is centrosymmetric with each metal
coordinated to a salicylate carboxylate oxygen and to an ammonia nitrogen atom in an
almost linear fashion. The two [Ag(NH3)(salH)] units in the complex are linked by an
Ag-Ag bond.

Figure 11: X-ray crystal structure of [Ag2(NH3)2(salH)2]42
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SalH2, [Ag2(salH)2] and [Ag2(NH3)2 (SalH)2] were screened for their ability to inhibit
the growth of Candida albicans, whilst metal-free salH2 was essentially ineffective at
controlling the growth of the organism, [Ag2(salH)2] did show quite marked activity.
However, the ammonia complex [Ag2(NH3)2(salH)2] displayed an approximately
tenfold superior activity at controlling yeast cell proliferation.
In 2004, Liu et al 43 reported the reaction of Ag2O and sulfamic acid in a 30% ammonia
and

4%

NaOH

solution

resulting

in

a

http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6VM7-4DTP5W15&_user=2322584&_coverDate=12%2F01%2F2004&_alid=771923479&_rdoc=234&
_fmt=high&_orig=search&_cdi=6143&_st=5&_docanchor=&view=c&_ct=446&_acct
=C000056897&_version=1&_urlVersion=0&_userid=2322584&md5=3fb49f49e3c49f0
091bfa8cb963d0ed0

-

hit1silverhttp://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6VM74DTP5W15&_user=2322584&_coverDate=12%2F01%2F2004&_alid=771923479&_rdoc=234&
_fmt=high&_orig=search&_cdi=6143&_st=5&_docanchor=&view=c&_ct=446&_acct
=C000056897&_version=1&_urlVersion=0&_userid=2322584&md5=3fb49f49e3c49f0
091bfa8cb963d0ed0 - hit3(I) polymer, Na[Ag(NH2SO3)2]n (Figure 12). The X-ray
crystal

structure

analysis

indicates

that

the

complex

is

a

http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6VM7-4DTP5W15&_user=2322584&_coverDate=12%2F01%2F2004&_alid=771923479&_rdoc=234&
_fmt=high&_orig=search&_cdi=6143&_st=5&_docanchor=&view=c&_ct=446&_acct
=C000056897&_version=1&_urlVersion=0&_userid=2322584&md5=3fb49f49e3c49f0
091bfa8cb963d0ed0

-

hit2silverhttp://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6VM74DTP5W15&_user=2322584&_coverDate=12%2F01%2F2004&_alid=771923479&_rdoc=234&
_fmt=high&_orig=search&_cdi=6143&_st=5&_docanchor=&view=c&_ct=446&_acct
=C000056897&_version=1&_urlVersion=0&_userid=2322584&md5=3fb49f49e3c49f0
091bfa8cb963d0ed0 - hit4 polymer through Na–O bonds forming a 3D framework. And
the complex shows high cytotoxicity properties to normal cells and carcinoma cells.
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Figure 12: The structure of Na[Ag(NH2SO3)2]n43
In 2004 five Ag(I) complexes containing the ligands bis(imidazol-2-yl)methane (2BIM) and its derivatives were reported by Abuskhuna et al44 and [Ag2(2BIM)2]ClO4)2
and

[Ag2(2-BIM(Bz)OH)2](ClO4)2.EtOH

were

characterized

using

X-ray

crystallography. In each dimer the two Ag(I) ions are two-co-ordinate and there are
small but definite argentophilic Ag-Ag(d10-d10) interactions. All of the complexes
display antifungal activity when tested in vitro against the fungal pathogen Candida
albicans.
The X-ray crystal structure of [Ag2(2-BIM)2](ClO4)2 (Figure 13) showed the complex to
be centrosymmetric, containing two Ag(2-BIM)+ units. The two metal ions are twocoordinate and have identical atoms in the plane of the chelating ligand. Using its two
imine N atoms each 2-BIM ligand bridges the pair of Ag(I) ions. All four N atoms (N1,
N4A, N4, N1A) are coplanar and the two imidazole groups in each 2-BIM ligand have
an interplanar angle of 75.52(8)°.
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Figure 13: X-ray crystal structure of [Ag2(2-BIM)2](ClO4)244
The X-ray crystal structure of [Ag2(2-BIM(Bz)-OH)2](ClO4)2.EtOH (Figure 14) shows
the asymmetric unit containing one [Ag2(2-BIM(Bz)-OH)2]2+ unit, two perchlorate
anions and a solvate ethanol. The two Ag(I) ions are again bridged by the two ligands
and each metal is approximately linearly coordinated to a pair of imine nitrogens. There
are additional longer interactions with the perchlorate anions. The metal-metal distance
of 3.018(4)Å is considerably shorter than for the [Ag2(2-BIM)2](ClO4)2.EtOH complex
and there appears to be some degree of intermolecular π-π interaction between the
imidazole and phenyl rings of the opposing two 2-BIM(Bz)OH ligands in the dimer.

Figure 14: X-ray crystal structure of [Ag2(2-BIM(Bz)-OH)2](ClO4)2.EtOH.44
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All of the metal-free ligands were found to be inactive against the fungal cells. As
aqueous suspensions, the silver complexes were moderately active with MIC value
ranges indicated in brackets:[Ag2(2-BIM)2](ClO4)2 (10-20µg/cm3); [Ag2(2BIM(Bz)OH)2](ClO4)2.EtOH (50-100µg/cm3); [Ag2{2-BIM(Me)}2](ClO4)2 (20-50
µg/cm3) [Ag2{2-BIM(CN)}2](ClO4)2 (20-50 µg/cm3).
A considerable improvement in antifungal activity was observed upon testing the
complexes as DMSO/water solutions as opposed to aqueous suspensions: [Ag2(2BIM)2](ClO4)2

(5-10µg/cm3);

[Ag2(2-BIM(Bz)OH)2](ClO4)2.EtOH

(2.5-5µg/cm3);

[Ag2{2-BIM(Me)}2](ClO4)2 (2.5-5µg/cm3); [Ag2{2-BIM(CN)}2](ClO4)2 (5-10 µg/cm3).
The highly fluorinated tris(pyrazolyl)borate ligand [HB(3,5-(CF3)2Pz)3]- has been used
in

the

isolation

of

the

air-

and

light

stable

silver

complex,

[HB(3,5-

(CF3)2Pz)3]Ag(OSMe2) as reported by Rasika Dias et al45 in 2006. It is a monomeric
tetrahedral silver complex with O-bonded dimethylsulfoxode ligand (Figure 15). The
silver

adduct

[HB(3,5-(Cf3)2Pz)3]Ag(OSMe2)

and

the

related

[HB(3,5-

(CF3)2Pz)3]Ag(THF) (where OSMe2= dimethyl sulfoxide; THF= tetrahydrofuran) show
good antibacterial activity, and their antibacterial efficacy against staphylococcus aureus
is greater than those of AgNO3 and silver sulphadiazine.
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Figure 15: X-ray crystal structure of [HB(3,5-(Cf3)2Pz)3]Ag(OSMe2)45
In 2007, Lei Zhang et al46 reported two new polymeric silver (I)-fluconazole
complexes: [Ag(HFlu)(NO3)]n and {[Ag(HFlu)2](ClO4)}n (Figures 16 and 17). The
crystal structure of [Ag(HFlu)(NO3)]n consists of infinite 1D single strand helical
coordination arrays with alternative...pmpm... arrangements, which are interlinked
through hydrogen bonding interactions to generate a 3D network. The shortest
intrachain

Ag Ag

distance

bridged

by

HFlu

ligand

is

8.287(1) Å.

In

{[Ag(HFlu)2](ClO4)}n, each Ag(I) ion is coordinated by four triazole N atoms from four
HFlu ligands to form a 2D coordination layer, which has a helical arrangement along
the direction. The results of anti-fungal studies demonstrate that both silver (I)
complexes are more active in comparison to the fluconazole drug.
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Figure 16: The structure of [Ag(HFlu)(NO3)]n46

Figure 17: The structure of {[Ag(HFlu)2](ClO4)}n46
Ag4(9-aca)4(NH3)2] 47 was shown to be over 30 times more active against C. albicans
than the commonly used antifungal agent ketoconazole (Table 2). Although [Ag2(9aca)2]n appears to be only half as active as [Ag4(9-aca)4(NH3)2], when their MIC100
values are equated to their silver ion content (58 μM and 56 μM, respectively) then both
complexes display approximately equal activity. Against MRSA and E. coli [Ag2(9aca)2]n and [Ag4(9-aca)4(NH3)2] both appeared to perform significantly better than the
topical antibacterial agent silver(I) sulfadiazine. These two complexes also exhibited
significant cytotoxic activity against liver and lung cancer derived cells (HepG and
A.498 repectively).
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Table 2: Antimicrobial activity (μM concentrations)47

Drug

C.albicans MRSA
MIC100

MIC50

E.coli

Hep-G2 A-498

MIC50

IC50

IC50

[Ag2(9-aca)2]n

0.29

55.91

61.53

27.8

30.0

[Ag4(9-aca)4(NH3)2]

0.14

28.36

40.73

3.6

5.5

Ketoconazole

4.70
120.40

154.00
15.0

14.0

Silver(I) sulfadiazine
Cisplatin

Organo silver complex exhibiting biological activityare rare in the literature. The simple
alkyl complexes AgR are thermally unstable.48 The stability decreases with increasing
chain length of R, thermolysis gives a mixture of alkenes and alkanes. Vinyl and aryl
silver compounds are more readily accessible, usually by the reaction of a mild agent
(ZnR2, PbR4) with silver nitrate:
AgNO3 + ZnAr2

AgAr +

ArZn(NO)3

They are sensitive to light, air and moisture. Alkyl compounds stabilized by donor
ligands are significantly more stable, for example Figure 18. The linear L-Ag-C
arrangement is typical.

Figure 18: Alkyl compounds stabilized by donor ligands 48
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Silver perfluoroalkyl compounds are thermally much more stable. For example,
(CF3)2CFAg(NCMe)

decomposes

above

60ºC.

The

adducts

CF3AgPR3

are

photosensitive but are oxidized by air to stable Ag3+ anion [Ag(CF3)4]-. Complexes with
the strongly electron- withdrawing pentaflouro- and pentachlorophenyl ligands are
stable to water and oxygen, e.g., the yeild adduct (C6F5)Ag(CH2PPh3).
Alkynyl silver compounds are readily accessible from AgNO3 and HC=CR in methanol
or water in the presence of base and they are thermally stable. Like many heavy metal
acetylides, silver compounds of unsubstituted acetylene are shock sensitive and
explosive.
With an excess of alkylating agents linear argentite(I) anions are formed, [R-Ag-R]-.
These may associate to clusters, such that as in [Li2Ag3Ph6]-, where three [Ph-Ag-Ph]units are held together by Ph...Li interactions.
Complexes with alkenes and arenes are formed when the hydrocarbons are shaken with
aqueous solutions of silver(I) salts. Di- or polyalkenes often give crystalline compounds
with Ag+ bound to one to three double bonds. The formation of alkene complexes of
varying stability may be used for the purification of alkenes, or for the separation of
isomeric mixtures (e.g., 1,3-, 1,4-, and 1,5- cyclooctadienes), or of the optical isomers
of α- and β-pinene. There is very little back-bonding contribution in the formation of
AgI π-complexes. For example, the planar complex (hfa)Ag(Ph-C=C-Ph)47 (hfa=
hexafluoroacetylacetonate) contains an almost linear acetylene ligand with a C=C bond
that is only marginally longer than in free diphenylacetylene, while the Ag-C bonds are
long (2.26Å).
Until recently, isolable CO complexes of silver were unknown. However, if the
counteranion possesses only very weak basicity, fairly stable CO adducts are obtained.
Carbon monoxide acts in these compounds as a σ-donor ligand only. Back-bonding is
virtually absent and the C-O stretching frequencies are substantially higher than that of
free CO (2143 cm-1). The compounds [Ag(CO)]+X- (νco= 2204 cm-1) and [OC-AgCO]+X- (νco= 2198 cm-1) [X=B(OTeF5)4] were characterized by X-ray diffraction. The
[Ag(CO)3]+ ion is formed under CO pressure.
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As shown in Table 3, the carbene–silver complexes, 2a and 2b, shown in Figure 19
showed better bacteriostatic effect (lower MIC value) than silver nitrate at about 2.7
times lower initial silver ion concentration.49 This result showed that although the
theoretical amounts of the silver cations released from carbene–silver complexes were
lower than silver nitrate, more silver cations were in the solution from carbene–silver
complexes. Most of the silver cations from silver nitrate were precipitated as silver
chloride and lost activity. The amount of 0.1% chloride anions in the culture medium is
close to physiological concentrations of chloride (0.15 M sodium chloride). Under these
conditions, carbene–silver complexes were more stable than silver nitrate. Moreover,
when the solutions demonstrating the lowest MIC value were inoculated onto agar
plates, the growth of organisms treated with carbene–silver complexes was delayed for
a longer time than was the growth of organisms treated with silver nitrate. The observed
results can be explained by the slow decomposition of the silver–NHC complexes in the
aqueous culture medium to imidazolim cation and biologically active silver species.
Carbene–silver complexes were observed to decompose over a period of weeks in
deionized water.

Figure 19: Structure of complex 2a and 2b49
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Table 3: MIC results of the silver compounds49
Test compounds Ag (mg/mL)

E. coli

P. aeruginosa

S. aureus

Day 1 Day 2 Day 1 Day 2 Day 1 Day 2

−

−

−

−

−

−

1DF

−

+

−

−

−

+

2DF

−

+

−

+

+

3DF

+

+

+

4DF

+

+

+

2a

1186

−

−

−

−

−

−

1DF

−

+

−

+

−

+

2DF

−

+

−

+

−

3DF

+

+

+

4DF

+

+

+

2b

AgNO3

1125

3176

−

+

−

+

+

1DF

+

+

+

2DF

+

+

+

3DF

+

+

+

4DF

+

+

+

DF: dilution factor (1 mL); growth (+); no growth (−).
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I.8 SILVER COMPLEXES CONTAINING PHOSPHINE
I.8.1 Silver Phosphine Complexes exhibiting Biological Activity
Three novel silver(I) complexes consisting of both hard Lewis bases (O and N atoms)
and one soft Lewis base (P atom) ((DL-a-alaninato)(triphenylphosphine)silver(I) (1),
(DL-asparaginato)(triphenylphosphine)silver(I) (2) and
(Lasparaginato)(triphenylphosphine)silver(I) (3)) were prepared from stoichiometric
reactions of amino acid–silver(I) complexes with PPh3 in a 1:1 molar ratio in a mixed
organic solvent.
The antimicrobial activities of the silver (I) complexes {[Ag(dl-ala)(PPh3)]2 · 2H2O},
{[Ag(dl-asn)(PPh3)]2 · 2EtOH · 2H2O},{[Ag(l-asn)(PPh3)]2 · 2EtOH · H2O}are listed in
Table 4.50 Water-insoluble Ag2O showed modest activity against two bacteria, whereas
the aqueous Ag+ ion in AgNO3 solution, showed effective activity against Gramnegative
bacteria (Escherichia coli and Pseudomonas aeruginosa), modest activity against
Grampositive bacteria (Bacillus subtilis), and no activity against yeasts and moulds.
Complex {[Ag(dl-ala)(PPh3)]2 · 2H2O}showed moderate antimicrobial activities against
the selected bacterium (Staphylococcus aureus), and modest antimicrobial activities
against bacteria (E. coli, B. subtilis and P. aeruginosa) and yeasts (Candida albicans
and Saccharomyces cerevisiae); however, its effectiveness was less than that of (DLalaninato) silver(I). Complexes {[Ag(DL-asn)(PPh3)]2 · 2EtOH · 2H2O}, and {[Ag(lasn)(PPh3)]2 · 2EtOH · H2O}showed favourable antimicrobial activities against four
selected bacteria and moderate to modest activities against two selected yeasts. The
MIC values of complexes 2 and 3 are comparable to those of the precursors, except for
moulds. These results support the conclusion that the number of coordinating PPh3
ligands per silver(I) atom in the complexes significantly influences the antimicrobial
activities and presumably the ligand-exchangeability of the silver (I) complexes.

33

Table 4: Antimicrobial activities of silver(I) complexes 1–3 evaluated by using
minimum inhibitory concentration (MIC; µg/ml)50
{[Ag(DLala)(PPh3)]2.
2H2O} (1)

{[Ag(DLasn)(PPh3)]2
2EtOH. 2H2O} (2)

{[Ag(Lasn)(PPh3)]2
2EtOH. H2O} (3)

Escherichia coli

125

62.5

31.3

Bacillus subtilis

125

31.3

15.7

Staphylococcus aureus

62.5

62.5

62.5

Pseudomonas aeruginosa

500

125

62.5

Candida albicans

500

250

62.5

Saccharomyces cerevisiae

500

125

31.3

Aspergillus niger

>1000

>1000

125

Penicillium citrinum

1000

>1000

125

Organism

Antibacterial

and

antifungal

activities

of

[Ag(tetz)]n,

[Ag(tetz)(PPh3)2]n,

[Au(tetz)(PPh3)] and the free ligand Htetz (where Htetz= tetrazole), were evaluated by
MIC.51
Antimicrobial activity of the complex [Ag(tetz)(PPh3)2]n was estimated as >1000 μg
ml−1 for bacteria, yeast and mould, showing no activity. The free Htetz ligand and
complex [Au(tetz)(PPh3)] showed only poor activities against Grampositive bacteria (B.
subtilis, S. aureus). On the other hand, the precursor [Ag(tetz)]n has shown effective
activities against Grampositive and negative bacteria, and yeast, but no activities against
mould. These facts are consistent with the recently observed results; the polymeric
silver (I) complexes without a PPh3 ligand such as [Ag(im)]n] (im=imidazole), [Ag(1,triz)]n(triz= triazole) and [Ag(1,2,4-triz)]n have shown effective antimicrobial activities,
while almost all of their triphenylphosphine derivatives such as [Ag(im)(PPh3)3], have
shown no activity (>1000 μgml−1). These facts have been attributed to the restricted
ligand exchange ability of the Ag---P bonding complexes. From a viewpoint of metalbased drug design, no activity of the PPh3 derivatives is also crucial.
In 2003, Tao WuF et al52 synthesized a novel trinuclear silver (I)- triphenylphosphine
complex with nitrogen-containing hetrocyclic ligand benzimidazole (Hbim). [Ag3(μ34

bim)3(PPh3)5], was synthesized by the reaction of the precursor complex [Ag(bim)]n
with two equivalents of PPh3 in dichloromethane. The complex has been identified by
IR, UV/VIS, EA, and X-ray diffraction crystallography. Three silver ions are bridged by
three bim- ligands to form an asymmetric twelve–membered ring structure with rare
twisted conformation (Figure 20). Each silver (I) ion occupied a three- or four coordination environment bound to one or two triphenylphosphine(s).

Figure 20: Molecular structure of [Ag3(μ-bim)3(PPh3)5] 51
In 2005 Li et al53 reported four new luminescent silver(I) sulfonate complexes with
PPh3, namely Ag(L1)(PPh3)2, Ag(L2)(PPh3)3, g2(L3)(PPh3)4(H2O)].1.5CH3CN.0.5H2O
and

[Ag4(L4)(PPh3)10].8H2O,

where

L1=

p-toluenesulfonate,

L2=

1-

naphthalenesulfonate, L3= 3-carboxylate- 4- hydroxybenzenesulfonate,L4= 1, 3,6, 8pyrenetetrasulfonate (structure of L1-L4 shown in Figure 21) and PPh3=
triphenylphosphine. The crystal structures were determined by single crystal X-ray
diffraction method. The complexes adopt discrete structures (Figure 22-25) rather than
polymeric

structures.

mononuclear

structure

Compounds
while

Ag(L1)(PPh3)2,

and

Ag(L2)(PPh3)3

show

Ag2(L3)(PPh3)4(H2O)].1.5CH3CN.0.5H2O

and

[Ag4(L4)(PPh3)10].8H2O are dinuclear and tetranuclear molecules, respectively.
Moreover the numbers of PPh3 molecules coordinating to one silver center are two or
three.
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Figure 21: The structures of the sulfonate ligands53

Figure 22: Molecular structure of [Ag(L1)(PPh3)2] 53
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Figure 23: Molecular structure of [Ag(L2)(PPh3)3]53

Figure 24: Molecular structure of [Ag2L3(PPh3)4(H2O)].1.5CH3CN.0.5H2O53
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Figure 25: Molecular structure of [AgL4(PPh3)10].8.H2O53
In

2005

Noguchi

et

al54

reported

a

novel

tetranuclear

silver(I)

cluster,

[Ag2(Himdc)(PPh3)2]2 (H3imdc = imidazole-4-5-dicarboxylic acid) which was obtained
by a reaction of the Ag-O bonding precussor [Ag(R-Hpyrrld)]2 (H2pyrrld= 2pyrrolidone-5-carboxylic acid), PPh3 and H3imdc. The mononuclear complex,
[Ag(H2imdc)PPh3)2] , was also formed by the reactions using increased amounts of
PPh3 . In the solid state, the complex [Ag2(Himdc)(PPh3)2]2 was “bivalve”- like the Ag4
cluster (Figure 26), while complex [Ag(H2imdc)PPh3)2] (Figure 27) showed a
supramolecular arrangement of 4-coordinate AgP2(N2O) unit via an intermolecular
hydrogen bonding interaction.
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Figure 26: Molecular structure of [Ag2(Himdc)(PPh3)2]254

Figure 27: Crystal and molecular structure of [Ag(H2imdc)PPh3)2]254
In 2008 Ardizzoia et al55 reported the crystal structure of a compound composed of
dimers of [Ag(H2L1)(PPh3)]2 formula lying on a crystallographic twofold axis, the
asymmetric unit being composed by one silver (I) ion, one H2L1 and one PPh3 ligand
(Figure 28). Each metal centre possesses a slightly distorted trigonal stereochemistry
and is coordinated to two triazole nitrogen atoms of two distinct H2L1 moieties and to
the phosphorous atom of one phosphine ligand. The two H2L1 ligands, acting in the
N,N′-exobidentate mode, bridge metal centres 3.72 Å apart, and form dimers in which
the six-membered rings composed by the four coordinated nitrogen atoms and the two
silver (I) centres adopt a boat-shape disposition. The oxygen atoms of the –OH groups
are not involved in the coordination to the metal centres, as expected for a metal with
soft nature like Ag(I). Nevertheless, intermolecular hydrogen bonds of moderate
strength (H–D A 2.63 Å) are present between the hydroxy groups and the
neighbouring iminic nitrogen atoms.
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Figure 28: The structure of [Ag(H2L2)(PPh3)]2 55
In

2008,

Zhang

et

al56

reported

the

X-ray

single

crystal

structure

of

[(Ph3PAgO3SCH3)4·4CH2Cl2] (Figure 29) and [(Ph3P)2AgO3SCH3·CH2Cl2]. Because of
the different molar ratio of triphenylphosphine with silver methylsulofonate, the
complex [(Ph3P)2AgO3SCH3·CH2Cl2] is a monomer (Figure 30) with each silver atom
coordinated by two PPh3 groups. Complex [(Ph3PAgO3SCH3)4 · 4CH2Cl2], however, is
a tetramer with the silver atom coordinated by one PPh3 group.
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Figure 29: Crystal structure of [(Ph3PAgO3SCH3)4·4CH2Cl2] 56

Figure 30: Crystal structure of [(Ph3P)2AgO3SCH3·CH2Cl2]56
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I.9 METAL CARBOXYLATE CHEMISTRY
I.9.1 Coordination modes of monocarboxylic acids
Carboxylates serve as an important class of ligand in inorganic and bioinorganic
chemistry.57 The versatility of the RCO2- ligand is attributed to the wide range of
coordination modes that it can adopt. The coordination chemistry of monocarboxylic
acids is well established, and a large number of carboxylate complexes have been
structurally characterized. In metal carboxylates the positively charged metal centres
(Mn+) are found in combination with negatively charged carboxylate groups (RCO2-),
and the bonding between the metals and the carboxylate group ranges from ionic to
polar covalent. For a given type of compound (i.e. a given metal, oxidation state and
structural type) a wide variety of physical and chemical properties can be conferred by
varying the nature of the R group.
The carboxylate functional group has four lone pairs of electrons available for metal
binding. These lone pairs subtend to an angle of 120o and are referred to as the syn- and
anti-lone pairs (Figure 31). On the basis of stereoelectronic arguments it has been
suggested that the syn-lone pairs are more basic than those in the anti position.
.. anti
O:
R

syn

C
:
O
..
anti

Figure 31: The carboxylate functional group57
The various coordination modes of the RCO2- ligand are listed below:
(i) Ionic. The carboxylate salts of Na, K, Rb, and Cs have been shown to be ionic, with
only coulombic interactions between the metal and the carboxylate ions.
(ii) Monodentate. In lithium acetate the metal is coordinated to one of the carboxylate
oxygens.
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(iii) Bidentate Chelating. Carboxylates may chelate either in a symmetrical mode, with
both metal-oxygen bonds being of equal length, or in the asymmetrical mode (Figure
32(d)) where one metal-oxygen bond is shorter than the other. In zinc(II) acetate
dihydrate the bonding mode of the acetate is symmetrical bidentate chelating, while in
the mixed-ligand complex [Zn(phen)2(O2CCH3)][ClO4] it is asymmetrical bidentate
chelating. It has been found that the “bite angle” (i.e. the O-M-O angle) for a chelating
carboxylate is ca. 60o which, being fairly small, distorts the octahedral geometry of
many metal complexes.
(iv) Bidentate Bridging. The planar carboxylate ion is ideally suited to the formation of
complexes in which the carboxylate bridges two metal atoms (Figure 32(e-g)). The
syn-syn mode is of particular interest since it is the type of bridging observed in the
“lantern shaped” (paddlewheel) bimetallic carboxylates such as copper(II) acetate
dihydrate. The syn-syn coordination mode is the only one which allows the ligand to
bridge the short metal-metal bonds found in these binuclear complexes. Several
binuclear ruthenium complexes57 have carboxylate bridges in which the anti-anti mode
of binding is found.
(v) Monodentate Terminal Bridging. This is one of the rarer binding modes (Figure
33(h)) and it has been suggested to be important biologically, and it is thought to act as
an intermediate between other carboxylate bridging modes.58
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Figure 32: Coordination modes of monocarboxylic acids58

I.9.2 Coordination modes of dicarboxylic acids
Dicarboxylic acids contain two -CO2- functional groups, both of which can coordinate
to a metal centre. This class of ligand can generate a myriad of structural motifs and has
been chosen for this project to promote variation in structure and nuclearity. The
unique versatility in the range of binding modes that dicarboxylic acids can adopt are
broadly divided into three classes (Figure 32).59
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(i) Unidentate. The simple dibasic acid, ethanedioic acid (H2OCCO2H) behaves as a
unidentate ligand in the octahedral cobalt(III) complex [Co(en)2(X)(O2CCO2)] (en =
ethylenediamine; X = OH- or halide).
(ii) Chelating.

The dicarboxylic acid group can chelate to the metal centre in a

symmetrical or asymmetrical fashion, in which only one of the carboxylate groups is
used for coordination. Small dibasic acids can utilise the close proximity of the two
RCO2- groups to act as chelating ligands where only one carboxylate oxygen from each
of the RCO2- groups binds the metal centre. An example in which the latter type of
diacid

coordination

is

present

is

the

ethanedioic

dicopper(II,II)

complex

[tmen(H2O)Cu(O2CCO2)Cu(H2O)tmen](ClO4)2(tmen=1,1,4,4tetramethylethylenediamin
e)

O-

O
C (R) C

M
O

O
(a) unidentate
O-

O
C (R) C

M

O
O
(b) symmetrical (or asymmetrical)
using one carboxylate function
O

O
C (R) C
O

O
M

(R = alkyl, aryl)

(c) chelation using both carboxylate functional
Figure 33: Unidentate and chelating coordination modes for dicarboxylic acids.59
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(iii) Bridging (Figure 34). This mode of binding is divided into three categories
depending on the number of oxygen atoms that are complexed to the metal centre(s);
bidentate (bridging via two oxygen atoms), tridentate (bridging via three oxygen atoms),
and tetradentate (bridging via four oxygen atoms).
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Figure 34: Mode of binding of dicarboxylate ligands59

I.9.3 Infra-red spectra of carboxylate complexes
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Infrared spectroscopy is a useful tool for assigning structural detail to carboxylate
complexes. Upon complexation to a metal centre the C=O absorption band of the -CO2H
group in the free acid disappears, and two new bands relating to the antisymmetric
(OCOasym) and symmetric (OCOsym) stretch appear around 1630-1585 cm-1 and 13551330 cm-1, respectively. The magnitude of separation between these two bands (OCO
cm-1) has been used as a diagnostic aid in the determination of the nature of the
carboxylate coordination. OCO = (OCOasym - OCOsym) cm-1.
Deacon and Phillips60 compiled guidelines for diagnosing the type of carboxylate
coordination based on a metal complex’s infra-red spectrum. Their findings were based
on spectral data obtained for eighty four complexed acetates and halogenoacetates, and
are summarised below:
(i) Ionic acetates, such as those of the alkali metals, have OCO values of ca. 165 cm-1.
For ionic trifluoroacetates the OCO value was ca. 235 cm-1.
(ii) OCO values < 105 cm-1 indicated symmetric chelating carboxylate coordination.
Complexes in which the carboxylates bridge short metal-metal bonds may also show
such low values.
(iii) OCO values substantially less than the ionic values (i.e. < 150 cm-1 for acetates)
indicate the presence of chelating or bridging carboxylate. Unidentate carboxylates
which are strongly hydrogen-bonded (“pseudo-bridging”) may also fall into this
category.
(iv) For complexes with OCO values similar to those for ionic carboxylates the
assignments were counted as untrustworthy. Deacon and Phillips found many examples
of each type of coordination mode (except for symmetric chelating) in this category.
(v) Unidentate coordination was suggested for complexes where the OCO value was
substantially greater than those for the ionic carboxylates (i.e. > 200 cm-1 for acetates)
An explanation for this difference in energy may be that the bonding of one oxygen to a
metal, with the other oxygen free, increases the energy of the antisymmetric stretching
mode.The above observations are summarised in Table 5. For a variety of reasons there
can be many contradictions in the OCO proposed band assignments. For example anion
exchange from the alkali halide infra-red discs can occur, and there can also be
uncertainties in locating exactly the OCOsym stretching band.
Table 5: Infra-red spectral data (OCO) for coordinated acetate ligands61
48

OCO(CH3CO2-) (cm-1)

Coordination mode

< 105

symmetric chelating or short bridging

< 150

chelating or bridging

ca. 165

untrustworthy assignments

> 200

Unidentate

Caution should be applied to using these estimates as phenomena such as hydrogen
bonding can significantly distort the OCO values.

I.10 SILVER(I) CARBOXYLATE COMPLEXES

I.10.1 Silver(I) carboxylate complexes
In the solid state, silver(I) carboxylates mostly form bridged dimers as in
[Ag2(OOCC6H5)2].62 They also exhibit aggregation of these dimers into a ladder
forming a polymeric network. Their poor solubility and light-sensitivity make their
structural characterization difficult.

I.10.2 Silver(I) carboxylate complexes with tertiary Phosphines
Reactions of silver(I) carboxylates with tertiary phosphines such as triphenylphosphine
can lead to complexes which contain monodentate, bridging or chelating carboxylate
ligands62 and the number of phosphines attached to the silver can vary from one to three
(Figure 35).
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(a) Monodentate carboxylate

(b) Bridging carboxylate
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(c) Chelating carboxylate
Figure 35: The structures of [Ag(OOCC2F5){(PPh3)3}] (a), [Ag(OOCC2F5)(PPh3)]2 (b)
and [Ag(OOC(CH2)16CH3)(PPh3)2] (c)62
In 2005 Han et al63 reported a series of triphenylphosphine co-ordinated silver α,βunsaturated

carboxylates

of

type

[Ag(O2CR)(PPh3)n:n=1,

R=CH3CH=CH(2a),

(CH3)2C=CH(2b), CH3CH2CH=CH(2c), CH3CH2CH2CH=CH(2d), PhCH=CH(2e),
CH2=CH(2f),

n=2,

CH3CH=CH(3a),

(CH3)2C=CH(3b),

CH3CH2CH=CH(3c),

CH3CH2CH2CH=CH(3d) were prepared by reaction of relative silver carboxylates (1a1f) with triphenylphosphine in chloroform. These complexes were obtained in high
yields and characterised by elemental analysis, 1H NMR,

13

C NMR,

31

P NMR and IR

spectroscopy. The molecular structure of [Ag((O2CCH=C(CH3)2))(PPh3)2] (3b) (Figure
36,37) shows that the senecioato ligand is chelated to the silver atom and generates, a
distorted tetrahedron. Complex 3b exists as a monomer in crystal structure. The Silver
atom is bonded to two oxygen atoms of the carboxyl at the same time. The angle P1Ag1-P2 is 130.62o. The angle of P1-Ag1-P2 is much more than the expected value of
ideal tetrahedron geometry. This is due to the presence of six phenyl groups, which
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creates

a

relatively

more

crowded

environment

around

silver.

`
Figure 36: The crystal structure of [Ag((O2CCH=C(CH3)2))(PPh3)2]63
The use of smaller phosphines such as PMe3 leads to the formation of polymeric chain
structures such as that of [Ag(OOCC2F5)(PMe3)]n

Figure 37: The chain-like structure of [Ag(OOCC2F5)(PMe3)]n62

I.10.3 Silver(I) carboxylate complexes with diphosphines
Diphosphines effectively stabilize Ag(I) carboxylate complexes through possible
chelate and bridge binding, a feature which makes them attractive for generating
52

possible silver-based antimicrobial agents. These ligands stabilize silver(I) in its
tetrahedral and trigonal planar geometries, and influence the nuclearity of the
complexes. In comparison to monophosphines more complicated dinuclear, tetranuclear
or polynuclear structures are observed. The Ag(I) carboxylate complexes with
diphenylphosphinoferrocene (dppf) illustrate the variability of carboxylate bonding and
nuclearity that can be achieved by this type of ligand when the type of carboxylate is
varied (Figure 38) .

(a) Carboxylate = formate

Figure 38:

(b) Carboxylate = benzoate

(c) Carboxylate = acetate

The variation

[Ag(OOCCH)2(dppf)3].2CH2Cl2 (a)

in structures of

[Ag2(OOCC6H5)2(μ-dppf)] (b) and [Ag4(OOCCH3)4(dppf)2] (c)62
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The versatility of carboxylates when used in conjunction with diphosphine ligands is
also demonstrated for the stable diphenylphosphinomethane (dppm) complexes shown
in Figure 39.

(a) carboxylate = acetate

(b) carboxylate = acetate

(c) carboxylate = pentaflouroacetate
Figure 39: The variation

in structures of

[Ag4(OOCCH3)4{(μ-dppm)2].2H2O (a)

[Ag2(OOCCH3)2{(μ-dppm)2]. 2CHCl3 (b) and [Ag4(OOCC2H5)4{(μ-dppm)2] (c)62

I.10.4 Silver(I) dicarboxylate complexes with phosphines
Silver(I) dicarboxylate complexes with phosphine ligands are relatively scarce.63 It has
been proposed that silver(I) dicarboxylates form complexes with triphenylphosphines in
which two silver atoms are bridged by the dicarboxylate ligand and each metal either
has two or three phosphine attached to them (Figure40,41).64
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Figure 40: The proposed structure of silver(I)dicarboxylate triphenylphosphine
complexes.64

Figure 41: Structure of [Cu2(terph)(PPh3)4] (terphH2 = terephthalic acid).65
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RATIONALE
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Silver(I) salts and simple silver(I) complexes are generally excellent antimicrobial
agents. However it can be difficult to control the rate of silver ion release from these
systems and they are often indiscriminate antimicrobials. A further problem arises from
the fact that generally they are not photostable. The purpose of this study was to
generate a series of light stable silver complexes as potential antimicrobial agents. The
strategy employed the use of the aliphatic α, ω-dicarboxylic acids HOOC-(CH2)nCOOH (where n = 1-11) as primary ligands and counter ions with the intention of
generating a series of novel compounds capable of releasing silver ions. These versatile
dicarboxylate ligands have previously been shown, in this laboratory, to promote
variations in structure and nuclearity (chain length dependent) when employed to make
copper(II), manganese(II) and cobalt(II) complexes in the presence of auxiliary nitrogen
donor ligands.66 Because of the known instability of silver(I) carboxylate complexes the
neutral donor phosphines PPh3, dppm and dppe were employed as auxiliary ligands, as
they are known to stabilize Ag (I) complexes and modify their silver ion release
capabilities. It was hoped that the series of complexes generated using this approach
would be stable, exhibit variation in structure and antimicrobial properties and that
some interesting lead compounds with potential applications as novel antimicrobials
would be identified.
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DISCUSSION
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D.1 SYNTHESIS AND CHARACTERISATION OF SILVER (I)
DICARBOXYLATE COMPLEXES
The synthetic route to the silver dicarboxylate complexes [Ag2(prda)] (1), [Ag2(bda)]
(2), [Ag2(pda)] (3), [Ag2(hxda)] (4), [Ag2(hpda)](5), [Ag2(oda)] (6), [Ag2(nda)] (7),
[Ag2(dda)] (8), [Ag2(udda)] (9), [Ag2(ddda)] (10) and [Ag2(uddca)] (11) is shown in
Scheme 1. The 11 complexes were generated by the reaction of [Ag(CH3COO)] with
the relevant dicarboxylic acid.
HOOC-(CH2)n-COOH
Reflux
2.5hrs

+

2[Ag(CH3COO)]

Toluene
30ml

AgOOC-(CH2)n-COOAg

+ CH3COOH

n =1-11
Scheme 1: The synthetic route to the silver dicarboxylate complexes
The reaction was facilitated by removal of the condenser which removed the acetic acid
byproduct and essentially drove the reaction forward.
Complex 1-11 were obtained as off-white powders. They were formulated as shown
below in Table 6.
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Table 6: Elementary Analysis of complexes 1-11
Elementary Analysis
Complex

% Calculated

% Found

C

H

C

H

[Ag2(prda)]

(1)

11.34

0.63

11.32

0.64

[Ag2(bda)]

(2)

14.48

1.22

14.22

1.68

[Ag2(pda)]

(3)

17.36

1.75

17.22

1.6

[Ag2(hxda)]

(4)

20.03

2.24

20.59

2.16

[Ag2(hpda)]

(5)

22.49

2.7

22.43

2.26

Ag2(oda)]

(6)

24.77

3.12

24.27

3.17

[Ag2[(nda)]

(7)

26.89

3.51

26.39

3.01

[Ag2(dda)]

(8)

28.87

3.88

28.11

3.5

[Ag2(udda)]

(9)

28.87

3.66

28.34

3.84

[Ag2(ddda)]

(10)

32.46

4.54

32.22

4.94

[Ag2(uddca)] (11)

34.09

4.84

34.44

4.77
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Table 7: Characteristic IR bands (cm-1, KBr discs) of the complexes 1– 11
(1)

(2)

(3)

(4)

(5)

(6)

(7)

*

*

2959

2925

2932

2930

2934

ν(asym)(OCO)

1570

1566

1569

1564

1564

1566

1567

1567

ν(sym)(OCO)

1356

1410

1400

1409

1407

1410

1408

∆OCO

214

156

169

155

157

156

159

ν(C-H)aliphatic

(8)

(10)

(11)

2918

2848

1585

1568

1562

1408

1408

1409

1409

159

177

159

153

2930,2851

(9)
2930,2913,2846

Carboxylate band

* Bands precluded by others in the infrared spectrum.
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The IR spectra of complexes 1-11 are shown in the Appendix 1. Complexes 1-11 all
have very similar IR spectra (Table 7) reflecting similar structural characteristics of this
family of complexes. The important feature of the IR spectra of these complexes is the
presence of the νasym(OCO) and νsym(OCO) bands which are indicative of the presence
of the carboxylate ligand (Table 7). These bands are not split and therefore it is most
likely that the two carboxylate groups are bound to the silver centres in the same mode
for each dicarboxylate ligand. The ∆OCO values for all complexes (153-214 cm-1) are
indicative of carboxylate groups bound to a metal centre in a monodentate coordination
mode.60 The presence of bands in the 2000-2950 cm-1 of the IR spectra for these
complexes further supports the presence of the dicarboxylate ligands and the increasing
intensity of these bands results from the increase in fatty nature of the dicarboxylate
ligands as the molecular weight of the ligands increases.
It is worth noting that early attempts to generate complexes 1-11 via the ligand
exchange reaction between the diacids and the silver acetate (Scheme 1) yielded
colourless powders which were difficult to formulate and had IR spectra that exhibited ν
asym(OCO)

and ν

sym(OCO)

groups that were split. Furthermore, the IR spectrum of

silver acetate (Appendix1) is very similar to the spectra of complexes 1-11 in the
carboxylate region. It transpired that these early products were mixtures of
dicarboxylate and acetate silver salts and it was discovered that the critical element in
the protocol for achieving pure samples of 1-11 was the removal of the condenser
periodically during the reaction process. This allowed excess acetic acid to evolve out of
the reaction vessel and yielded pure products.
Complexes 1-11 were found to have very limited solubility in the organic solvents. All
attempts to obtain NMR spectra and conductivity of the complexes were unsuccessful
due to the insolubility of the compounds.
A proposed structure that fits the physico-chemical properties of the complexes 1-11 is
shown in Figure 42.
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Ag O
O

O
C (CH2)n C

O Ag

n= 1-11

Figure 42: A proposed structure of the complexes 1-11
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D.2 SYNTHESIS AND CHARACTERISATION OF SILVER (I)
DICARBOXYLATE COMPLEXES WITH TRIPHENYLPHOSPHINE (PPh3)
LIGAND
Complexes 1-11 were reacted with PPh3 in 1:2.5, 1:4 and 1:6 molar ratios.
The synthetic route to the silver dicarboxylate triphenylphosphine complexes
[Ag2(prda)(PPh3)3] (12), [Ag2(bda)(PPh3)3].C7H8 (13), [Ag2(pda)(PPh3)3].2H2O (14),
[Ag(hxdaH)(PPh3)2]

(15){Ag(hpdaH)(PPh3)3.2H2O

}n(16),{Ag2(oda)(PPh3)3.2H2O}n

(17), [Ag(ndaH)(PPh3)2](18), [Ag2(dda)(PPh3)4].2C7H8(19), [Ag2(udda)(PPh3)2] (20),
[Ag(ddda)(PPh3)3] (21) and [Ag(uddcaH)(PPh3)2] (22) is shown in Scheme 2. Complex
12-22 resulted from the reaction of the relevant Ag(I) dicarboxylate salt with 2.5
equivalents of PPh3 as shown in Scheme 2.
[Ag2(OOC-(CH2)n-COO)]

+

2.5PPh3

Reflux Toluene
2.5hrs 30ml

[Agx(OOC-(CH2)n-COOHy)(PPh3)z]
n=1-11

x = 1or 2, y = 0 or 1 and z = 2 – 4
Scheme 2: The synthetic route to the silver dicarboxylate triphenylphosphine complexes
Complex 12 to 21 were obtained as off-white powders. Complex 22 was obtained as
colourless crystals. They were formulated as shown below in Table 8.
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Table 8: Elementary Analysis of complexes 12 to 22
Elementary Analysis
Complex

% Calculated

% Found

C

H

P

C

H

[Ag(prdaH)(PPh3)2].C7H8 (12)

63.69

4.52

8.42

64.49

4.61

[Ag2(bda)(PPh3)3].C7H8 (13)

64.48

4.74

7.67

64.98

[Ag2(pda)(PPh3)3].2H2O (14)

60.63

4.74

7.95

60.51

4.43

[Ag2(hxda)(PPh3)2] (15)

57.04

4.33

7.00

57.04

4.30

6.43

[Ag2(hpda)(PPh3)2].2H2O (16)

61.12

5.13

7.75

61.60

4.87

7.27

{[Ag2(oda)(PPh3)3].2H2O}n (17)

61.40

5.24

7.66

61.02

5.07

7.44

[Ag(ndaH)PPh3)2] (18)

65.94

5.53

7.56

66.95

5.16

8.50

[Ag2(dda)(PPh3)4].2C7H8 (19)

69.82

5.74

7.50

69.23

5.21

7.58

[Ag2(udda)(PPh3)2] (20)

59.01

5.27

6.48

59.46

5.00

6.63

[Ag2(ddda)(PPh3)3] (21)

64.40

5.33

7.55

64.55

5.53

7.43

[Ag(uddcaH)(PPh3)2] (22)

67.20

6.10

7.07

66.83

6.02

7.31

4.98

P
7.22
7.89
7.86

Complexes 12-22 formulate in three categories (i) {Ag2(O2C-(CH2)nCO2)(PPh3)3}n ;
(ii)[Ag(O2C-(CH2)n-COOH)(PPh3)2];

and

(iii)

{Ag2(O2C-(CH2)n-CO2(PPh3)4}n.

Complexes 12, 13, 14, 17 and 21 fall into category (i), complexs 15, 16, 18 and 22 fall
into category (ii) and complexes 19 and 20 formulate as shown in category (iii).
Furthermore, early attempts to react the PPh3 with complex 1-11 in a 2.5 : 1 ratio were
flawed as a result of using the mixtures of [Ag(CH3COO)] and [Ag2(dicarboxylate)]
inadvertently. This point was demonstrated when crystals from the intial reaction of 2.5
PPh3 and what was believed to be [Ag2(O2C-(CH2)5-CO2)] were isolated. These turned
out to be a co-crystallised product ( ie 2 complexes present in one crystal lattice). The
crystal

comprised

two

components

[Ag(PPh3)2(CH3COO)]

and

{Ag(hpdaH)(PPh3)2}n.These structures are shown in Figures 43, 44 and 45 and selected
bond lengths and angles for them are listed in Tables 9 and 10.
The [Ag(PPh3)2(CH3COO)] (Figure 44) component is reasonably well-behaved and
does not show any very striking interactions with the other species present (though there
are many weak interactions involving the phenyl groups- see (Figure 45). The other
silver species forms a {Ag(PPh3)2(OOC(CH2)5COOH)}n polymeric chain running
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parallel to the b axis in which the silver ions are bridged by OOC(CH2)5COOH anions,
Figure 45. This link is reinforced by H-bonding between the chains. There is some
disorder in this component – in which the silver ion and one of the PPh3 groups take up
alternate positions.67 Since the minor component is quite small (estimated 15%) only the
Ag and P positions have been modelled. A second data set shows this disorder more
clearly.The toluene solvate is disordered and modelled with equal occupancy of two
overlapping sites.

Figure 43: Structure of the [Ag(PPh3)2(CH3COO)] component of the co-crystallised
product from the reaction of impure [Ag2(hpda)] complex with PPh3
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Figure 44: The polymeric structure of {Ag(hpdaH)(PPh3)2}n component of the cocrystallised product from the reaction of the impure [Ag2(hpda)] complex with PPh3

Figure 45: Packing diagram for the co-crystallised
[Ag(PPh3)2(CH3COO)]/{Ag(hpdaH)(PPh3)2}n product.
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Table 9: Selected bond lengths [Å] and angles [] around the silver centres in
[Ag(PPh3)2(OAc)] component of the co-crystallised product from the
reaction of impure [Ag2(hpda)] complex with PPh3

Complex (16A)
Bond lengths Å
Ag(1)-O(2)

2.417(2)

Ag(1)-P(2)

2.4232(8)

Ag(1)-P(1)

2.4394(8)

Ag(1)-O(1)

2.441(2)

Bond angles 
O(2)-Ag(1)-P(2)

115.91(6)

O(2)-Ag(1)-P(1)

105.10(6)

P(2)-Ag(1)-P(1)

129.58(3)

O(2)-Ag(1)-O(1)

53.99(7)

P(2)-Ag(1)-O(1)

112.18(6)

P(1)-Ag(1)-O(1)

115.34(6)
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Table 10: Selected bond lengths [Å] and angles [] around the silver centres in
the{Ag(hpdaH)(PPh3)2}n1 component of the co-crystallised product from the
reaction of impure [Ag2(hpda)] complex with PPh3

Complex (16)
Bond lengths Å
Ag(1)-O(1)

2.386(9)

Ag(1)-P(1)

2.419(2)

Ag(1)-P(2)

2.4524(19)

Ag(1)-O(3)#1

2.500(9)

Ag(1')-P(2)

2.320(5)

Ag(1')-P(1')

2.530(11)

Bond angles 
O(1)-Ag(1)-P(1)

111.0(3)

O(1)-Ag(1)-P(2)

109.6(2)

P(1)-Ag(1)-P(2)

125.86(7)

O(1)-Ag(1)-O(3)#1

100.4(5)

P(1)-Ag(1)-O(3)#1

110.1(3)

P(2)-Ag(1)-O(3)#1

95.9(2)

When pure [Ag2(hpda)] was reacted with 2.5 equivalents of PPh3 the complex
[Ag2(hpda)(PPh3)2].2H2O 16 was isolated.
Crystals of 17 suitable for X-ray structural analysis were obtained when the mother
liquor was left to stand for several weeks. The structure of 17 is shown in Figures 45
and 46 and selected bond lengths and angles are listed in Table 11.
The polymeric structure results from the bridging nature of the dicarboxylate anions
(Figure 46). The repeating unit comprises two silver ions linked by two oxygen bridges,
Note that the metal ions have different coordination numbers.68 Quite likely some of
this is driven by the packing interactions between the phenyl groups (Figure 47). There
is possibly a weak interaction between Ag2 and the second carboxylate oxygen. The
68

Ag1-Ag2 distance is 3.7254(2) Å. and therefore no significant Ag…..Ag interaction is
found in the complex.

Figure 46: The polymeric structure of {Ag2(oda)(PPh3)3}n (17)
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Figure 47: Packing diagram for {Ag2(oda)(PPh3)3}n (17)
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Table 11: Selected bond lengths [Å] and angles [] around the silver centres in
{Ag2(oda)(PPh3)3}n (17)
Complex 17
Bond lengths Å
Ag(1)-O(1)

2.3214(12)

Ag(1)-P(1)

2.4245(5)

Ag(1)-P(2)

2.4293(4)

Ag(1)-O(3)#1

2.4680(13)

Ag(2)-O(3)#1

2.2205(13)

Ag(2)-O(1)

2.2726(12)

Ag(2)-P(3)

2.3314(4)

Bond angles 
O(1)-Ag(1)-P(1)

112.70(4)

O(1)-Ag(1)-P(2)

113.23(4)

P(1)-Ag(1)-P(2)

129.402(15)

O(1)-Ag(1)-O(3)#1

70.41(4)

P(1)-Ag(1)-O(3)#1

109.53(4)

P(2)-Ag(1)-O(3)#1

104.81(4)

O(3)#1-Ag(2)-O(1)

75.91(4)

O(3)#1-Ag(2)-P(3)

145.61(4)

O(1)-Ag(2)-P(3)

137.50(3)

Crystals of 18 suitable for X-ray structural analysis were obtained when the mother
liquor was left to stand for several weeks. The structure of 18 is shown in Figures 48
and 49 and selected bond lengths and angles are listed in Tables 12 and 13.
The carboxylic acid is mono-deprotonated; the carboxylate end acts as a bidentate
ligand to the silver while the carboxylic acid end is linked to a neighbouring complex by
hydrogen bonding (Figure 49).69 The result is H-bonded chains running through the
structure parallel to the b axis.
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Figure 48: The structure of [Ag(ndaH)(PPh3)2] (18)

Figure 49: Packing diagram for [Ag(ndaH)(PPh3)2] (18)
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Table 12: Selected bond lengths [Å] and angles [] around the silver centres in
[Ag(ndaH)(PPh3)2] (18)
Complex 18
Bond lengths Å
Ag(1)-O(1)

2.3736(14)

Ag(1)-P(2)

2.4255(5)

Ag(1)-P(1)

2.4319(6)

Ag(1)-O(2)

2.5409(15)

Bond angles 
O(1)-Ag(1)-P(2)

109.75(4)

O(1)-Ag(1)-P(1)

114.44(4)

P(2)-Ag(1)-P(1)

131.221(19)

O(1)-Ag(1)-O(2)

53.19(5)

P(2)-Ag(1)-O(2)

118.08(4)

P(1)-Ag(1)-O(2)

104.62(4)

Table 13: Hydrogen bonds for [Ag(ndaH)(PPh3)2] (18)
[Å and °].
______________________________________________________________________
D-H...A

d(D-H)

d(H...A)

d(D...A)

<(DHA)

______________________________________________________________________
O(3)-H(3)...O(2)#1

0.95

1.70

2.627(2)

166.1

______________________________________________________________________
Symmetry transformations used to generate equivalent atoms: #1 x,y+1,z
Crystals of 22 suitable for X-ray structural analysis were obtained when the mother
liquor was left to stand for several weeks. The structure of 22 is shown in Figures 50
and 51 and selected bond lengths and angles are listed in Table 14 and 15.
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Each silver ion is coordinated to two PPh3 ligands and to a bidentate carboxylate group.
The second acid group of the diacid is not deprotonated but hydrogen-bonded to a
neighbouring coordinated carboxylate (under symmetry operation -x+1,-y+1,-z+1).70 This
results in the formation of H-bonded centrosymmetric dimers. There is a slight disorder
in part of the alkyl chain modelled as 90:10 occupancy of two related positions.

Figure 50: The structure of [Ag(uddcaH)(PPh3)2] (22) showing the hydrogen bonding
between molecules
It is worth noting the significant difference in the way the dicarboxylate group behaves
in 22 compared to those in complex 18. The –(CH2)n- chain length in the dicarboxylate
acid has a profound effect on the way the complexes pack into the crystal.
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Figure 51: Packing diagram for [Ag(uddcaH)(PPh3)2] (22)
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Table 14: Selected bond lengths [Å] and angles [] around the silver centres in
[Ag(uddcaH)(PPh3)2] (22)

Complex (22)
Bond lengths Å
Ag(1)-O(1)

2.3697(15)

Ag(1)-P(1)

2.3958(6)

Ag(1)-P(2)

2.4500(6)

1Ag(1)-O(2)

2.5095(16)

Bond angles 
O(1)-Ag(1)-P(1)

124.66(4)

O(1)-Ag(1)-P(2)

103.77(4)

P(1)-Ag(1)-P(2)

129.48(2)

O(1)-Ag(1)-O(2)

53.42(5)

P(1)-Ag(1)-O(2)

122.17(4)

P(2)-Ag(1)-O(2)

96.63(5)

Table 15: Hydrogen bonds for [Ag(uddcaH)(PPh3)2] (22) [Å and °].
______________________________________________________________________
D-H...A

d(D-H)

d(H...A)

d(D...A)

<(DHA)

______________________________________________________________________
O(4)-H(4)...O(1)#1

0.83(3)

1.72(3)

2.553(2)

175(3)

______________________________________________________________________
Symmetry transformations used to generate equivalent atoms: #1 -x+1,-y+1,-z+1
The IR spectra of complexes 12-22 are shown in the Appendix 1.The IR spectral data
that are indicative of the structural features of the complexes 12-22 are shown in Table
14. The spectra of the complexes 13, 14, 15 and 21 are all similar to that of complex 17
and therefore it is likely that they share a similar structure. Complex 12 formulates as
having one Ag, two PPh3 groups and a mono deprotonated dicarboxylic acid ligand and
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the IR spectral data support a structure similar to those of the structurally characterised
complexes 18 and 22.60 Furthermore, the presence of the COOH group in 12, 18 and 22
is supported by C=O stretches in their IR spectra (Table16).
Complexes 19 and 20 formulate as [Ag2(dicarboxylate)(PPh3)4] and the IR spectral
features are the same for both complexes. A structure that fit’s the physico-chemical
properties of 19 and 20 is shown in Figure 52.

O
PPh3

C
Ag

O

O
(CH2)n

Ag

PPh3
PPh3

C
O

PPh3

Figure 52: Possible structure for complexes 19 and 20
Complexes 12-22 were found to have very limited solubility in organic solvents and all
attempts to obtain NMR spectra and the conductivity of the complexes were
unsuccessful.
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Table 16: Characteristic IR bands (cm-1, KBr discs) of the complexes (12)-(22) along with the free ligand
PPh3

(12)

(13)

(14)

(15)

ν (C-H) aromatic

3053

3053

3052

3049

ν (C-H) aliphatic

*

2962,2920

2934

ν (C=O)

1731

*

(16)
3052
2941

(17)
3053
2930,2851

(18)
3053.22
2938

(19)
*
2921

(20)

(21)

(22)

3051

3051

3054

2924,2851

2922

2922

1736

1703

Carboxylate
band

1598

1549

1549

1620

1548

1593

1546

1478

1547

1560

1562

ν (asym)(OCO)

1370

1393

1393

1366

1400

1407

1403

1433

1397

1406

1402

ν (sym)(OCO)

228

156

156

254

148

186

143

45

150

154

160

753.18 745.25

745.26

746.58

748.28

746.56

746

752

745

745

694.60 693.43

693.62

693.08

694.52

693.60

694

693.85

Δ OCO
Phosphine bands
νC-P

744

νasym

692

νsym

745
694.55

695

694

* Bands precluded by others in the infrared spectrum.
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D.3 SYNTHESIS AND CHARACTERISATION OF SILVER (I)
DICARBOXYLATE COMPLEXES WITH TRIPHENYLPHOSPHINE (PPh3)
The synthetic route to the silver dicarboxylate triphenylphosphine complexes
[Ag2(prda)(PPh3)3].H2O (23), [Ag2(bda)(PPh3)4] (24), [Ag2(pda)(PPh3)4] (25),
[Ag(hxda)(PPh3)4] .2H2O(26), [Ag2(hpda)(PPh3)4].C7H8(27),
[Ag2(oda)(PPh3)4].2.C7H8(28), [Ag2(oda)(PPh3)4] (28A), [Ag2(ndaH)(PPh3)4].2H2O
(29), [Ag2(dda)(PPh3)4].H2O (30), [Ag2 (udda) (PPh3)3] (31), [Ag2 (udda)
(PPh3)4](31A), [Ag(ddda)(PPh3)3]n (32) and Ag(PPh3)2(HOOC(CH2)9COO)(33) is
shown in Scheme 3.
Complex 23-33 resulted from the reaction of the relevant Ag(I)dicarboxylate salt with 4
equivalents of PPh3 as shown in Scheme 3

[Ag2(OOC-(CH2)n-COO)]

Reflux
2.5hrs

+

4PPh3

Toluene
30ml

[Agx(OOC-(CH2)n-COOHy)(PPh3)z]
n=1- 11

X=1or2, y = 0 or 1 and z = 2-4
Scheme 3: The synthetic route to the silver dicarboxylate triphenylphosphine complexes
Complex 23 to 33 were obtained as off-white powders. They were formulated as shown
below in Table 17.
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Table 17: Elementary Analysis of complexes 23 to 33
Elementary Analysis
Complex

% Calculated

% Found

C

H

P

C

H

[Ag2(prda)(PPh3)3].H2O (23)

60.98

4.4

8.28

60.95

4.29

[Ag2(bda)(PPh3)4] (24)

66.1

4.67

8.97

66.05

[Ag2(pda)(PPh3)4] (25)

66.3

4.77

8.88

66.96

4.75

8.88

[Ag(hxdaH)(PPh3)4].3H2O (26)

65.88

5.53

8.49

65.22

4.98

8.39

[Ag2(hpda)(PPh3)4].C7H8 (27)

68.17

5.19

8.18

68.72

5.20

8.14

[Ag(odaH)(PPh3)2].C7H8 (28)

68.23

5.73

6.90

69.96

5.43

7.86

[Ag(ndaH)(PPh3)2] (29)

65.94

5.53

7.56

65.59

4.92

8.71

[Ag2(dda)(PPh3)4].H2O (30)

66.41

5.3

8.35

66.05

5.66

8.47

[Ag2 (udda) (PPh3)3] (31)

64.16

5.22

7.64

64.52

5.03

7.69

[Ag2(udda)(PPh3)4] (31A)

67.75

5.61

8.21

67.08

5.92

7.96

[Ag(dddaH)(PPh3)2] (32)

66.90

5.97

7.19

66.38

5.72

8.06

[Ag2(uddca)(PPh3)5] (33)

71.53

5.56

9.15

71.33

5.55

9.10

4.76

P
8.18
8.44

Complexes 23-33 formulate in four categories.
(i)

{Ag2(O2C-(CH2)n-CO2(PPh3)3}n;

(ii)

[Ag(O2C-(CH2)n-CO2H)(PPh3)2];

(iii)

[Ag2(O2C-(CH2)n-CO2)(PPh3)4] and

(iv)

[Ag(O2C-CH2)n-CO2H(PPh3)3]

Complexes 23 and 31 fall into category (i), complex 28, 29 and 33 fall into category (ii),
complexes 24, 25, 27, 30 and 31A fall into category (iii) and complex 26 and 32 fall
into category (iv).
Crystals of 28 suitable for X-ray structural analysis were obtained when the reaction
was carried out in toluene and the mother liquor left to stand for several weeks. The
structure of 28 is shown in Figures 53 and 54 and selected bond lengths and angles are
listed in Table 18 and 19.
H-bonding links the Ag(odaH)(PPh3)2 units into a zig-zag one dimensional chain along
the b direction (O4 ···· O2 2.573(2)Å, under –x, y-½, -z+½).71 One toluene solvate
81

molecule is present for each formula unit and is disordered, it was modelled with 50%
occupancy each of two overlapping sites.
The structure is similar to that of complexes 18 (Figure 48) and 22 (Figure 51) with the
dicarboxylate only singly deprotonated.The deprotonated group is bound to the silver
centre in a chelating mode. The metal is overall four coordinate with the two PPh3
groups completing the ligation around the silver ion. Once again the hydrogen bonding
links individual molecules to their neighbours through out the crystal lattice.

Figure 53: Crystal Structure of [Ag(odaH)(PPh3)2].C7H8 (28)

82

Figure 54: Packing diagram for [Ag(odaH)(PPh3)2].C7H8 (28)
Table 18: Selected bond lengths [Å] and angles [] around the silver centres in
[Ag(odaH)(PPh3)2].C7H8 (28)

Bond lengths Å
Ag(1)-P(1)

2.4187(5)

Ag(1)-P(2)

2.4369(5)

Ag(1)-O(2)

2.4690(16)

Ag(1)-O(1)

2.4760(15)

Bond angles 
P(1)-Ag(1)-P(2)

129.516(19)

P(1)-Ag(1)-O(2)

109.02(5)

P(2)-Ag(1)-O(2)

118.53(5)

P(1)-Ag(1)-O(1)

117.29(4)

P(2)-Ag(1)-O(1)

104.81(4)

O(2)-Ag(1)-O(1)

52.72(5)
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Table 19: Hydrogen bonds for {Ag(oda)(PPh3)2]C7H9}n [Å and °]
______________________________________________________________________
D-H...A

d(D-H)

d(H...A)

d(D...A)

<(DHA)

______________________________________________________________________
O(4)-H(4)...O(2)#1

0.84

1.81

2.573(2)

150.3

______________________________________________________________________
Symmetry transformations used to generate equivalent atoms: #1 -x,y-1/2,-z+1/2
When the mother liquor from the reaction for complex 31 was allowed to stand, crystals
of 31A were obtained after several weeks. 31A and 31 do not formulate the same and
the x-ray crystal structure of 31A revealed it to be [Ag2(udda)(pph3)4]
The structure of 31A is shown in Figures 55 and 56 and selected bond lengths and
angles are listed in Table 20.
The asymmetric unit contains 1½ independent molecules. The [Ag2(PPh3)4(O2C-RCO2)] molecule containing Ag1 and Ag2 has no crystallographically imposed
symmetry, while that containing Ag3 has a crystallographic 2-fold axis passing through
C17 and bisecting the Ag3 ….Ag3A vector.72 Despite this difference, the structures of
the two molecules are similar, in each case two Ag(PPh3)2 units are linked by a
dicarboxylate chain. The carboxylate binds to Ag1 in a reasonably symmetric manner,
but this is not the case for Ag2 or Ag3.
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Asymmetric unit – 1½ molecules

Figure 55: Crystal Structure [Ag2 (udda) (PPh3)4](31A)

Figure 56: Packing diagram for [Ag2 (udda) (PPh3)4] (31A)

85

Complex 31A formulates the same as complexes 19 and 20 and it is likely that they all
share a similar structure.
Table 20: Selected bond lengths [Å] and angles [] around the silver centres in [Ag2
(udda) (PPh3)4] (31A)

Bond lengths Å
Ag(1)-O(1)

2.448(6)

Ag(1)-P(2)

2.4495(18)

Ag(1)-P(1)

2.4535(19)

Ag(1)-O(2)

2.526(6)

Ag(2)-O(3)

2.287(5)

Ag(2)-P(4)
Ag(2)-P(3)

2.4082(19)
2.4425(18)

Ag(2)-O(4)

2.619(6)

Ag(3)-O(5)

2.354(5)

Ag(3)-P(6)

2.4240(18)

Ag(3)-P(5)

2.4547(18)

Ag(3)-O(6)

2.600(5)

Bond angles 
O(1)-Ag(1)-P(2)

107.51(14)

O(1)-Ag(1)-P(1)

125.12(14)

P(2)-Ag(1)-P(1)

123.99(6)

O(1)-Ag(1)-O(2)

52.06(18)

P(2)-Ag(1)-O(2)

123.83(13)

P(1)-Ag(1)-O(2)

104.36(13)

O(3)-Ag(2)-P(4)

120.79(15)

O(3)-Ag(2)-P(3)

107.35(15)

P(4)-Ag(2)-P(3)

131.28(7)
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O(3)-Ag(2)-O(4)

52.04(18)

P(4)-Ag(2)-O(4)

114.09(16)

P(3)-Ag(2)-O(4)

100.47(17)

O(5)-Ag(3)-P(6)

120.92(13)

O(5)-Ag(3)-P(5)

98.71(13)

P(6)-Ag(3)-P(5)

128.95(7)

O(5)-Ag(3)-O(6)

52.69(17)

P(6)-Ag(3)-O(6)

105.58(13)

P(5)-Ag(3)-O(6)

124.53(13)

Crystals of 32 suitable for X-ray structural analysis were obtained when the mother
liquor was left to stand for several weeks. It should be noted that no powder was
obtained from this reaction. The structure of 32 is shown in Figures 57 and 58 and
selected bond lengths and angles are listed in Tables 21 and 22.
H-bonding links the units into a one dimensional chain along the a direction (O4 ···· O2
2.502(2)Å, under x+1, y, z).

Figure 57: Crystal Structure for [Ag(dddaH)(PPh3)3] (32)
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Figure 58: Packing diagram for [Ag(dddaH)(PPh3)3] (32)
The structure of 32 (Figure 58) reveals that the dicarboxylic acid has only singly
deprotonated and that the deprotonated carboxylate group is bound to the silver in a
monodentate fashion. The silver ion is four coordinate with three PPh3 groups
completing the ligation. The tetrahedral silver complexes are hydrogen bonded to
neighbours through the hydroxyl hydrogen of the COOH groups in one molecule and
the uncoordinated carboxylate oxygen (O2A) of another molecule (Figures 59 and 60)
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Table 21: Selected bond lengths [Å] and angles [] around the silver centres in
[Ag(dddaH)(PPh3)3] (32)

Complex (32)
Bond lengths Å
Ag(1)-O(1)

2.3488(13)

Ag(1)-P(2)

2.4792(5)

Ag(1)-P(3)

2.5035(5)

Ag(1)-P(1)

2.5820(5)

Bond angles 
O(1)-Ag(1)-P(2)

109.29(4)

O(1)-Ag(1)-P(3)

107.63(4)

P(2)-Ag(1)-P(3)

119.209(15)

O(1)-Ag(1)-P(1)

90.20(4)

P(2)-Ag(1)-P(1)

116.060(15)

P(3)-Ag(1)-P(1)

110.240(15)

Table 22: Hydrogen bonds for [Ag(dddaH)(PPh3)3] (32)
[Å and °]
______________________________________________________________________
D-H...A

d(D-H)

d(H...A)

d(D...A)

<(DHA)

______________________________________________________________________
O(4)-H(4)...O(2)#1

0.84

1.69

2.502(2)

162.6

______________________________________________________________________
Symmetry transformations used to generate equivalent atoms: #1 x+1,y,z
Crystals of 33 suitable for X-ray structural analysis were obtained when the mother
liquor was left to stand for several weeks. Again no powder was obtained from this
reaction. The structure of 33 is shown in Figures 59 and 60 and selected bond lengths
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and

angles

are

listed

in

Tables

23

and

24.

H-bonds

link

the

Ag(PPh3)2(HOOC(CH2)11COO) units into centrosymmetric dimers (O1-O4A 2.552(2)
Å).(Figure 58)

Figure 59: Crystal Structure for [Ag(uddcaH)(PPh3)2] (33)

Figure 60: Packing diagram for [Ag(uddcaH)(PPh3)2] (33)
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Table 23: Selected bond lengths [Å] and angles [] around the silver centres in
[Ag(uddcaH)(PPh3)2] (33)

Bond lengths Å
Ag(1)-O(1)

2.3675(17)

Ag(1)-P(2)

2.3966(6)

Ag(1)-P(1)

2.4505(6)

Ag(1)-O(2)

2.5114(18)

Bond angles 
O(1)-Ag(1)-P(2)

124.63(4)

O(1)-Ag(1)-P(1)

103.79(4)

P(2)-Ag(1)-P(1)

129.51(2)

O(1)-Ag(1)-O(2)

53.38(6)

P(2)-Ag(1)-O(2)

122.21(5)

P(1)-Ag(1)-O(2)

96.60(5)

Table 24: Hydrogen bonds for [Ag(uddcaH)(PPh3)2] (33)
[Å and °].
______________________________________________________________________
D-H...A

d(D-H)

d(H...A)

d(D...A)

<(DHA)

______________________________________________________________________
O(4)-H(4O)...O(1)#1

0.84

1.72

2.552(2)

173.6

______________________________________________________________________
Symmetry transformations used to generate equivalent atoms: #1 -x+1,-y+1,-z+1
Complex 33 formulates the same as complexes 18 and 22 and has a very similar
hydrogen bonded dimeric structure to that of 22 (Figure 50).
The IR spectra of complex 23-33 are shown in the Appendix 1. The IR spectral data that
are indicative of structural features of complexes 23-33 are shown in Table 25, 26.The
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spectral features of complexes 29 and 33 are similar to those of the structurally
characterized 28 and it is likely they share similar structural features based on
formulation and IR spectral features.60 Complexes 24, 25, 27 and 30 are probably quite
similar to 31A in structure. Complex 26 formulates as [Ag(hxdaH)(PPh3)3].3H2O and its
IR spectrum suggests that it has a similar structure to that of 32. The presence of a C=O
stretch in the IR spectra of complexes 26, 28, 29, 32 and 33 supports the presence of undissociated-COOH groups in their formulae.
Complexes 23 and 31 are unusual as they formulate as [Ag2(dicarboxylate)(PPh3)3]. The
structurally characterized complex 17 has the same formulation and its IR spectrum is
similar to those of 23 and 31. It is possible that 23 and 31 are similar in structure to 17
(Figure 46).
Complexes 23-33 were found to have very limited solubility in organic solvents and all
attempts to obtain NMR spectra and conductivity readings of the complexes were
unsuccessful due to the insolubility of the compounds.
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Table 25: Characteristic IR bands(cm-1, KBr discs) of the complexes (23)-(31) along with the free ligand PPh3
PPh3
ν (C-H)

(23)

(24)

(25)

(26)

(27)

(28)

(29)

(30)

(31)

*

3051

*

3057

3048

*

3053

3051

*

*

*

*

2931

*

aeromatic
ν (C-H)

2921,2851

2931

2921,2850

*

aliphatic
ν (C=O)

1708

1704

1700

*

Carboxylate
band
ν (asym)(OCO)

1546

1542

1548

1555

1546

1547

1551

1479

1557

ν (sym)(OCO)

1317

1386

1391

1395

1394

1399

1389

1283

1384

Δ OCO

229

156

157

160

152

148

162

196

173

Phosphine
bands νC-P
νasym

744

742

743

743

745

747

747

744

752

743

νsym

692

694

694

693

694

693

694

694

694

694

* Bands precluded by others in the infrared spectrum.
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Table 26: Characteristic IR bands (cm-1, KBr discs) of the complexes 31-33 along with
the free ligand
(31A)
(32)
(33)
PPh3
ν (C-H) aeromatic

3052

ν (C-H) aliphatic

2921,2853

ν (C=O)

1717

3052

3054

2923 2922,2851
1703

Carboxylate band
ν (asym)(OCO)

1557

1585

1574

ν (sym)(OCO)

1395

1409

1401

Δ OCO

162

176

173

Phosphine bands
νC-P
νasym

744

743

744

745

νsym

692

694

694

695
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D.4 SYNTHESIS OF SILVER (I) DICARBOXYLATE COMPLEXES WITH
TRIPHENYLPHOSPHINE (PPh3)
Attempts to react complexes 1-11 with PPh3 in a 1:6 ratio yielded the same product as
obtained when 4 equivalents of PPh3 were employed and where the dicarboxylate
ligands were propanedioate (prda), butanedioate (bda), pentanedioate (pda),
nonanedioate (nda) and decanedioate (dda). The synthetic route to the six novel
complexes

[Ag(hxdaH)(PPh3)3].C7H8

(34),

Ag2(hpda)(PPh3)5].C7H8

(35)

[Ag2(oda)(PPh3)5].2C7H8 (36) [Ag2(udda)(PPh3)4] (37), [Ag2(uddca)(PPh3)5] (38),
[Ag2(uddca)(PPh3)6] (38A) is shown in Scheme 4.
[Ag2(OOC-(CH2)n-COO)]

Reflux
2.5hrs

6PPh3

+

Toluene
30ml

[Agx(OOC-(CH2)n-COOHy)(PPh3)2]
where n= 4-6 and 9,11; x= 2; y= 0 or 1 and z= 3-6

Scheme 4: The synthetic route to silver(I) dicarboxylate complexes with
triphenylphosphine.
Compounds 34 to 38 were obtained as white powders and were formulated as shown
below in Table 27.
Table 27: Elementary Analysis of complexes 34 to 38
Elementary Analysis
Complex

% Calculated

% Found

C

H

P

C

H

[Ag(hxdaH)(PPh3)2].C7H8 (34)

64.87

5.06

7.97

64.78

5.13

[Ag2(hpda)(PPh3)5].C7H8 (35)

70.28

5.27

8.71

70.64

[Ag2(oda)(PPh3)4].2C7H8 (36)

69.63

5.47

7.64

69.02

5.44

7.86

[Ag2(udda)(PPh3)4] (37)

67.40

5.32

8.38

67.28

5.27

8.51

[Ag2(uddca)(PPh3)5] C7H8 (38)

70.97

5.69

8.32

70.87

5.57

9.03

5.17

P
7.80
9.67
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When the mother liquor from the reaction for complex 38 was set aside crystals of
[Ag2(uddca)(PPh3)6] 38A deposited after several weeks. These crystals were suitable
for x-ray crystallographic analysis. The structure of 38A is shown in Figures 61 and 62
and selected bond lengths and angles are listed in Table 28.
The structure consists of centrosymmetric dimers linked by a dicarboxylate chain.73 The
chain is disordered and this has been modelled using two overlapping chains of equal
occupancy. The disorder is not resolved by refinement in the lower symmetry space
group.

Figure 61: Crystal Structure of [Ag2(uddca)(PPh3)5].C7H8 38A
The structure of 38A is dinuclear with two pseudo-penta coordinated silver ions. The
carboxylate groups are almost chelating the metal centres with one definite bonding Agoxygen interaction (2.37Å for Ag1-O1) (Table 28).The second oxygen O2 is weakly
bound to the silver with a bonding distance of 3.03 Å (Table 23). The geometry around
each silver is completed by phosphorous atoms from three PPh3 groups. It is most likely
the resultant steric crowding that prevents the carboxylate group from chelating fully to
the silver ions as seen for [Ag2(udda)(PPh3)4] 31A (Figure 55 and Table 20). The
molecules of 38A do not associate by any hydrogen bonding in the crystal (Figure 62)
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Figure 62: Packing diagram for [Ag2(uddca)(PPh3)6] 38A
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Table 28: Selected bond lengths [Å] and angles [] around the silver centres in
[Ag2(uddca)(PPh3)6] 38A

Bond lengths Å
Ag(1)-O(1')#1

2.341(9)

Ag(1)-O(1)

2.370(6)

Ag(1)-P(2)

2.5216(5)

Ag(1)-P(3)

2.5468(5)

Ag(1)-P(1)

2.6753(5)

Ag(1)-O(2)

3.030(5)

Bond angles 
O(1')#1-Ag(1)-O(1)

2.6(4)

O(1')#1-Ag(1)-P(2)

116.7(3)

O(1)-Ag(1)-P(2)

119.10(14)

O(1')#1-Ag(1)-P(3)

110.1(2)

O(1)-Ag(1)-P(3)

108.95(15)

P(2)-Ag(1)-P(3)

116.569(15)

O(1')#1-Ag(1)-P(1)

83.9(2)

O(1)-Ag(1)-P(1)

82.16(9)

P(2)-Ag(1)-P(1)

112.274(15)

P(3)-Ag(1)-P(1)

113.035(15)

O(1')#1-Ag(1)-O(2)

45.6(3)

O(1)-Ag(1)-O(2)

46.76(12)

P(2)-Ag(1)-O(2)
P(3)-Ag(1)-O(2)
P(1)-Ag(1)-O(2)

103.76(9)
80.46(11)
127.66(9)

The IR spectra for complexes 34-38 are shown in the Appendix 1. The IR spectral data
that are indicative of structural features of complexes 34-38 are shown in Table 29. The
spectra of all five complexes contain νasym(OCO)

and

νsym(OCO) bands which are
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characteristic of complexes in which carboxylate groups are found bound to a metal
centre. The Δoco values (148-173 cm-1) are in the region expected for chelating or
bridging COO groups.60 Complex 34 formulates as having an undissociated carboxylic
acid group with a silver atom and three PPh3 ligands. This is the same formulation as
[Ag(ddaH)(PPh3)3] (32) and the spectral data for 34 suggest that it has a similar
structure to 32 (Figure 57).
Complex 37 formulates similarly to complex 31A and the similarities in the IR spectra
support the hypothesis that 37 has a similar structure to that of 31A (Figure 56). The
remaining complexes 35, 36 and 38 all formulate as [Ag2(dicarboxylate)(PPh3)5 ].
Splitting of the carboxylate bands in the IR spectra of 35, 36 and 38 supports the
presence of two different binding modes for the carboxylate groups in each compound.
Complexes 34-38 and 38A were found to have very limited solubility in organic
solvents and all attempts to obtain NMR spectra and the conductivity of the complexes
were unsuccessful.
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Table 29: Characteristic IR bands (cm-1, KBr discs) of the complexes (34)-(38) along with the free PPh3 ligand
PPh3

(34)

(35)

(36)

(37)

ν (C-H) aeromatic

*

3045

3054

3052

3052

ν (C-H) aliphatic

*

2921

2931

2923

2920

ν (C=O)

(38)

1723

Carboxylate
band
ν (asym)(OCO)

1547

1555

1547

1556

1585

ν (sym)(OCO)

1398

1382

1399

1395

1434

Δ OCO

149

173

148

161

151

Phosphine bands
νC-P
νasym

744

746

743

747

743

744

νsym

692

695

693

695

694

694

* Bands precluded by others in the infrared spectrum.
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D.5 SYNTHESIS AND CHARACTERISATION OF SILVER(I)
DIPHENYLPHOSPHINEMETHANE COMPLEXES
Complexes 1-11 were reacted with bis (diphenylphosphino) methane (dppm) in a 1:2
molar ratio. The synthetic route to the silver dicarboxylate dppm complexes
[Ag2(prda)(dppm)3]C7H8 (39), [Ag2(bda)(dppm)3].C7H8 (40), [Ag2(pda)(dppm)4] (41),
[Ag2(hxda)(dppm)4]

(42),

[Ag2(hpda)(dppm)4]

(43),

[Ag2(oda)(dppm)4]

(44),

[Ag2(nda)(dppm)4] (45), [Ag(ddaH)(dppm)3].3H2O (46), [Ag2(udda)(dppm)4] (47),
[Ag2(ddda)(dppm)4].H2O (48), [Ag2(uddca)(dppm)4].2H2O (49), [Ag2(dppm)2(OAc)2].3
C7H8 (49A) is shown in Scheme 5

[Ag2(OOC-(CH2)n-COO)] +2dppm

Reflux
2.5hrs

Tolune
30ml

{Agx(OOC-(CH2)n-COOHy)(dppm)z}
where n=1-11, x=1or 2, y= 0 or 1 and z=3 or 4

Scheme 5: The synthetic route to the silver dicarboxylate dppm complexes
Complexes 39 to 49 were obtained as off white powders.The mother liquor from the
reaction of complex 48 yielded colourless crystals of {Ag2(OOC-(CH2)10COO)
(dppm)2}n.H2O}48A. Complexes 39-49 were formulated as below in Table 30
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Table 30: Elementary Analysis of complexes 39 to 49
Elementary Analysis
Complex

% Calculated

% Found

C

H

P

C

H

[Ag2(prda)(dppm)3].C7H8 (39)

58.24

4.89

9.19

58.72

4.50

[Ag2(bda)(dppm)3]. C7H8 (40)

58.61

5.02

9.07

57.40

[Ag2(pda)(dppm)4] (41)

59.05

4.87

11.08

58.07

4.47

10.41

[Ag2(hxda)(dppm)4] (42)

60.02

5.21

10.87

59.00

4.66

10.26

Ag2(hpda)(dppm)4] (43)

60.32

5.32

10.55

59.46

4.65

11.02

[Ag2(oda)(dppm)4] (44)

60.62

5.43

10.42

60.47

4.99

10.00

[Ag2(nda)(dppm)4] (45)

60.91

5.53

10.30

59.67

4.93

10.82

[Ag(ddaH)(dppm)3] .3H2O (46)

61.06

6.48

9.64

60.61

5.29

9.88

[Ag2(udda)(dppm)4] (47)

61.48

5.73

10.07

60.84

5.15

10.46

[Ag2(ddda)(dppm)4].H2O (48)

61.57

6.32

9.48

61.43

5.61

9.36

[Ag2(uddca)(dppm)4].2H2O (49)

60.29

6.07

9.57

59.71

5.25

9.93

4.31

P
9.98
9.97

The crystals of 48A were suitable for X-ray crystallographic analysis.
The structure of 48A is shown in Figures 63 and 64 and selected bond lengths and
angles are listed in Tables 31 and 32.
The structure is a linear polymer in which centrosymmetric Ag2(dppm)2 units are linked
by diacid anions.74 The chains are linked via H-bonding through the water solvate
molecule (one of the hydrogen atoms on the water is necessarily disordered).

Figure 63: Crystal Structure for {Ag2(dppm)2(ddda)(H2O)}n 48A
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Figure 64: Packing diagram for {Ag2(dppm)2(ddda)(H2O)}n 48A
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Table 31: Selected bond lengths [Å] and angles [] around the silver centres in
{Ag2(dppm)2(ddda)(H2O)}n 48A
Complex (48A)
Bond lengths Å
Ag(1)-O(2)

2.303(3)

Ag(1)-P(1)

2.4235(9)

Ag(1)-P(2)#1

2.4295(10)

Ag(1)-Ag(1)#1

3.0430(7)

Bond angles 
O(2)-Ag(1)-P(1)

106.66(8)

O(2)-Ag(1)-P(2)#1

98.96(9)

P(1)-Ag(1)-P(2)#1

150.47(4)

O(2)-Ag(1)-Ag(1)#1

132.06(9)

P(1)-Ag(1)-Ag(1)#1

92.80(2)

P(2)#1-Ag(1)-Ag(1)#1

80.36(3)

Table 32: Hydrogen bonds for {Ag2(dppm)2(ddda)(H2O)}n 48A
[Å and °]
______________________________________________________________________
D-H...A

d(D-H)

d(H...A)

d(D...A)

<(DHA)

______________________________________________________________________
O(1W)-H(1WA)...O(1)

0.86

O(1W)-H(1WB)...O(1W)#30.85

1.92

2.782(6)

179.2

1.96

2.815(11)

179.4

______________________________________________________________________
Symmetry transformations used to generate equivalent atoms: #1 -x+1,-y+1,-z+1

#2 -

x,-y,-z+2 #3 -x,-y+1,-z+2

Crystals of [Ag2(dppm)2(OAc)2].3C7H8, suitable for X-ray structural analysis were
obtained when impure complex 10 was reacted with dppm and the reaction was carried
out in toluene and the mother liquor left to stand for several weeks. The structure of
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[Ag2(dppm)2(OAc)2].3C7H8, is shown in Figures 65 and 66 and selected bond lengths and

angles are listed in Table 33.
The dimeric silver molecule lies on a centre of symmetry, so that the asymmetric unit
contains half of the molecule. The asymmetric unit also contains 1.5 toluene molecules;
one is disordered about a centre of symmetry and the second is disordered over two
overlapping positions. The geometry of the phenyl rings of the latter toluene was
restrained to that of a regular hexagon. The acetate bonding is asymmetric but probably
best thought of as bidentate.75 There are some  and edge-to-face interactions but that
is not unusual for these types of molecules.

Figure 65: Crystal Structure for [Ag2(dppm)2(OAc)2].3 C7H8 49A
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Figure 66: Packing diagram for [Ag2(dppm)2(OAc)2].3C7H8 49A
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Table 33: Selected bond lengths [Å] and angles [] around the silver centres in
[Ag2(dppm)2(OAc)2].3C7H8

Complex(54A)
Bond lengths Å
Ag(1)-P(1)

2.4232(5)

Ag(1)-O(1)

2.4376(14)

Ag(1)-Ag(1)#1

3.2509(3)

Ag(1)-P(2)#1

2.4504(4)

Ag(1)-O(2)

2.7053(17)

Bond angles 
P(1)-Ag(1)-O(1)

107.40(3)

P(1)-Ag(1)-P(2)#1

146.021(15)

O(1)-Ag(1)-P(2)#1

102.25(4)

P(1)-Ag(1)-O(2)

130.70(3)

O(1)-Ag(1)-O(2)

50.46(5)

P(2)#1-Ag(1)-O(2)

81.50(3)

P(1)-Ag(1)-Ag(1)#1

89.779(11)

O(1)-Ag(1)-Ag(1)#1

140.14(4)

P(2)#1-Ag(1)-Ag(1)#1

77.551(11)

O(2)-Ag(1)-Ag(1)#1

90.95(3)

The formulations for complexes 39-49 are such that it is not likely that they share the
same structure as that of 48A. Indeed complxes 39-49 formulate in three categories (i)
[Ag2(O2C-CH2)n-CO2)(dppm)3], (ii) [Ag2(O2C-(CH2)n-CO2)(dppm)4] and (iii) [Ag(O2CCH2)n-CO2H)(dppm)3] . The complexes 39 and 40 formulate as shown in category (i),
complexes 41-45 and 47-49 formulate as shown in category (ii) and complex 46 is
unusual as it formulates as shown in category (iii).
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The IR spectra of complexes 39-49 (with that of 48A) are shown in Appendix1. The IR
spectral data that are indicative of the structural features of the complexes are shown in
Tables 34 and 35. Although the complexes 39 and 40 formulate somewhat similarly
they do not appear to have similar structures as evidenced by their IR spectra. In the
spectrum of 39 the νasym OCO band is split indicating that two carboxylate ligands are
bound to the metal centres in different modes.60 In the IR spectrum of 40 the νasym OCO
is not split (Table 34). Furthermore, the elemental analytical results for 40 are slightly
inconclusive. The spectral bands indicative of the presence of the dppm group (750-680
cm-1) are split in the spectra of both 39 and 40 and the shape and position of the bands is
different for each complex suggesting that the dppm ligands may be bound to the metal
centre in different co-ordination modes for each complex.
The IR spectra for complexes 41-45 and 47-49 are all very similar. The carboxylate
νasym OCO and νsym OCO bands are not split. The spectra of these complexes also
contain bands that are indicative of the presence of the dppm ligands and again the
shape and values for these bands suggests that they are bound to the silver centres in
similar modes for all eight complexes. A structure that fits the physico-chemical data of
complexes 41-45 and 47-49 is shown in Figure 67. This structural motif is known for
silver dppe complexes where the counter ion is NO-3.
2+

Ph2
P

Ph2
P
Ph2P

PPh2

Ag

P
Ph2

Ph2P

-O2C -(CH2)n - CO2-

Ag
PPh2

P
Ph2

Figure 67: Possible structure for complexes 41-45 and 47-49.
Complex 46 is unusual in that it appears to have a dicarboxylate group which is only
mono- deprotonated. The IR spectrum clearly shows the presence of the C=O band at
1714 cm-1 (Table 34) and it formulates as [Ag (ddaH)(dppm)3].3H2O (although the %
hydrogen is low and therefore this formulation may be erroneous like complexes 49 and
40 it is difficult to assign a structure to complex 46.
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Complex 39-49 (and complex 48A) were found to have very limited solubility in
organic solvents and all attempts to obtain NMR spectra and the conductivity of
complexes were unsuccessful.
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Table 34: Characteristic IR bands(cm-1, KBr discs) of the complexes 39-49 along with the free ligand
PPh3

(39)

ν (C-H) aeromatic

3049

ν (C-H) aliphatic

*

ν (C=O)

(40)

(41)

(42)

(43)

(44)

(45)

(46)

(47)

(48)

3052

3050

3049

3050

3050

3051

3051

3050

3052

*

*

2922

2937

2940

2930

2924

2922

2923

2920

2850

2850

2850

2850

*

*

*

*

ν (asym)(OCO)

1537

1547

ν (sym)(OCO)

1434

Δ OCO

*

(49)
3051,3019

*

*

*

*

1714

*

1557

1555

1559

1561

1553

1555

1552

1563

1560

1385

1382

1390

1395

1390

1392

1387

1395

1386

1397

103

162

175

165

164

171

161

168

157

177

163

Carboxylate band

Phosphine bands
νC-P
νasym

744

737

736

737

739

738

740

741

740

740

740

740

νsym

692

692

693

696

695

694

694

694

695

693

695

694

* Bands precluded by others in the infrared spectrum.
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Table 35: Characteristic IR bands (cm-1, KBr discs) of the complexes (54A) along with
the free ligand
PPh3

(48A)

ν (C-H) aeromatic

3052

ν (C-H) aliphatic

2920

ν (C=O)

1717

Carboxylate band
ν (asym)(OCO)

1585

ν (sym)(OCO)

1401

Δ OCO

184

Phosphine bands
νC-P
νasym

744

744

νsym

692

694
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D.6 SYNTHESIS OF SILVERDICARBOXYLATE DIPHENYLPHOSPHINE
ETHANE COMPLEXES
Complexes 1-11 were reacted with bis(diphenylphosphino)ethane(dppe) in a 1:2 molar ratio
using the same procedure employed for the dppm reactions to yield the complexes
[Ag2(prda)(dppe)4].H2O (50), [Ag2(bda)(dppe)4](51), [Ag2(pda)(dppe)3].4H2O(52),
[Ag2(hxda)(dppe)4] (53), [Ag2(hpda)(dppe)3] (54), [Ag2(oda)(dppe)4](55),
[Ag2(nda)(dppe)4].2H2O (56), [Ag2(dda)(dppe)4] (57), [Ag2(udda)(dppe)4].H2O (58),
[Ag2(ddda)(dppe)4] (59), [Ag2(uddca)(dppe)4](60)
Complexes 50-60 were obtained as off white powders and they were formulated as shown in
Table 36.
Table 36: Elementary Analysis of complexes 50 to 60
Elementary Analysis
Complex

% Calculated

% Found

C

H

P

C

H

P

[Ag2(prda)(dppe)4].H2O (50)

59.41

5.41

10.39

58.24

4.48

11.32

[Ag2(bda)(dppe)4] (51)

60.62

5.43

10.42

59.63

[Ag2(pda)(dppe)3].4H2O (52)

53.22

5.61

8.76

52.17

4.21

9.46

[Ag2(hxda)(dppe)4] (53)

61.20

5.63

10.18

61.78

5.10

10.53

[Ag2(hpda)(dppe)3] (54)

57.89

5.45

9.14

56.84

4.80

10.26

[Ag2(oda)(dppe)4] (55)

61.75

5.83

9.95

60.13

5.02

10.25

[Ag2(nda)(dppe)4].2H2O (56)

60.29

6.07

9.57

60.43

5.17

10.71

[Ag2(dda)(dppe)4] (57)

62.27

6.02

9.73

62.52

5.57

10.29

[Ag2(udda)(dppe)4].H2O (58)

61.67

6.18

9.49

61.49

5.51

9.29

[Ag2(ddda)(dppe)4] (59)

62.78

6.20

9.52

63.62

5.74

9.59

[Ag2(uddca)(dppe)4] (60)

63.02

6.29

9.42

62.40

5.66

9.89

4.75

10.98

Complexes 50-60 formulate into two categories (i) [Ag2(O2C-(CH2)n-CO2)(dppe)3] and
(ii) [Ag2(O2C(CH2)n-CO2)(dppe)4]. Complexes 52 and 55 formulate in category (i)
whilst the remaining nine complexes formulate in category (ii).
The IR spectra of complexes 50-60 are shown in the Appendix 1 and the IR spectral
bands indicative of structural features are listed in Table 37. The spectra are all very
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similar with the carboxylate bands (νasym OCO and νsym OCO) for all complexes being
unsplit. Furthermore, all of the IR spectra of the complexes contain bands that are
characteristic of the presence of the dppe ligands (790-680 cm-1). It is most likely that
complexes 50, 51, 53 and 55-60 have structures similar to their dppm counterparts
(complexes 41-45 and 47-49) and that of the published nitrate silver dppe complex salt
(Figure 68).
2+
Ph
P

Ph

Ph
Ph

Ph

Ph

P

Ph

-

Ag
P

Ph

P

P

Ag

P

Ph

Ph
Ph

O2C-(CH2)n-CO2-

P
Ph

Ph

Ph
Ph

P
Ph

Figure 68: Possible structure for complexes 50, 51, 53, and 55-60
Complexes 50-60 were found to have very limited solubility in organic solvents and all
attempts to obtain NMR spectra and the conductivity of the complexes were
unsuccessful due to the insolubility of the compounds.
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Table 37: Characteristic IR bands(cm-1, KBr discs) of the complexes 50-60 along with the free ligand
PPh3

(50)

(51)

(52)

(53)

(54)

(55)

(56)

(57)

(58)

(59)

(60)

ν (C-H) aeromatic

3052

3052

3050

3049

3049

*

3050

3052

3052

3052

3052

ν (C-H) aliphatic

*

2915

*

2919

2927

2935

2923

2924

2923

2920

2923

2851

2850

2849

2850

ν (C=O)

*

*

*

*

*

*

*

*

*

*

ν (asym)(OCO)

1556

1552

1552

1555

1548

1545

ν (sym)(OCO)

1434

1405

1400

1403

1401

Δ OCO

122

147

152

152

*

1561

1556

1550

1555

1551

1398

1399

1404

1399

1403

1400

147

147

162

152

151

152

151

Carboxylate band

Phosphine bands
νC-P
νasym

744

742

744

741

741

743

740

742

745

*

743

743

νsym

692

694

694

694

692

693

693

695

695

695

695

695

* Bands precluded by others in the infrared spectrum
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D.7

ANTIMICROBIAL ACTIVITY OF THE SILVER (I) DICARBOXYLATE

The onset of antibacterial resistance to these therapeutic treatments exerted considerable
pressure on scientists and clinicians to develop novel, targeted multi-modal antibacterial
agents with minimal cytotoxicity to mammalian cells.
The decline in the number of available antibacterial therapies for the treatment of multidrug resistant pathogens, has resulted in a reversion to older antimicrobial metallic
agents, such as silver. In clinical terms, silver is the antimicrobial metal best known for
its broad spectrum activity against intractable infectious microorganisms, including
antibiotic resistant strains.76 The multiple modes of action of the silver ion include
binding with cell DNA, inhibiting enzymes that mediate respiration and reacting with
sensitive thiol groups on bacterial proteins - thereby destroying the normal biological
activity of the protein. A key advantage of employing silver based inorganic
antimicrobials instead of traditional silver nitrate is the potential for controlled release
of silver ions and reduced photosensitivity. The success of these silver based
antimicrobials depends on the appropriate ancillary ligands and the stabilization of
specific oxidation states. In addition, they play a pivotal role in modifying reactivity and
lipophilicity. It has been reported that the primary challenge in designing silver based
antimicrobial drugs lies in the slow and sustained release of Ag+ ions over a period of
time.77 However if the ligands are too tightly bound to the metal centre, this can impede
the release of the silver ions. This can result in compromised and reduced antibacterial
activity with the potential for silver resistant microorganisms.

D.7.1 Antifungal agents in clinical use
There are four major classes of systemic antifungal compounds currently in clinical use:
the polyene antibiotics, the azole derivatives, the allyamines and thiocarbamates, and
the morpholines.78 The first three are targeted against ergosterol, the major fungal sterol
in the plasma membrane. Echinocandins (a recent discovery) are successors to
cilofungin, which was abandoned in the 1980s. The echinocandins inhibit synthesis of
fungal β-1,3 glucan, and this represents the first novel target in 20 years of antifungal
drug discovery in terms of clinically useful drugs. Of these the polyene antibiotics and
the azole derivatives are the most effective.
116

All of the novel silver complexes 1-60 generated during this project were assessed for
anti-microbial activity against fungal (Candida albicans) and bacterial (Grampositive
and Gramnegative) cells over a range of concentrations.

D.7.2 Antifungal activity of the complexes
The complexes were assessed for their ability to inhibit growth of an isolate of
C.albicans over a range of concentrations in minimal media (Tables 38-41). The
antifungal activity of these complexes was compared to that of (i) Silver Nitrate (Ag
NO3) and Silver acetate [Ag(CH3COO)] {known sources of simple Ag+ ions}(Table 38)
(ii) Amphotericin B (Amp B) a well known antifungal drug (Table 41) and (iii) the
metal free dicarboxylic acid, PPh3, dppm and dppe ligands (Table 41). Tables 38-41
also list the IC50 values for each of the compounds.
The experiments were carried out as described in the experimental section, each sample
was tested in tripclicate and each experiment was repeated three times. The results
shown represent the average of these results. The percentage growth of strain of
C.albicans ATCC 10231on AgNO3 was 79% at 0.08 µg/ml and 18% at 1µg/ml with an
IC50 (concentration that causes 50% reduction in cell viability) of 0.1µg/ml. For silver
acetate the sensitivity is similar with 80% at 0.08 µg/ml and 20% at 1µg/ml with IC50 0f
0.1µg/ml. For Amphotericin B the percentage growth was 6% at 1.0 µg/ml.
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Table 38: Anti-Candida activity and IC50 values of silver dicarboxylate complexes 1-11
and AgNO3 & [AgCH3COO]
Compound

% growth at concentration
(µg/ml)
1.0

0.5

0.1

0.09 0.08 IC50 (µg /ml)

IC50 (µM)

[Ag2(prda)](1)

23

54

70

81

89

0.5

1.57

[Ag2(bda)](2)

16

28

35

50

77

0.09

0.27

[Ag2(pda)](3)

22

35

41

59

69

0.09

0.26

[Ag2(hxda)](4)

07

16

25

36

52

0.08

0.22

[Ag2(hpda)](5)

11

45

55

65

89

0.1

0.26

[Ag2(oda)](6)

09

16

34

47

50

0.08

0.20

[Ag2(nda)](7)

12

36

51

65

78

0.1

0.24

[Ag2(dda)](8)

05

25

35

46

80

0.09

0.21

[Ag2(udda)](9)

06

52

58

75

89

0.5

1.16

[Ag2(ddda)](10)

17

29

38

50

76

0.09

0.20

[Ag2(uddca)](11) 15

34

48

68

82

0.1

0.21

Ag NO3

18

25

45

60

79

0.1

0.58

[Ag(CH3COO)]

20

38

52

65

80

0.1

0.59
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Table 39: Anti-Candida activity and IC50 values of PPh3 complexes 12-38
Compound

% growth at concentration
(µg /ml)
20

10

5

2.5

1.0

IC50

IC50 (µM)

(µg
/ml)
[Ag2(prdaH)(PPh3)2].C7H8 (12)

16

45

53

94

-

5

5.3

[Ag2(bda)(PPh3)3].C7H8 (13)

18

45

56

92

-

5

4.1

[Ag2(pda)(PPh3)3].2H2O (14)

15

28

50

59

65

5

4.2

[Ag2(hxda)(PPh3)2] (15)

19

25

38

50

75

2.5

2.8

[Ag2(hpda)(PPh3)2].2H2O (16)

15

29

37

48

86

2.5

2.6

{[Ag2(oda)(PPh3)3].2H2O}n(17)

13

26

40

52

68

2.5

2.1

[Ag(ndaH)PPh3)2] (18)

18

34

46

50

75

2.5

3.1

[Ag2(dda)(PPh3)4].2C7H8 (19)

06

26

38

45

85

2.5

1.5

[Ag2(udda)(PPh3)2] (20)

12

34

52

68

76

5

5.2

[Ag2(ddda)(PPh3)3](21)

09

26

37

52

65

2.5

2.0

[Ag(uddcaH)(PPh3)2] (22)

12

24

39

50

68

2.5

2.8

[Ag2(prda)(PPh3)3].H2O (23)

25

45

56

86

-

5

4.4

[Ag2(bda)(PPh3)4] (24)

24

46

51

85

96

5

3.6

[Ag2(pda)(PPh3)4] (25)

12

15

36

51

96

2.5

1.8

[Ag(hxdaH)(PPh3)4].3H2O(26)

15

28

34

54

98

2.5

1.8

[Ag2(hpda)(PPh3)4].C7H8 (27)

12

29

40

57

92

2.5

1.6

[Ag(odaH)(PPh3)2].C7H8(28)

15

19

28

35

50

1.0

1.1

[Ag(ndaH)(PPh3)2] (29)

12

19

29

50

68

2.5

3.1

[Ag2(dda)(PPh3)4].H2O (30)

16

18

35

50

64

2.5

1.7

[Ag2 (udda) (PPh3)3] (31)

15

28

34

56

69

2.5

2.1

[Ag(dddaH)(PPh3)2](32)

16

28

37

50

96

2.5

2.9

[Ag2(uddca)(PPh3)5](33)

16

26

45

50

69

2.5

1.4

[Ag(hxdaH)(PPh3)2].C7H8 (34)

06

26

38

46

85

2.5

2.8

[Ag2(hpda)(PPh3)5].C7H8 (35)

15

35

50

64

87

5.0

2.8

[Ag2(oda)(PPh3)4].2C7H8 (36)

12

35

48

53

89

5.0

3.1

Ag2(udda)(PPh3)4] (37)

16

48

59

75

96

5.0

3.4

[Ag2(uddca)(PPh3)5].C7H8(38)

12

56

85

96

-

10.0

5.3
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Table 40: Anti-Candida activity and IC50 values of dppm and dppe complexes 39-60
Compound

% growth at concentration
(µg /ml)
20

10

5

2.5

1.0

IC50 IC50
(µg

(µM)

/ml)
[Ag2(prda)(dppm)3].C7H8 (39)

16

22

35

45

56

1.0

0.9

[Ag2(bda)(dppm)3].C7H8 (40)

04

15

29

35

46

1.0

0.9

[Ag2(pda)(dppm)4] (41)

06

15

38

47

75

2.5

2.2

[Ag2(hxda)(dppm)4] (42)

08

25

37

45

68

2.5

2.1

[Ag2(hpda)(dppm)4] (43)

09

35

46

58

72

2.5

2.1

[Ag2(oda)(dppm)4] (44)

05

15

46

86

-

5.0

4.2

[Ag2(nda)(dppm)4] (45)

16

28

58

95

-

5.0

4.1

[Ag(ddaH)(dppm)3].3H2O (46)

15

25

35

46

50

1.0

1.0

[Ag2(udda)(dppm)4](47)

12

16

28

35

50

1.0

0.8

[Ag2(ddda)(dppm)4].H2O (48)

24

56

69

73

85

10.0

7.9

[Ag2(uddca)(dppm)4].2H2O (49)

19

45

62

89

90

10.0

7.7

[Ag2(prda)(dppe)4].H2O (50)

12

25

30

46

59

2.5

2.1

[Ag2(bda)(dppe)4] (51)

13

27

39

48

59

2.5

2.1

[Ag2(pda)(dppe)3].4H2O (52)

18

38

49

75

89

5.0

4.7

[Ag2(hxda)(dppe)4] (53)

12

35

48

65

89

5.0

4.1

[Ag2(hpda)(dppe)3] (54)

15

29

30

52

69

2.5

2.4

[Ag2(oda)(dppe)4] (55)

16

38

46

86

-

5.0

4.0

[Ag2(nda)(dppe)4].2H2O (56)

17

29

56

66

85

5.0

3.9

[Ag2(dda)(dppe)4] (57)

3

12

29

40

50

1.0

0.8

[Ag2(udda)(dppe)4].H2O (58)

6

18

29

34

46

1.0

0.7

[Ag2(ddda)(dppe)4] (59)

9

16

18

29

48

1.0

0.8

[Ag2(uddca)(dppe)4] (60)

26

37

52

75

89

5.0

3.8
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Table 41: Anti-Candida activity and IC50 values of Amp B and the free ligands
(dicarboxylic acids, PPh3, dppm and dppe)
% growth at concentration (µg /ml)

Compound

IC50 (µM)

IC50 (µg /ml)

20

10 5

2.5

1.0

Amphotericin B

00

00 00

00

6

1.0

0.9

prdaH2

50

90

-

-

-

20.0

192

bda H2

40

57

-

-

-

10.0

84

pda H2

25

56

-

-

-

10.0

75

hxda H2

38

48

-

-

-

10.0

68

hpdaH2

26

50

-

-

-

10.0

62

odaH2

35

52

-

-

-

10.0

57

ndaH2

56

90

-

-

-

20.0

106

ddaH2

38

51

-

-

-

10.0

49

uddaH2

48

95

-

-

-

20.0

92

dddaH2

50

94

-

-

-

20.0

86

uddcaH2

46

96

-

-

-

20.0

82

PPh3

39

51

-

-

-

10.0

38

dppm

50

95

-

-

-

20.0

100

dppe

52

96

-

-

20.0

93
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The silver dicarboxylate complexes 1-11 exhibit potent anti-Candida activity at
extremely low concentrations (1.0 g/ml, 0.5 g/ml, 0.25 g/ml and 0.1 g/ml) which
compare favourably with the activities of AgNO3 and [Ag(CH3COO)] (Table 38).
Clearly the inclusion of the PPh3 groups as auxiliary ligands in the silver complexes 1238 has reduced their activity by between 10 and 100 times that of simple dicarboxylates
1-11. These triphenylphosphine (PPh3) derivatives of complexes 1-11 are all effectively
inactive towards the Candida albicans at concentrations below 1g/ml (Table 38). At
10 g/ml these complexes are good to moderate antifungal agents and when the
concentration is increased to 20 g/ml the compounds all exhibit excellent activity
(Table 39)
Like the PPh3 derivatives the dppm and dppe complexes 39-60 are significantly less
active than the simple silver carboxylate complexes 1-11 with their activity reduced by
between 10 and 100 fold (Table 40). When compared to the PPh3 complexes (12-38) the
dppm and dppe derivatives show a similar activity profile at 20 g/ml, 10 g/ml and 5
g/ml but when the concentration drops to 1µg/ml a number of the complexes are still
moderately active (Table 39).

It is clear that the dppm and dppe derivatives have a

concentration dependent activity profile and at 10 g/ml and 20 g/ml all of these
compounds exhibit excellent activity towards the Candida albicans.

D.7.3 Anti-bacterial activity of the complexes
The antibacterial activity of complexes 1-60, the free ligands and AgNO3 against
Grampositive and Gramnegative bacteria was determined over seven concentrations (50
µg /ml , 25 µg /ml, 10 µg /ml, 5 µg /ml, 2.5 µg /ml, 1 µg /ml and 0.1 µg /ml). The
bacterial strains tested were (i) a clinical isolate of MRSA, (ii) S. aureus (ATCC 25922as reference), (iii) a clinical isolate of E. coli and (iv) E.coli (ATCC 25923-as
reference).
The experiments were carried out as described in the experimental section, each sample
was tested in duplicate and each experiment was repeated three times. The results
shown represent the average of these results. The majority of the complexes and all of
the free ligands were found to be effectively inactive towards the pathogens over the
concentration range tested. Table 42 lists the IC50 values (µg/ml) for the 13 active
complexes and the activities for AgNO3.
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AgNO3 is a very potent antibacterial agent with a similar activity profile against the four
test microbes. Of the simple silver dicarboxylates 1-11 only complexes 1, 4, 5, 6 and 7
exhibit significant activity.

Of the PPh3, dppm and dppe derivatives 12-60 only

complexes 14, 31, 33, 37, 38, 39, 41 and 52 were found to be active.
Complexes 31, 37 and 38 exhibit exceptional activity against the test microbes and have
activity comparable to that of the silver nitrate.
Table 42: Anti-bacterial activity as IC50 values of AgNO3 and the complexes that
exhibited activity
S. aureus

S.aureus

ref.

clinical

E. coli ref.

E. coli

ATCC25923

(MRSA)

ATCC25922

clinical

AgNO3

<0.1

<0.1

<0.1

<0.1

[Ag2(prda)] (1)

15

13

38

18

[Ag2(hxda)] (4)

50

50

50

30

[Ag2(hpda)] (5)

8

30

8

4

[Ag2(oda)] (6)

6

8

6

8

[Ag2(nda)] (7)

8

10

12

10

[Ag2(pda)(PPh3)3].2H2O (14)

30

12

inactive

15

[Ag2(udda)(PPh3)] (31)

<0.1

<0.1

<0.1

<0.1

[Ag2(uddca)(PPh3)2] (33)

8

50

50

50

[Ag2(udda)(PPh3)4] (37)

<0.1

<0.1

<0.1

<0.1

[Ag2(uddca)(PPh3)] (38)

<0.1

<0.1

<0.1

<0.1

[Ag2(prda)(dppm)3].C7H8 (39)

*

5

10

*

[Ag2(pda)(dppm)4] (41)

*

12

inactive

inactive

[Ag2(pda)(dppe)3].4H2O (52)

*

18

28

*

Compound Code

The antimicrobial experiments carried out as part of this study have shown that all of
the metal free dicarboxylic acids and phosphine based ligands are relatively poor
antifungals and display no antibacterial activity. The simple dicarboxylate complexes
1-11 are potent in-vitro anti-Candida agents which display activity superior/comparable
to the clinically used AgNO3 and the state-of -the -art organic drug Amphothericin B.
Indeed the majority of complexes 1-11 are twice as active as AgNO3, which may arise
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from the fact that they contain two silver ions per molecule. Therefore the assumption
could be that they elute twice as many silver ions into the media than the simple silver
nitrate salt. It has been reported that a higher dose of AgNO3 was required to kill Gram
positive (S. aureus) than Gramnegative (E. coli) cells. The authors claimed that this
reflected the fact that the cell wall of the latter species was considerably thinner. In
contrast, under the experimental conditions in which the present study was conducted
the AgNO3 is a potent antibacterial agent and did not discriminate in its activity against
the Gram positive and Gram negative species. The antibacterial activity of the
complexes 1-11 showed a surprising deviation from that of the simple silver salt.
Indeed only five of the silver dicarboxylates (complexes 1, 4, 5, 6 and 7) displayed good
antibacterial activity, although it was significantly less than that of AgNO3.
Furthermore, unlike the AgNO3 the activity of these five complexes displayed some
discrimination in activity towards the Grampositive (S. aureus /MRSA) and Gram
negative (E.coli) bacteria.

Therefore, it is suggested that the silver dicarboxylate

complexes 1-11 do not act on microbial cells in the same way as AgNO3 and that the
ligand must play some role in their mode of antimicrobial action contributing to their
selectivity between antibacterial and antifungal activity.
Addition of the PPh3 ligands to silver dicarboxylates 1-11 yielded the photo-stable
complexes 12-38. All 27 of these complexes exhibited significant antifungal activity
against the Candida albicans cells although their activity is, on average, over ten times
less than that of the equivalent silver dicarboxylate. This may reflect the relative
stability of the PPh3 derivatives which would not be expected to leach the silver ions
easily. Of the 27 PPh3 derivatives only complexes 14, 31, 33, 37 and 38 are active
against the bacterial cells tested. Complex 14 is interesting as it displays no activity
against the reference E.coli (ATCC 25922) cell line but is significantly effective at
killing the clinical isolate. Complexes 31, 37 and 38 are the only complexes that
display higher antibacterial activity than antifungal activity, a trend not previously
observed for any silver based antimicrobials studied in this and collaborating
laboratories. Indeed these complexes display antibacterial activity comparable to that of
AgNO3 but are very photostable, and over 20, 30 and 50 times (respectively) more
active against the Grampositive and Gramnegative bacterial cells than the fungal cells.
The fact that complexes 31, 37 and 38 did not manifest similar antifungal activity when
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incubated with C. albicans suggests that their mode of action is not due simply to
release of silver ions. The unique structure, which incorporates fatty dicarboxylic acid
ligands {-OOC-(CH2)n-COO- where n = 9 (complexes 31 and 37) and 11 (complex 38)}
and the stablising phosphines, of these synthesised complexes may explain these
observations. Due to cell wall differences, traditional prophylactic treatments differ for
both bacterial and fungal infections. We propose, from this study, that the ligated
structures passively diffused through the peptidoglycan cell wall of Grampositive
bacterial and the lipopolysaccaride cell wall of Gramnegative bacteria. At this stage, it
is difficult to elucidate definitely whether the complexes reached the targeted
compartments of either the perisplasmic space or the cytoplasm. Furthermore, bacterial
functional groups may exchange with ligands from the metallo-complexes, promoting
silver ion discharge. Complexes 31, 37 and 38 represent potential therapeutics that
warrent further investigation as novel antimicrobial agents. Further studies such as
Graphite Furnace AAS (silver release determination), Raman (silver bonding) and
Transmission Electron Spectroscopy (TEM, imaging of metal deposition) will help to
clarify further the observed novel broad-spectrum properties of these three structures.
Addition of the dppm and dppe ligands to the silver dicarboxylates 1-11 yielded the
photo-stable complexes 39-60 which all exhibited significant antifungal activity against
the Candida albicans cells. However, with the exception of complex 39, most of their
activities are again significantly less than that of the equivalent silver dicarboxylate.
Again this may reflect the relative stability of the dppm and dppe derivatives which
would not be expected to leach the silver ions easily. Of the 22 diphosphine derivatives
only complexes 39, 41 and 52 display any activity against the bacterial cells tested.
Complex 41 is interesting as it exhibits good activity against the Grampositive MRSA
but it is inactive against the Gramnegative E.coli. Complexes 39 and 52 display some
discrimination in activity towards the Grampositive (MRSA) and Gramnegative (E.coli)
bacteria. Again as all of the dppm and dppe derivatives 36-60 were found to be active
against the fungal cells and only three of them displayed activity against MRSA and
E.coli it is suggested that they do not act on microbial cells in the same way as AgNO3
and that the ligands must play some role in their mode of antimicrobial action
contributing to their selectivity between antibacterial and antifungal activity.
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EXPERIMENTAL
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E.1 INSTRUMENTATION
Infrared (IR) spectra were recorded in the region 400- 4000cm-1 on a Nicolet FT-IR 400
Impact spectrometer. All solids to be tested were prepared in a KBr matrix.
C. Albicans cells were measured using a 20 Genesys Spectrophotometer. All solutions
were prepared using 5 mls of Phosphate Buffer Saline (PBS).
Antimicrobial susceptibility testing was carried out using BIOTEC EL808 machine used
for 96 well microtitreplate analysis.
Elemental analysis was carried out by the Microanalytical Laboratory, University
College Dublin, Ireland.
X-ray crystal structures were carried out by Professor Vickie McKee, Loughborough
University

E.2 CHEMICALS
All chemicals were purchased from commercial sources and were used without further
purification.
All reported solubility tests were carried out in hot solvent.
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E.3

SYNTHESIS OF SILVER (I) DICARBOXYLATE COMPLEXES

E.3.1 [Ag2(prda)] (prdaH2= Propanedioic acid) (1)
The following procedure was conducted with the exclusion of all light sources. To a
suspension of prdH2 (0.261 g, 2.5 mmol) in 30 mls of Toluene, 0.834 g (0.5 mmol) of
[Ag(CH3COO)] was added and refluxed for two and half hours. At regular intervals of
30 mins the reflux condenser was removed for a minimum of five minutes to allow any
acetic acid formed in the reaction to evaporate off. After two and half hours the heat
was switched off and the mixture was left to stir for a further half an hour to cool down.
The mixture was then filtered and the resulting precipitate was washed using small
portions of toluene and 5-10 mls of diethyl ether and then air dried.
Yield: 0 .626 g (57.16%)
% Calc: C 11.34, H 0.63, Ag 67.89
% Found: C 11.32, H 0.64, Ag 65.01
Melting point: 132-136 ºC
IR (KBr): 3500, 2360, 1570, 1436, 1403, 1356, 1268, 1190, 668, 589 cm-1.
Solubility: Not soluble in water, methanol, chloroform, acetone and DMSO.

E.3.2 [Ag2(bda)] (bdaH2= Butanedioic acid) (2)
0.301g (2.55 mmol) of bdaH2 in 30 mls of toluene reacted with 0.834 g (0.5 mmol) of
[Ag(CH3COO)].
Yield: 0.7336 g (64.63%).
% Calc: C 14.48, H 1.22, Ag 65.02
% Found: C 14.22, H 1.68, Ag 64.88
Melting point: 122-126 ºC
IR (KBr): 3428, 2349, 1655, 1566, 1410, 1296, 1019, 925, 652, 420cm-1.
Solubility: Partially soluble in water, not soluble in methanol, chloroform,
acetone and DMSO.

E.3.3 [Ag2(pda)] (PdaH2= Pentanedioic acid) (3)
0.336 g (2.55 mmol) of pdaH2 in 30mls of toluene reacted with 0.834 g (0.5 mmol) of
[Ag(CH3COO)].
Yield : 0.5063 g (43.27%).
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% Calc: C 17.36, H 1.75, Ag 62.38
% Found: C 17.22, H 1.6, Ag 63.06
Melting point: 128-133 ºC
IR (KBr): 3405, 2959, 2362, 1589, 1400, 1314, 1065, 912, 738, 601cm-1.
Solubility: Partially soluble in water, not soluble in methanol, chloroform,
acetone and DMSO.

E.3.4 [Ag2(hxda)] (hxdaH2= Hexanedioic acid) (4)
0.372 g (2.55 mmol) of hxdaH2 in 30 mls of toluene reacted with 0.834 g (0.5 mmol) of
[Ag(CH3COO)].
Yield: 0.8710 g (72.22%).
% Calc: C 20.03, H 2.24, Ag 59.95
% Found: C 20.59, H 2.16, Ag 58.67
Melting point: 128-132 ºC
IR (KBr): 3419, 2925, 1650, 1564, 1409, 1199, 1019, 925, 737, 652cm-1.
Solubility: Partially soluble in water, not soluble in methanol, chloroform,
acetone and DMSO.

E.3.5 [Ag2(hpda)] (hpdaH2=Heptanedioic acid) (5)
0.408 g (2.55 mmol) of hpdaH2 in 30 mls of Toluene reacted with 0.834 g (0.5 mmol) of
[Ag(CH3COO)]
Yield: 0.5768 g (46.44%)
% Calc: C 22.49, H 2.7, Ag 57.70
% Found: C 22.43, H 2.26, Ag 57.89
Melting point: 131-135 ºC
IR (KBr): 3419, 2933, 2349, 1651, 1564, 1407, 654cm-1.
Solubility: Partially soluble in water, not soluble in methanol, chloroform,
acetone and DMSO.

E.3.6 [Ag2(oda)] (odaH2= Octanedioic acid) (6)
0.444 g (2.55 mmol) of odaH2 in 30 mls of toluene reacted with 0.834 g (0.5 mmol) of
[Ag(CH3COO)]
Yield: 0.6624 g (51.83%).
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% Calc: C 24.77, H 3.12, Ag 55.61
% Found: C 24.27, H 3.17, Ag 55.31
Melting point: 128-132 ºC
IR (KBr): 2930, 1653, 1566, 1409, 1285, 1192, 1018, 922, 791, 718, 651cm-1.
Solubility: Partially soluble in water, not soluble in methanol, chloroform,
acetone and DMSO.
E.3.7 [Ag2(nda)](ndaH2= Nonanedioic acid) (7)
0.470 g (2.5 mmol) of ndaH2 in 30mls of toluene reacted with 0.834 g (0.5 mmol) of
[Ag(CH3COO)]
Yield: 0.774 g (59.35%).
% Calc: C 26.89, H 3.51, Ag 53.67
% Found: C 26.39, H 3.01, Ag 53.41
Melting point: 130-135 ºC
IR (KBr): 3396, 2933, 1689, 1567, 1463, 1408, 1287, 1200, 1017, 916, 736cm-1.
Solubility: Partially soluble in water, not soluble in, methanol, chloroform,
acetone and DMSO.

E.3.8 [Ag2(dda)] (ddaH2= Decanedioic acid) (8)
0.515 g (2.55 mmol) of ddaH2 in 30mls of toluene reacted with 0.834 g (0.5 mmol) of
[Ag(CH3COO)]
Yield:

0.857 g (63.52%).

% Calc: C 28.87, H 3.88, Ag 51.86
% Found: C 28.11, H 3.5, Ag 52.01
Melting point: 127-132 ºC
IR (KBr): 3417, 2929, 1679, 1567, 1471, 1408, 1257, 1188, 1018, 924, 753cm-1.
Solubility: Not soluble in water, methanol, chloroform, acetone and DMSO.

E.3.9 [Ag2(udda)] (uddaH2= Undecanedioic acid) (9)
0.541g (2.5 mmol) of uddaH2 in 30mls of toluene reacted with 0.834 g (0.5 mmol) of
[Ag(CH3COO)]
Yield: 0.9469 g ( 68.86%)
% Calc: C 28.87, H 3.66, Ag 50.17
% Found: C 28.34, H 3.84, Ag 50.77
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Melting point: 133-138 ºC
IR (KBr): 3407.49, 2929.42, 2913.25, 2846.61, 1584.90, 1466.37, 1409.26,
1315.53, 1251.31, 721.30 cm-1.
Solubility: Partially soluble in DMSO, insoluble in methanol, ethanol,
chloroform, acetone and water.

E.3.10 [Ag2(ddda)] (dddaH2= Dodecanedioic acid) (10)
0.587 g (2.55 mmol) of dddaH2 in 30 mls of toluene reacted with 0.834g (0.5 mmol) of
[Ag(CH3COO)]
Yield: 0.5163 g (36.33%).
% Calc: C 32.46, H 4.54, Ag 48.59
% Found: C 32.22, H 4.94, Ag 48.83
Melting point: 134-138 ºC
IR (KBr): 3417, 2910, 1688, 1567, 1470, 1408, 1230, 1186, 1018, 923, 651cm-1.
Solubility: Not soluble in water, methanol, chloroform, acetone and DMSO.

E.3.11 [Ag2(uddca)] (uddcaH2= Undecanedicarboxylic acid) (11)
0.623 g (2.55 mmol) of uddcaH2 in 30 mls of toluene reacted with 0.8345 g (0.5 mmol)
of [Ag(CH3COO)]
Yield: 0.787 g (54.01%)
% Calc: C 34.09, H 4.84, Ag 47.10
% Found: C 34.44, H 4.77, Ag 47.67
Melting point: 131-136 ºC
IR (KBr): 3417, 2917, 1693, 1562, 1467, 1409, 1272, 1229, 1110, 1019,
921cm-1.
Solubility: Not soluble in water, methanol, chloroform, acetone and DMSO.
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E.4

SYNTHESIS OF SILVER (I) DICARBOXYLATE COMPLEXES WITH

TRIPHENYLPHOSPHINE (PPh3)
E.4.1 [Ag(prdaH)(PPh3)2] (12)
The following procedure was conducted with the exclusion of all light sources. To a
conical flask containing a suspension of PPh3 (0.669 g, 2.5 mmol) in 30ml of toluene,
0.319 g (1.0 mmol) of [Ag2(prda)] was added. The flask was then refluxed for two and
half hours and left to stand for a further half an hour at room temp, allowing the mixture
to cool. The solution was then filtered off and the resulting precipitate was washed
using small portions of toluene and 5-10 ml of diethyl ether and then air dried. The flask
containing the filtrate, were covered with foil and crystals were deposited over several
weeks.
Yield: 0.7001 g (70.81%)
% Calc: C 63.69, H 4.52, P 8.42, Ag 14.67
% found: C 64.49, H 4.61, P 7.22, Ag 14.00
Melting point: 126-131 ºC
IR (KBR): 3053.46, 2923.84, 1730.96, 1598.67, 1548.18, 1478.65, 1434.16,
1402.56, 1370.28, 1181.33, 1158.16, 1095.67, 1070.46, 1026.96, 997.43,
891.95, 753.18, 694.60, 514.71, 494.09, 466.66, 441.58cm−1.
Solubility: Partially soluble in methanol, ethanol, DMSO, acetone, chloroform,
insoluble in water.
This procedure was used to generate all of the PPh3 derivative of complexes 1-11 (using
2.5, 4 and 6 equivalents of phosphine ligands)

E.4.2 [Ag2(bda)(PPh3)3].C7H8 (13)
0.334 g (1.0 mmol) of [Ag2(bda)] in 30mls of toluene reacted with 0.669 g (2.5 mmol)
of PPh3.
Yield: 0.7946 g (79.24%)
% Calc: C 64.48, H 4.74, P 7.67, Ag 17.82
% found: C 64.98 , H 4.98, P 7.89, Ag 18.53
Melting point: 132-137 ºC
IR (KBR): 3053.28, 2962.96, 2921.08, 1644.58, 1549.09, 1478.64, 1434.22,
1393.12, 1306.32, 1275.43, 1182.74, 1156.90, 1095.27, 1068.93, 1027.80,
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995.96, 888.28, 798.64, 768.78, 745.25, 705.52, 693.43, 618.01, 501.49,
432.40cm−1.
Solubility: Partially soluble in chloroform insoluble in water, methanol, ethanol,
acetone, DMSO.

E.4.3 [Ag2(pda)(PPh3)3].2H2O (14)
0.348 g (1.0 mmol) of [Ag2(pda)] in 30mls of toluene reacted with 0.669g (2.5 mmol) of
PPh3.
Yield:

0.4820 g (47.40%)

% Calc:

C 60.63, H 4.74, P 7.95, Ag 18.46

% found:

C 60.51, H 4.43, P 7.86, Ag 18.87

Melting point: 129-134 ºC
IR (KBR): 3052.53, 2962.66, 2920.86, 1961.23, 1887.41, 1816.34, 1770.72,
1633.75, 1571.00, 1548.82, 1478.78, 1434.22, 1392.67, 1345.85, 1306.33,
1275.60, 1182.99, 1156.95, 1095.36, 1069.26, 1027.86, 996.14, 942.38, 917.18,
888.71, 848.54, 798.90, 768.99, 745.26, 705.47, 693.62, 618.17, 501.76, 432.29
cm−1.
Solubility: insoluble in water, acetone soluble in methanol, ethanol, chloroform,
DMSO.

E.4.4 [Ag2(hxda)(PPh3)2] (15)
0.362 g (1.0mmol) of Ag2(hxda) in 30mls of toluene reacted with 0.669 g (2.5 mmol) of
PPh3
Yield: 0.4178 g (40.53%)
% Calc: C 57.04, H 4.33, P 7.00, Ag 24.34
% found: C 57.04, H 4.30, P 6.43, Ag 22.89
Melting point: 133-138 ºC
IR (KBR): 3049.25, 2934.11, 2892.38, 1620.02, 1552.16, 1478.59, 1459.58,
1435.04, 1414.08, 1365.95, 1309.41, 1193.33, 1095.25, 1071.67, 1025.28,
997.49, 912.48, 758.21, 746.58, 693.08, 520.36, 505.50, 496.15, 444.96 cm−1
Solubility: Partially soluble in methanol, ethanol, DMSO, acetone, chloroform,
water.
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E.4.5 [Ag2(hpda)(PPh3)2].2H2O (16)
0.376 g (1.0 mmol) of [Ag2(hpda)] in 30 mls of toluene reacted with 0.669 g (2.5 mmol)
of PPh3.
Yield: 0.3099 g (29.68%)
% Calc: C 61.12, H 5.13, P 7.75, Ag 23.09
% found: C 61.60, H 4.87, P 7.27, Ag 23.00
Melting point: 130-135 ºC
IR (KBR): 3052.54, 2941.03, 2856.28, 2360.29, 1965.48, 1893.97, 1822.77,
1646.76, 1548.69, 1496.47, 1478.45, 1463.42, 1400.42, 1330.85, 1309.22,
1264.68, 1217.31, 1182.73, 1157.75, 1094.35, 1069.35, 1026.56, 996.26,
973.24, 917.26, 851.32, 748.28, 694.52, 655.38, 617.80, 514.46, 503.93, 466.61,
439.04 cm−1.
Solubility: insoluble in water, ethanol, acetone, DMSO, partially soluble in
chloroform, methanol.

E.4.6 {[Ag2 (oda)(PPh3)3].2H2O} (17)
0.390 g (1.0 mmol) of [Ag2(oda)] in 30mls of toluene reacted with 0.669 g (2.5 mmol)
of PPh3.
Yield:

0.649 g (61.35%)

% Calc: C 61.40, H 5.24, P 7.66, Ag 17.82
% found: C 61.02, H 5.07, P 7.44, Ag 17.34
Melting point: 131-136 ºC
IR (KBR): 3053.39, 2930.54, 2851.22, 2349.98, 2284.60, 1593.34, 1570.17,
1479.36, 1434.64, 1407.48, 1361.56, 1337.93, 1309.06, 1285.20, 1256.11,
1180.50, 1155.62, 1095.73, 1026.54, 996.84, 746.56, 693.60, 665.85, 618.58,
515.18, 499.60 cm−1.
Solubility: insoluble in water, ethanol, partially soluble in methanol, acetone,
chloroform and DMSO.

E.4.7 [Ag(ndaH)(PPh3)2] (18)
0.404 g (1.0 mmol) of [Ag2(nda)] in 30mls of toluene reacted with 0.669 g (2.5 mmol)
of PPh3
Yield: 0.578 g (53.91% )
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% Calc: C 65.94, H 5.53, P 7.56, Ag 13.16
% found: C 65.67, H 5.01, P 7.88, Ag 12.96
Melting point: 127-132 ºC
IR

(KBR):

2929.70,

2852.90,

2359.54,

1689.02,

1574.72,

1471.55,

1430.12,1405.66, 1344.10, 1273.17, 1232.96, 1193.77, 1098.25, 923.18, 904.06,
775.05, 719.11, 696.09, 539.67 cm−1 .
Solubility: insoluble in water, partially soluble in methanol, ethanol, acetone,
chloroform and DMSO.

E.4.8 [Ag2(dda)(PPh3)4].2C7H8 (19)
0.418 g (1.0 mmol) of [Ag2(dda)] in 30 mls of toluene reacted with 0.669 g (2.5 mmol)
of PPh3.
Yield: 0.7142 g (65.71%)
% Calc: C 69.82 , H 5.74, P7.50, Ag 12.86
% found: C 69.23, H 5.21, P 7.58, Ag 12.73
Melting point: 133-138 ºC
IR (KBR): 3051.98, 2923.75, 2849.14, 2359.49, 1893.40, 1714.21, 1597.09,
1569.64, 1479.67, 1466.11, 1434.47, 1407.79, 1357.90, 1307.97, 1267.09,
1236.04, 1186.45, 1156.84, 1096.38, 1070.92, 1027.06, 997.26, 916.34, 849.91,
753.70, 744.53, 694.60, 513.41, 502.11, 437.27 cm−1.
Solubility: partially soluble in water methanol, ethanol, acetone, chloroform and
DMSO.

E.4.9 [Ag2(udda)(PPh3)2] (20)
0.432 g (1.0 mmol) of [Ag2(udda)] in 30 mls of toluene reacted with 0.669 g (2.5 mmol)
of PPh3.
Yield: 0.6402 g (58.15%)
% Calc:

C 58.01, H 5.32 , P 6.63, Ag 22.60

% Found: C 59.46, H 5.00, P 6.63, Ag 22.38
Melting point: 126-131 ºC
IR (KBr): 3439.02, 3051.26, 2924.10, 2850.86, 1603.12, 1560.08, 1480.48,
1434.26, 1406.48, 1434.26, 1406.40, 1364.38, 1258.71, 1096.14, 744.65,
694.38, 520.06, 502.42 cm-1.
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Solubility: Partially soluble in chloroform and DMSO, insoluble in methanol,
acetone, water, ethanol.

E.4.10 [Ag2(ddda)(PPh3)3] (21)
0.446 g (1.0 mmol) of [Ag2(ddda)] in 30mls of toluene reacted with 0.669 g (2.5 mmol)
of PPh3.
Yield: 0.4967 g (45.70%)
% Calc: C 64.40, H 5.33, P 7.55, Ag 17.53
% found: C 64.55, H 5.53, P 7.43, Ag 17.23
Melting point: 128-133 ºC
IR (KBR): 3053.06, 2955.07, 2927.15, 2677.98, 2359.55, 2341.68, 1965.49,
1893.38, 1822.16, 1770.71, 1668.20, 1569.99, 1543.87, 1478.82, 1434.38,
1387.95, 1328.69, 1309.81, 1268.46, 1182.19, 1157.05, 1096.02, 1070.55,
1027.25, 996.89, 971.96, 914.78, 876.29, 850.42, 807.43, 744.97, 694.70,
660.08, 617.89, 513.15, 493.70, 439.68 cm−1.
Solubility: insoluble in water, partially soluble in methanol, ethanol, acetone,
chloroform, DMSO.

E.4.11 [Ag(uddcaH)(PPh3)2] (22)
0.460 g (1.0 mmol) of [Ag2(uddca)] in 30mls of toluene reacted with 0.669 g (2.5
mmol) of PPh3.
Yield: 0.487 g (43.13%)
% Calc: C 67.20, H 6.10, P 7.07, Ag 12.32
% found: C 66.83, H 6.02, P 7.31, Ag 12.45
Melting point: 134-138 ºC
IR (KBR): 3053,921, 2849, 1703, 1561, 1478, 1402, 1258, 1095, 996, 618, 523,
444 cm−1.
Solubility: insoluble in water, partially soluble in methanol, ethanol, acetone,
chloroform, DMSO.
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E.5 SYNTHESIS OF SILVER (I) DICARBOXYLATE COMPLEXES WITH
TRIPHENYLPHOSPHINE (PPh3)
E.5.1 [Ag2(prda)(PPh3)3].H2O (23)
0.319 g (1.0 mmol) of [Ag2(prda)] in 30 mls of toluene reacted with 1.049 g (4.0 mmol)
of PPh3.
Yield: 0.681 g (49.85%)
% Calc: C 60.98, H 4.4, P 8.28, Ag 19.22
% Found: C 60.95, H 4.29, P 8.18, Ag 19.22
Melting point: 132-137 ºC
IR (KBr): 3427, 1602, 1546, 1477, 1432, 1317, 1093, 1030, 983, 742, 694, 579,
514, 493 cm-1
Solubility: Partially soluble in water, chloroform, methanol and DMSO. Not
soluble in acetone.

E.5.2 [Ag2(bda)(PPh3)4] (24)
0.334 g (1.0 mmol) of [Ag2(bda)] in 30 mls of toluene reacted with 1.049 g (4.0 mmol)
of PPh3.
Yield: 0.9561 g (69.13%)
% Calc: C 66.1, H, 4.67, P 8.97, Ag 15.62
% Found: C 66.05, H, 4.76, P 8.44, Ag 15.53
Melting point: 131-136 ºC
IR (KBr): 3441, 3052, 1542, 1477, 1433, 1386, 1179, 1093, 1026, 995, 913, 743,
693, 659, 507, 491, 441cm-1.
Solubility: Partially soluble in chloroform, methanol, acetone and DMSO, not
soluble in water.

E.5.3 [Ag2(pda)(PPh3)4] (25)
0.348 g (1.0 mmol) of [Ag2(pda)] in 30 mls of toluene reacted with 1.049 g (4.0 mmol)
of PPh3.
Yield: 0.6251 g (44.74%)
% Calc: C 66.3, H 4.77, P 8.88, Ag 15.47
% Found: C 66.96, H 4.75, P 8.88, Ag 15.83
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Melting point: 130-135 ºC
IR (KBr): 3050, 1548, 1477, 1433, 1391, 1305, 1094, 1023, 990, 798, 743, 692,
499 cm-1.
Solubility: Partially soluble in water, chloroform and methanol, not soluble in
acetone and DMSO.

E.5.4 [Ag(hxdaH)(PPh3)3].3H2O (26)
0.362 g (1.0 mmol) of [Ag2(hxda)] in 30mls of toluene reacted with 1.049 g (4.0 mmol)
of PPh3.
Yield: 0.6425 g (45.53%)
% Calc: C 65.88, H 5.53, P 8.49, Ag 9.86
% Found: C 65.22, H, 4.98, P 8.39, Ag 9.12
Melting point: 126-131 ºC
IR (KBr): 3053, 3931, 1708, 1572, 1551, 1478, 1434, 1395, 1310, 1246, 1095,
1026, 996, 745, 693, 612, 512, 501, 426 cm-1.
Solubility: Partially soluble in chloroform and methanol, not soluble in water,
acetone and DMSO.

E.5.5 [Ag2(hpda)(PPh3)4].C7H8 (27)
0.376 g (1.0 mmol) of [Ag2(hpda)] in 30mls of toluene reacted with 1.049 g (4.0 mmol)
of PPh3.
Yield: 0.7753 g (54.40%)
% Calc: C 68.17, H 5.19, P 8.18, Ag 14.24
% Found: C 68.72, H 5.20, P 8.14, Ag 14.77
Melting point: 127-132 ºC
IR (KBr): 3433, 3048, 1546, 1477, 1433, 1393, 1308, 1093, 1025, 994, 883, 837,
747, 692, 503 cm-1.
Solubility: Partially soluble in water, chloroform, methanol, acetone and DMSO.

E.5.6 [Ag(odaH)(PPh3)2].C7H8 (28)
0.390 g (1.0 mmol) of [Ag2(oda)] in 30 mls of toluene reacted with 1.049 g (4.0 mmol)
of PPh3.
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Yield: 0.8449 g (58.71%)
% Calc: C 68.23, H 5.73, P 6.90, Ag 12.02
% Found: C 69.96, H 5.43, P 7.86, Ag 12.34
Melting point: 128-132 ºC
IR (KBr): 2920, 2851, 1704, 1583, 1546, 1494, 1478, 1433, 1399, 1254, 1180,
1156, 1094, 1025, 995, 746, 694, 515, 493, 417 cm-1.
Solubility: Partially soluble in chloroform and methanol, not soluble in water,
acetone and DMSO.
Note: Crystals of 28 deposited when the mother liquor was allowed to stand for
several weeks.

E.5.7 [Ag(ndaH)(PPh3)2]. (29)
0.404 g (1.0 mmol) of [Ag2(nda)] in 30 mls of toluene reacted with 1.049 g (4.0 mmol)
of PPh3.
Yield: 0.7992 g (55.00%)
% Calc: C 65.94, H 5.53, P 7.56, Ag 13.16
% Found: C 65.59, H 4.92, P 8.71, Ag 13.87
Melting point: 129-134 ºC
IR (KBr): 3053, 2931, 2360, 2341, 1700, 1572, 1550, 1478, 1434, 1389, 1312,
1095, 1026, 996, 911, 744, 705, 693, 668, 503, 427cm-1.
Solubility: Partially soluble in chloroform, methanol, acetone and DMSO, not
soluble in water.

E.5.8 [Ag2(dda)(PPh3)4].H2O (30)
0.418 g (1.0 mmol) of [Ag2(dda)] in 30 mls of toluene reacted with 1.049 g (4.0 mmol)
of PPh3.
Yield: 0.7499 g (51.11%)
% Calc: C 66.41, H 5.3, P 8.35, Ag 14.28
% Found: C 66.05, H 5.66, P 8.47, Ag 14.89
Melting point: 130-135 ºC
IR (KBr): 3442, 3051, 2921, 2849, 2360, 1635, 1478, 1433, 1282, 1180, 1095,
1027, 995, 752, 693, 512, 499 cm-1.
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Solubility: Partially soluble in water, chloroform, methanol and acetone, not
soluble in DMSO.

E.5.9 [Ag2(udda)(PPh3)3] (31)
0.432 g (1.0 mmol) of [Ag2(udda)] in 30 mls of toluene reacted with 1.049 g (4.0 mmol)
of PPh3
Yield: 0.5171g (34.91%)
% Calc: C 64.16, H 5.22, P 7.64, Ag 17.73
% Found: C 64.52, H 5.03, P 7.69, Ag 17.86
Melting point: 131-136 ºC
IR (KBr): 3441.02, 3050.80, 2922.24, 2852.36, 1556.15, 1479.38, 1433.11,
1394.80, 1304.04, 1183.92, 1157.17, 1094.59, 1068, 1027.29, 997.18, 743.29,
693.62, 617.78, 512.73, 503.19, 438.61cm-1.
Solubility: Insoluble in methanol, chloroform, ethanol, acetone, DMSO and
water.
Note: Crystals of [Ag2 (udda)(PPh3)4](31A) deposited from the mother liquor after it
was left standing for several weeks.

E.5.10 [Ag2(dddaH)(PPh3)3] (32)
0.446 g (1.0 mmol) of [Ag2(ddda)] in 30 mls of toluene reacted with 1.049 g (4.0 mmol)
of PPh3.
[Ag(dddaH)(PPh3)3] 32 deposited, in very low yield, as crystals. The formulation is
based on the X-ray crystallographic analysis.

E.5.11 [Ag2(uddcaH)(PPh3)2] (33)
0.460 g (1.0 mmol) of [Ag2(udda)] in 30 mls of toluene reacted with 1.049 g (4.0 mmol)
of PPh3. [Ag(uddcaH)(PPh3)2] 33 deposited in very low yield as crystals. The
formulation is based on the x-ray crystallographic analysis.
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E.6 SYNTHESIS OF SILVER (I) DICARBOXYLATE COMPLEXES WITH
TRIPHENYLPHOSPHINE (PPh3)
E.6.1 [Ag2(prda))(PPh3)3].H2O (23)
0.319 g (1.0 mmol) of [Ag2(prda)] in 30 mls of toluene reacted with 1.574 g (6.0 mmol)
of PPh3.
Yield: 0.8479 g (44.79%)
% Calc: C 60.98, H 4.40, P 8.28, Ag 19.22
% Found: C 62.97, H 4.47, P 8.41, Ag 19.76
Melting point: 132-137 ºC
IR (KBr): 3051, 1545, 1477, 1432, 1317, 1182, 1093, 1023, 990, 742, 694, 579,
514, 493 cm-1.
Solubility: Partially soluble in chloroform and methanol, not soluble in water,
acetone and DMSO.

E.6.2 [Ag2(bda)(PPh3)4](24)
0.334 g (1.0 mmol) of [Ag2(bda)] in 30 mls of toluene reacted with 1.574 g (6.0 mmol)
of PPh3.
Yield: 1.0701 g (56.08%)
% Calc: C 66.1, H 4.67, P 8.97, Ag 15.62
% Found: C 66.59, H 4.77, P 9.07, 15.01
Melting point: 133-138 ºC
IR (KBr): 3052, 1543, 1477, 1433, 1387, 1308, 1093, 1025, 995, 910, 744, 659,
503 cm-1.
Solubility: Partially soluble in chloroform, methanol, acetone and DMSO, not
soluble in water.

E.6.3 [Ag2(pda)(PPh3)4] (25)
0.348 g (1.0 mmol) of [Ag2(pda)] in 30 mls of toluene reacted with 1.574 g (6.0 mmol)
of PPh3.
Yield: 0.9519 g (49.52%)
% Calc: C 66.30, H 4.77, P 8.88, Ag 15.47
% Found: C 65.74, H 4.75, P 8.71, Ag 15.33
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Melting point: 134-138 ºC
IR (KBr): 3050, 1548, 1477, 1433, 1391, 1305, 1181, 1094, 1027, 994, 888, 743,
705, 692, 500, 431cm-1.
Solubility: Partially soluble in chloroform, methanol, ethanol, DMSO, insoluble
in acetone and water.

E.6.4 [Ag2(hxdaH)(PPh3)2].C7H8

(34)

0.362 g (1.0 mmol) of [Ag2(hxda)] in 30 mls of toluene reacted with 1.574 g (6.0 mmol)
of PPh3.
Yield: 1.311 g (67.71%)
% Calc: C 64.87, H 5.06, P 7.97, Ag 22.07
% Found: C 64.78, H 5.13, P7.80, Ag 22.76
Melting point: 126-131 ºC
IR (KBr): 2922, 1723, 1547, 1478, 1434, 1397, 1309, 1242, 1095, 1026, 995,
745, 694, 440 cm-1.
Solubility: Partially soluble in chloroform, methanol, ethanol, DMSO, insoluble
in acetone and water.

E.6.5 [Ag2(hpda)(PPh3)5].C7H8 (35)
0.376 g (1.0 mmol) of [Ag2(hpda)] in 30 mls of toluene reacted with 1.574 g (6.0 mmol)
of PPh3.
Yield: 1.401g (71.84%)
% Calc: C 70.28, H 5.27, P 8.71, Ag 12.14
% Found: C 70.64, H 5.17, P 9.67, Ag 12.86
Melting point: 127-132 ºC
IR (KBr): 3045, 1585, 1555, 1478, 1433, 1381, 1080, 1023, 994, 742, 692, 510,
434 cm-1.
Solubility: Partially soluble in chloroform and methanol, not soluble in water,
acetone and DMSO.
E.6.6 [Ag2(oda)(PPh3)4].2C7H8 (36)
0.390 g (1.0 mmol) of [Ag2(oda)] in 30 mls of toluene reacted with 1.574 g (6.0 mmol)
of PPh3
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Yield: 1.3786 g (70.19%)
% Calc:

C 69.63, H 5.47, P 7.64, Ag 13.31

% Found: C 69.02, H 5.44, P 7.86, Ag 13.66
Melting point: 128-133 ºC
IR (KBr): 3054, 2921, 2851, 1546, 1478, 1434, 1399, 1308, 1095, 1026, 996,
746, 694, 515, 504, 493,466, 418cm-1.
Solubility: Partially soluble in chloroform and methanol, not soluble in water,
acetone and DMSO.

E.6.7 [Ag(ndaH)(PPh3)2] (29)
0.404 g (1.0 mmol) of [Ag2(nda)] in 30 mls of toluene reacted with 1.574 g (6.0 mmol)
of PPh3
Yield: 1.206 g (60.97%)
% Calc:

C 65.94, H 5.53, P 7.56, Ag 13.16

% Found: C 65.59, H 4.92, P 8.71, Ag 13.91
Melting point: 129-134 ºC
IR (KBr): 3053, 2931, 1701, 1550, 1572, 1478, 1434, 1389, 1313, 1247, 1095,
1026, 996, 911, 744, 693, 612, 503, 427 cm-1.
Solubility: Partially soluble in chloroform and methanol, not soluble in water,
acetone and DMSO.

E.6.8 [Ag2(dda)(PPh3)4].H2O (30)
0.418 g (1.0 mmol) of [Ag2(dda)] in 30 mls of toluene reacted with 1.574 g (6.0 mmol)
of PPh3.
Yield: 1.298 g (65.16%)
% Calc:

C 66.41, H 5.3, P 8.35, Ag 14.55

% Found: C 66.05, H 5.66, P 8.47, Ag 14.67
Melting point: 130-135 ºC
IR (KBr): 3051, 2921, 2849, 1701, 1635, 1478, 1433, 1309, 1180, 1095, 1027,
995, 752, 693, 499 cm-1.
Solubility: Partially soluble in chloroform and methanol, not soluble in water,
acetone and DMSO.
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E.6.9 [Ag2(udda)(PPh3)4] (37)
0.432 g (1.0 mmol) of [Ag2(udda)] in 30 mls of toluene reacted with 1.574 g (6.0 mmol)
of PPh3
Yield: 1.364 g (67.99%)
% Calc:

C67.40, H 5.32, P 8.38, Ag 14.59

% Found: C 67.28, H 5.27, P 8.51, Ag 14.99
Melting point: 131-136 ºC
IR (KBr): 3051, 2923, 2852, 1556, 1479, 1433, 1395, 1304, 1094, 1027, 743,
693, 512, 503, 438 cm-1.
Solubility: Partially soluble in chloroform and methanol, not soluble in water,
acetone and DMSO.

E.6.10 [Ag2(uddca)(PPh3)5].C7H8 (38)
0.460 g (1.0 mmol) of [Ag2(uddca)] in 30 mls of toluene reacted with 1.574 g (6.0
mmol) of PPh3
Yield: 1.134 g (55.75%)
% Calc:

C70.97, H 5.69, P 8.32, Ag 11.59

% Found: C 70.87, H 5.57, P 9.03, Ag 11.34
Melting point: 132-137ºC
IR (KBr): 3051, 2918, 2846, 1563, 1433, 1476, 1380, 1307, 1178, 1091, 1068,
1026, 996, 742, 617, 512, 420 cm-1.
Solubility: Partially soluble in chloroform and methanol, not soluble in water,
acetone and DMSO.
Note : Crystals of [Ag2(uddca)(PPh3)6] 38A deposited from the mother liquor
when it was left to stand for several weeks.
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E.7 SYNTHESIS OF SILVER DIPHENYLPHOSPHINEMETHANE
COMPLEXES
E.7.1 [Ag2(prda)(dppm)3].C7H8 (39)
0.319 g (1.0 mmol) of [Ag2(prda)] in 30 mls of toluene reacted with 0.768 g (2.0
mmol) of Dppm.
Yield: 0.9759 g (89.77%)
% Calc: C 58.24, H 4.89, P 9.19, Ag 21.35
% Found: C 58.72, H 4.50, P 9.98, Ag 21.09
Melting point: 133-138 ºC
IR (KBr): 3644.35, 3426.46, 3049.19, 1592.27, 1537.01, 1483.35, 1434.77,
1336.15, 1241.36, 1164.94, 1100.61, 1025.67, 998.26, 910.64, 794.44, 737.94,
720.35, 692.76, 515.46, 503.81, 480.05 cm-1.
Solubility: Partially soluble in methanol, ethanol, DMSO, acetone, chloroform,
insoluble in water

E.7.2 [Ag2(bda)(dppm)3].C7H8 (40)
0.334 g (1.0 mmol) of [Ag2(bda)] in 30 mls of toluene reacted with 0.768 g (2.0
mmol) of Dppm.
Yield: 0.9164 g (83.15%)
% Calc: C 58.61, H 5.02, P 9.07, Ag 21.06
% Found: C 57.40, H 4.31, P 9.97, Ag 21.88
Melting point: 126-131 ºC
IR (KBr): 3660.25, 3426.30, 3052.71, 1547.11, 1483.81, 1435.41, 1385.50,
1100.09, 1000.04, 760.31, 736.84, 722.32, 693.77, 515.13, 480.51, 428.83 cm-1.
Solubility: insoluble in methanol, partially soluble in water, ethanol, acetone,
chloroform and DMSO

E.7.3 [Ag2(pda)(dppm)4] (41)
0.348 g (1.0 mmol) of [Ag2(pda)] in 30 mls of toluene reacted with 0.768 g (2.0
mmol) of Dppm.
Yield: 0.9236 g (82.75%)
% Calc: C 59.05, H 4.87, P 11.08, Ag 18.81
% Found: C58.07, H 4.47, P 10.41, Ag 18.91
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Melting point: 127-132 ºC
IR (KBr): 3432.35, 3050.34, 1557.02, 1483.46, 1435.28, 1382.45, 1100.70,
737.47, 696.16, 515.68, 480.30 cm-1.
Solubility: insoluble in water, ethanol, acetone, DMSO, partially soluble in
methanol, chloroform

E.7.4 [Ag2(hxda)(dppm)4] (42)
0.362 g (1.0 mmol) of [Ag2(hxda)] in 30 mls of toluene reacted with 0.768 g (2.0
mmol) of Dppm.
Yield: 0.580 g (51.32%)
% Calc: C 60.02, H 5.21, P 10.67, Ag 18.59
% Found: C 59.00, H 4.66 , P10.26, Ag 18.83
Melting point: 128-133 ºC
IR (KBr): 3434.27, 3049.86, 2922.70, 1555.25, 1483.83, 1436.18, 1390.71,
1311.50, 1142.58, 1100.20, 999.14, 784.56, 739.88, 720.78, 694.84, 516.29,
479.92 cm-1.
Solubility: partially soluble in ethanol, DMSO, chloroform, insoluble in
methanol, water, acetone.

E.7.5 [Ag2(hpda)(dppm)4] (43)
0.376 g (1.0 mmol) of [Ag2(hpda)] in 30 mls of toluene reacted with 0.768 g (2.0
mmol) of dppm.
Yield: 0.9505 g (83.08%)
% Calc:

C 60.32, H 5.32, P 10.55, Ag 18.36

% Found: C 59.46, H 4.65, P 11.02, Ag 18.78
Melting point: 129-134 ºC
IR (KBr): 3424.14, 3050.37, 2937.01, 1559.41, 1483.63, 1435.27, 1395.44,
1099.57, 1026.34, 999.10, 737.88, 720.10, 693.84, 515.35, 480.02cm-1.
Solubility: insoluble in water, ethanol, acetone, partially soluble in methanol,
chloroform and DMSO
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E.7.6 [Ag2(oda)(dppm)4] (44)
0.390 g (1.0 mmol) of [Ag2(oda)] in 30 mls of toluene reacted with 0.768 g (2.0
mmol) of dppm.
Yield: 0.689 g (59.49%)
% Calc: C 60.62, H 5.43, P 10.42, Ag 18.15
% Found: C 60.47, H 4.99, P 10.00, Ag 18.76
Melting point: 130-135 ºC
IR (KBr): 3432.58, 3050.99, 2940.41, 1560.87, 1484.33, 1435.37, 1389.85,
1100.00, 999.47, 740.40, 722.41, 694.79, 515.93, 482.32 cm-1.
Solubility: insoluble in water, partially soluble in methanol, ethanol, acetone,
chloroform and DMSO

E.7.7 [Ag2(nda)(dppm)4] (45)
0.404 g (1.0 mmol) of [Ag2(nda)] in 30 mls of toluene reacted with 0.768 g (2.0
mmol) of dppm.
Yield: 0.9435 g (80.50%)
% Calc: C 60.91, H 5.53, P 10.30, Ag 17.94
% Found: C 59.67, H 4.93, P 10.82, Ag 17.62
Melting point: 131-136 ºC
IR (KBr): 3426.72, 3051.37, 2929.90, 1553.79, 1483.62, 1435.34, 1392.50,
1099.21, 999.16, 740.87, 721.31, 693.97, 514.83, 480.77 cm-1.
Solubility: partially soluble in water methanol, ethanol, acetone, chloroform and
DMSO

E.7.8 [Ag(ddaH)(dppm)3].3H2O (46)
0.418 g (1.0 mmol) of [Ag2(dda)] in 30 mls of toluene reacted with 0.768 g (2.0
mmol) of dppm.
Yield: 0.5925 g (49.95%)
% Calc: C 61.10, H 5.79, P 10.16, Ag 11.19
% Found: C 60.61, H5.29, P 9.88, Ag 11.33
Melting point: 132-137 ºC
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IR (KBr): 3450.30, 3051.37, 2923.89, 2849.61, 1714.34, 1555.08, 1483.28,
1434.92, 1386.65, 1306.68, 1183.53, 1099.85, 1026.14, 998.65, 785.21, 740.09,
719.67, 694.71, 515.19, 481.69, 440.32 cm-1.
Solubility: insoluble in water methanol, ethanol, acetone, chloroform and
DMSO

E.7.9 [Ag2(udda)(dppm)4] (47)
0.432 g (1.0 mmol) of [Ag2(udda)] in 30 mls of toluene reacted with 0.768 g (2.0
mmol) of dppm.
Yield: 0.730 g (60.83%)
% Calc: C 61.48, H 5.73, P 10.07, Ag 17.53
% Found: C 60.84, H 5.15, P 10.46, Ag 17.98
Melting point: 133-138 ºC
IR (KBr): 3431.91, 3050.22, 2922.36, 2850.19, 1552.42, 1483.32, 1435.08,
1394.67, 1099.33, 999.03, 788.47, 739.67, 721.42, 693.37, 515.21, 480.47,
442.86 cm-1.
Solubility: Insoluble in water, partially soluble in methanol, ethanol, DMSO,
Chloroform and acetone.

E.7.10 [Ag2(ddda)(dppm)4].H2O (48)
0.446 g (1.0 mmol) of [Ag2(ddda)] in 30 mls of toluene reacted with 0.768 g (2.0
mmol) of dppm.
Yield: 0.7163 g (59.03%)
% Calc: C 61.57, H 6.32, P 9.48, Ag 17.08
% Found: C 61.43, H 5.61, P 9.36, Ag 17.69
Melting point: 126-131 ºC
IR (KBr): 3431.61, 3051.65, 2923.27, 2850.51, 2359.66, 1553.15, 1484.55,
1435.63, 1386.15, 1100.18, 999.41, 789.90, 740.27, 722.98, 694.61, 516.62,
481.04 cm-1.
Solubility: insoluble in water, ethanol, acetone, partially soluble in methanol,
chloroform, DMSO
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E.7.11 [Ag2(uddca)(dppm)4].2H2O (49)
0.460 g (1.0 mmol) of [Ag2(uddca)] in 30 mls of toluene reacted with 0.768 g
(2.0 mmol) of dppm.
Yield: 0.8652 g (70.45%)
% Calc:

C 60.29, H 6.07, P 9.57, Ag 16.66

% Found: C 59.71, H 5.25, P 9.93, Ag 16.98
Melting point: 127-132 ºC
IR (KBr): 3423.18, 3051.30, 3019.92, 2920.52, 2850.36, 1550.73, 1484.47,
1466.33, 1435.47, 1396.68, 1309.65, 1145.59, 1099.88, 1026.29, 999.31,
788.47, 740.26, 723.32, 693.96, 668.79, 516.56, 479.79, 438.99 cm-1.
Solubility: insoluble in water, partially soluble in methanol, ethanol, acetone,
chloroform and DMSO

E.8 SYNTHESIS OF SILVERDICARBOXYLATE
DIPHENYLPHOSPHINETHANE COMPLEXES

E.8.1 [Ag2(prda)(dppe)4].H2O (50)
0.319 g (1.0 mmol) of [Ag2(prda)] in 30 mls of toluene reacted with 0.797 g (2.0
mmol) of dppe.
Yield: 0.906 g (81.18%)
% Calc: C 59.41, H 5.41, P 10.39, Ag 18.09
% Found: C 58.24, H 4.48, P 11.32, Ag 18.81
Melting point: 128-133 ºC
IR (KBr): 3431.68, 3051.61, 1556.21, 1482.77, 1434.60, 1331.95, 1175.42,
1100.34, 1026.57, 998.93, 926.06, 742.99, 723.86, 694.59, 654.76, 509.74,
482.64, 447.22 cm-1.
Solubility: partially soluble in ethanol, DMSO, insoluble in methanol, acetone,
chloroform, water

E.8.2 [Ag2(bda)(dppe)4] (51)
0.334 g (1.0 mmol) of [Ag2(bda)] in 30 mls of toluene reacted with 0.797 g (2.0
mmol) of dppe.
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Yield: 0.608 g (53.75%)
% Calc: C 60.62, H 5.43, P 10.42, Ag 18.15
% Found: C 59.63, H 4.75, P 10.98, Ag 18.93
Melting point: 129-134ºC
IR (KBr): 3432.01, 3052.01, 1552.07, 1482.66, 1434.25, 1405.33, 1176.51,
1100.09, 1026.42, 998.84, 744.04, 729.65, 694.70, 656.18, 511.84, 479.87 cm-1.
Solubility: partially soluble in water, acetone, methanol, ethanol, chloroform and
DMSO

E.8.3 [Ag2(pda)(dppe)3].4H2O (52)
0.348 g (1.0 mmol) of [Ag2(pda)] in 30 mls of toluene reacted with 0.797g (2.0
mmol) of dppe.
Yield: 0.7261 g (63.41%)
% Calc:

C 53.22, H 5.61, P 8.76, Ag 20.34

% Found: C 52.17, H 4.21, P 9.46, Ag 20.49
Melting point: 130-135ºC
IR (KBr): 3418.67, 3050.54, 1552.60, 1482.99, 1434.13, 1400.26, 1311.86,
1176.71, 1099.57, 1069.05, 1026.53, 998.82, 884.74, 740.81, 726.81, 694.68,
511.33, 481.78, 449.11 cm-1.
Solubility: partially soluble in methanol, chloroform, insoluble in ethanol,
acetone, DMSO

E.8.4 [Ag2(hxda)(dppe)4] (53)
0.362 g (1.0 mmol) of [Ag2(hxda)] in 30 mls of Toluene reacted with 0.797 g
(2.0 mmol) of dppe.
Yield: 0.8416 g (72.56%)
% Calc: C 61.20, H 5.63, P 10.18, Ag 17.73
% Found: C 61.78, H 5.10, P 10.53, Ag 17.11
Melting point: 131-136 ºC
IR (KBr): 3432.85, 3049.13, 2919.94, 1691.01, 1555.63, 1483.18, 1434.45,
1403.85, 1310.76, 1239.33, 1099.39, 1069.60, 1026.86, 999.63, 881.40, 741.52,
718.84, 692.97, 513.53, 482.10 cm-1.
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Solubility: partially soluble in water, methanol, ethanol, DMSO, insoluble in
acetone, chloroform.

E.8.5 [Ag2(hpda)(dppe)3] (54)
0.376 g (1.0 mmol) of [Ag2(hpda)] in 30 mls of toluene reacted with 0.797 g (2.0
mmol) of dppe.
Yield: 0.6965 g (59.37%)
% Calc: C 57.89, H 5.45, P 9.14, Ag 21.22
% Found: C 56.84, H 4.80, P 10.26, Ag 21.99
Melting point: 132-137 ºC
IR (KBr): 3427.21, 3049.98, 2927.69, 1548.43, 1482.84, 1434.58, 1401.36,
1308.83, 1177.74, 1100.15, 1069.08, 1026.16, 998.58, 925.59, 743.48, 758.43,
693.36, 509.87, 480.28, 447.93 cm-1.
Solubility: insoluble in water methanol, ethanol, acetone, chloroform and
DMSO

E.8.6 [Ag2(oda)(dppe)4] (55)
0.390 g (1.0 mmol) of [Ag2(oda)] in 30 mls of toluene reacted with 0.797 g (2.0
mmol) of dppe.
Yield: 0.845 g (71.18%)
% Calc: C 61.75, H 5.83, P 9.95, Ag 17.73
% Found: C 60.13, H 5.02, P 10.25, Ag 17.86
Melting point: 133-138 ºC
IR (KBr): 3441.09, 2935.88, 1545.08, 1483.44, 1434.23, 1398.45, 1175.72,
1100.11, 1027.33, 740.83, 726.94, 693.94, 511.59, 477.76 cm-1.
Solubility: insoluble in water methanol, ethanol, acetone, chloroform and
DMSO

E.8.7 [Ag2(nda)(dppe)4].2H2O (56)
0.404 g (1.0 mmol) of [Ag2(nda)] in 30 mls of toluene reacted with 0.797 g (2.0
mmol) of dppe.
Yield: 0.7634 g (63.56%)
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% Calc: C 60.29, H 6.07, P 9.57, Ag 16.66
% Found: C 60.43, H 5.17, P 10.71, Ag 16.88
Melting point: 127-132ºC
IR (KBr): 3433.58, 3050.30, 2922.85, 1560.67, 1482.99, 1434.25, 1399.80,
1175.42, 1099.22, 1026.42, 999.34, 741.71, 723.43, 694.82, 510.84,481.90 cm-1.
Solubility: insoluble in water methanol, ethanol, acetone, chloroform and
DMSO.

E.8.8 [Ag2(dda)(dppe)4] (57)
0.418 g (1.0 mmol) of [Ag2(dda)] in 30 mls of toluene reacted with 0.797 (2.0
mmol) of dppe.
Yield: 0.8132 g (66.93%)
% Calc: C 62.27, H 6.02, P 9.73, Ag 16.95
% Found: C 62.52, H 5.57, P 10.29, Ag 16.17
Melting point: 128-133ºC
IR (KBr): 3438.20, 3051.81, 2923.91, 2850.61, 1556.19, 1482.94, 1434.57,
1404.53, 1233.75, 1174.62, 1099.92, 1026.53, 999.10, 744.66, 726.85, 694.85,
510.55, 481.80 cm-1.
Solubility: insoluble in water methanol, ethanol, acetone, chloroform, partially
soluble in DMSO

E.8.9 [Ag2(udda)(dppe)4].H2O (58)
0.432 g (1.0 mmol) of [Ag2(udda)] in 30 mls of toluene reacted with 0.797 g
(2.0 mmol) of dppe.
Yield: 0.950 g (77.29%)
% Calc: C 61.67, H 6.18, P 9.49, Ag 16.53
% Found: C 61.49, H 5.51, P 9.29, Ag 16.13
Melting point: 129-134 ºC
IR (KBr): 3439.42, 3052.04, 2923.37, 2850.50, 1550.42, 1483.01, 1434.50,
1399.88, 1311.59, 1176.36, 1099.98, 1026.51, 999.24, 729.77, 695.28, 509.52,
482.64 cm-1.
Solubility: partially soluble in water, DMSO, chloroform, insoluble in methanol,
ethanol and acetone.
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E.8.10 [Ag2(ddda)(dppe)4] (59)
0.446 g (1.0 mmol) of [Ag2(ddda)] in 30 mls of toluene reacted with 0.797 g (2.0
mmol) of dppe.
Yield: 0.5731 g (46.10%)
% Calc: C 62.78, H 6.20, P 9.52, Ag 16.57
% Found: C 63.62, H 5.74 , P 9.59, Ag 16.61
Melting point: 130-135ºC
IR (KBr): 3442.72, 3052.64, 2920.17, 2849.27, 1697.99, 1637.97, 1555.56,
1482.84, 1434.42, 1403.17, 1255.57, 1185.55, 1099.39, 1026.56, 999.35,
881.87, 743.43, 695.04, 512.03, 481.54 cm-1.
Solubility: insoluble in water methanol, ethanol, DMSO, soluble in acetone,
chloroform.

E.8.11 [Ag2(uddca)(dppe)4] (60)
0.460 g (1.0 mmol) of [Ag2(uddca)] in 30 mls of toluene reacted with 0.797 g
(2.0 mmol) of dppe.
Yield: 0.681 g (54.17%)
% Calc: C 63.02, H 6.29, P 9.42, Ag 16.41
% Found: C62.40, H5.66, P 9.89, Ag 16.75
Melting point: 131-136 ºC
IR (KBr): 3439.52, 3051.83, 2922.59, 2850.66, 1741.22, 1630.31, 1551.14,
1483.12, 1466.31, 1434.38, 1400.48, 1310.81, 1274.67, 1175.44, 1099.70,
1069.56, 1026.98, 999.30, 881.77, 743.05, 728.98, 694.95, 510.92, 481.88 cm-1.
Solubility: insoluble in water, DMSO, soluble in methanol, ethanol, acetone,
chloroform.
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E.9 BIOLOGICAL PREPARATIONS AND METHODS

Fungal isolates: A Candida albicans isolate was obtained from ATCC (American
Type Culture Collection, Maryland USA) 10231. The isolate was stored on
Sabouraud Dextrose Agar (SDA) plates at 4C, and was sub cultured monthly from
the initial culture received.
Sterilisation: was achieved by autoclaving at 121C and 100 lbs/inch for 15mins.
Cell density: 0.250 OD cells in 5mls of Phosphate Buffered Saline (PBS).
R1 Minimal Media (R1MM): is a media made up of Yeast Nitrogen Base without
amino acids (Ynb) obtained from Becton, Dickenson and Company (Ref: 291940) and
D (+) Glucose Monohydrate obtained from Reidal-de Haën (Charge lot: 61850). Ynb
(0.67g) was dissolved in 100 ml of cold distilled water along with D (+) Glucose
Monohydrate (2 g) in a 200 ml duran bottle. The resulting solution was then left to
stand for 5 mins and then autoclaved, after autoclaving the bottle was allowed to cool
before transfer to multiwell plate. The media was stored at 4C.
Tests were carried out on overnight cultures of candida grown in sabraud’s agar
(Oxoid) which was made up according to manufacturing instructions. The antifungal
experiments were carried out in R1 minimal media.
Phosphate buffer saline (PBS): was obtained from Sigma (Lot 71K8201) in tablet
form and was prepared as follows:
1 tablet was dissolved in cold distilled water (100 ml) and the resulting solution
autoclaved for 15 mins.
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E.9.1 Preparation of complex solutions for antimicrobial susceptibility testing
Solutions of suspensions of test complexes were prepared by dissolving (0.1 g) in 5%
(5 ml) of DMSO and diluting to 100 cm3 using distilled water to yield a stock solution
at a concentration of 1000 g/ml.

E.9.2 Antimicrobial Susceptibility testing methods
Yeast susceptibility testing: Each test complex was made into solution following the
method, from these stock solutions a series of different concentrations were obtained
by dilution. Concentrations of 1.0 g/ml, 0.5 g/ml, 0.25 g/ml, 0.1 g/ml, 0.09
g/ml, 0.08 g/ml, 0.07 g/ml and 0.05 g/ml were obtained and through testing the
IC50 (minimum inhibitory concentration) for each compound was calculated, this was
done as follows:
96 well microarray analysis plates (Figure 69) were used for yeast susceptibility
testing. These plates contained 96 wells in which 10g/ml of each test solution could
be added to every three consecutive wells. A Control, Blank, Amphotericin B (Amp
B), Silver Nitrate (AgNO3) and Silver Acetate (Ag2(CH3COO)2) were also added to
the plate. Before each experiment the candida cell density was determined and
adjusted to OD 0.25 by diluting in PBS (Sigma Aldrich), made up according to
manufacturer’s instructions.
Control 1: This was used as a standard to which the compounds could be tested
against. The control was a suspension of R1 minimal media containing 0.250 OD
cells of C. albicans. 100 l of the control media was then added to the first three wells
on the plate.
Control 2: Blank; this was a solution of R1MM (100 g/ml) usually added to the last
three wells on the plate, this was a reference to show that the media containing no
cells and no test solution would show no growth of cells.
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Control 3: Amphotericin B; Amp B is well known antifungal agent. This was added to
the cells to see how good the test compounds measured against one of the best on the
market. 100 g/ml of this solution was added to the next three consecutive wells after
the control 1.
Control 4: Silver Nitrate (AgNO3) and Silver acetate (AgAoc); were added to see how
silver compounds containing no ligand derivative would fair against the test
complexes containing a dicarboxylic acid. 10 g/ml of these solutions were added to
the next wells after Amp B. Test complexes were now added at different
concentrations to the next available wells.
To the wells containing the test complexes, Amp B, AgNO3 and Ag2(CH3COO)2, 90
g/ml of the R1MM containing C. albicans cells were added, the plate was then
loaded onto the spectrophotometer and measured at a temp of 37 ºC and left for 24
hrs, with readings being taken every 4 hrs. Each run was done in triplicate meaning it
was done once a day for three days. The results were then calculated for IC50 of each
complex.
Figure 69: 96 well plate
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E.9.2.1 Antibacterial test
The antibacterial activity of a series of silver inorganic complexes against a selection
of Grampositive and Gramnegative bacteria was determined using inoculated 96 well
plates. A total of seven concentrations of each of silver complex, ligand and silver
nitrate control were assessed for antibacterial activity. These concentrations were: 50
ppm, 25 ppm, 10 ppm, 5 ppm, 2.5 ppm, 1 ppm and 0.1 ppm. The water insoluble
complexes were initially dissolved in DMSO, and subsequently diluted in de-ionised
water to give the desired concentrations. The bacterial strains tested were MRSA
(clinical isolate), S. aureus (ATCC 25922), E. coli (ATCC 25923) and E. coli (clinical
isolate). Stock cultures of the bacteria were grown on plate count agar (PCA-3% w/v
tryptone, 1% w/v glucose, 2.5 % w/v yeast, 9 % w/v agar, Oxoid). These organisms
were grown overnight in nutrient rich broth to give a concentration of approximately
108 cfu/ml. These were diluted one in ten thousand with maximum recovery diluent
(MRD – 1 % w/v peptone, 8.5 % w/v NaCl, Oxoid) to give working concentrations of
approximately 104 cfu/ml. 10 l aliquots of each concentration of material was placed
in separate wells of a 96 well plate. Each test well was inoculated with 90 l of the
working 104 cfu/ml bacterial isolates. The resulting wells were incubated overnight at
37°C. Wells containing the ligands, silver nitrate (reference) and bacterial blanks were
also prepared. All tests were performed in duplicate. The optical absorbance of the
wells was obtained using an ELISA reader at 632 nm. The resulting absorbance
values were plotted against the concentration.
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CONCLUSION

158

The purpose of this study was to generate a series of light stable silver complexes for
application as potential antimicrobial agents. The strategy employed the use of the
aliphatic α, ω-dicarboxylic acids HOOC-(CH2)n-COOH (where n = 1-11) as primary
ligands and counter ions. These versatile ligands have previously been shown, in this
laboratory, to promote variations in structure and nuclearity (chain length dependent).
The auxiliary ligands chosen were the neutral donor phosphines PPh3, dppm and dppe
which are known to stabilize Ag+ complexes.66
The α, ω-dicarboxylic acids reacted smoothly with [Ag(CH3COO)] to yield the silver
dicarboxylate complexes [Ag2(prda)] (1), [Ag2(bda)] (2), [Ag2(pda)] (3), [Ag2(hxda)]
(4), [Ag2(hpda)](5), [Ag2(oda)] (6), [Ag2(nda)] (7), [Ag2(dda)] (8), [Ag2(udda)] (9),
[Ag2(ddda)] (10) and [Ag2(uddca)] (11). Complexes 1-11 were reacted with PPh3 in
1:2.5, 1:4 and 1:6 molar ratios and with the dppm and dppe in 1:2 molar ratios,
respectively.
Thecomplexes[Ag2(prda)(PPh3)3](12),[Ag2(bda)(PPh3)3].C7H8(13),
[Ag2(pda)(PPh3)3].2H2O (14), [Ag(hxdaH)(PPh3)2] (15)
{Ag(hpdaH)(PPh3)3.2H2O}n(16),{Ag2(oda)(PPh3)3.2H2O}n(17),
[Ag(ndaH)(PPh3)2](18),

[Ag2(dda)(PPh3)4].2C7H8(19),

[Ag2(udda)(PPh3)2]

(20),

[Ag(ddda)(PPh3)3] (21) and [Ag(uddcaH)(PPh3)2] (22) resulted from the reaction of
the relevant Ag(I) dicarboxylate salt with 2.5 equivalents of PPh3.
The complexes [Ag2(prda)(PPh3)3].H2O (23), [Ag2(bda)(PPh3)4] (24),
[Ag2(pda)(PPh3)4] (25), [Ag(hxda)(PPh3)4] .2H2O(26), [Ag2(hpda)(PPh3)4].C7H8(27),
[Ag2(oda)(PPh3)4].2.C7H8(28), [Ag2(oda)(PPh3)4] (28A), [Ag2(ndaH)(PPh3)4].2H2O
(29), [Ag2(dda)(PPh3)4].H2O (30), [Ag2 (udda) (PPh3)3] (31), [Ag2 (udda)
(PPh3)4](31A), [Ag(ddda)(PPh3)3]n (32) and [Ag(PPh3)2(HOOC(CH2)9COO)](33)
resulted from the reaction of the relevant Ag(I)dicarboxylate salt with 4 equivalents of
PPh3.
Attempts to react complexes 1-11 with PPh3 in a 1:6 ratio yielded the same product as
obtained when 4 equivalent of PPh3 were employed and where the dicarboxylate
ligands were propanedioate (prda), butanedioate (bda), pentanedioate (pda),
nonanedioate (nda) and decanedioate (dda). The complexes [Ag(hxdaH)(PPh3)3].C7H8
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(34), [Ag2(hpda)(PPh3)5].C7H8 (35) [Ag2(oda)(PPh3)5].2C7H8 (36) [Ag2(udda)(PPh3)4]
(37), [Ag2(uddca)(PPh3)5] (38), [Ag2(uddca)(PPh3)6] (38A) were successfully
generated.
Complexes 1-11 were reacted with dppm in a 1:2 molar ratio to yield the complexes
[Ag2(prda)(dppm)3]C7H8 (39), [Ag2(bda)(dppm)3].C7H8 (40), [Ag2(pda)(dppm)4] (41),
[Ag2(hxda)(dppm)4]

(42),

[Ag2(hpda)(dppm)4]

(43),

[Ag2(oda)(dppm)4]

(44),

[Ag2(nda)(dppm)4] (45), [Ag(ddaH)(dppm)3].3H2O (46), [Ag2(udda)(dppm)4] (47),
[Ag2(ddda)(dppm)4].H2O (48), [Ag2(uddca)(dppm)4].2H2O (49), [Ag2(dppm)2(OAc)2].3
C7H8 (49A).

Complexes 1-11 were reacted with dppe in a 1:2 molar ratio using the same procedure
employed for the dppm reactions to yield the complexes [Ag2(prda)(dppe)4].H2O(50),
[Ag2(bda)(dppe)4](51),

[Ag2(pda)(dppe)3].4H2O(52),

[Ag2(hpda)(dppe)3](54),

[Ag2(oda)(dppe)4](55),

[Ag2(hxda)(dppe)4](53),

[Ag2(nda)(dppe)4].2H2O

(56),

[Ag2(dda)(dppe)4] (57), [Ag2(udda)(dppe)4].H2O (58), [Ag2(ddda)(dppe)4] (59),
[Ag2(uddca)(dppe)4] (60).
All 60 complexes were found to have limited solubilities and complexes 12-60 were
all relatively light stable compared to simple silver salts such as AgNO3 and their
structures were found to be diverse (the structures of complexes 16, 17, 18, 22, 28,
31A, 32, 33, 38A and 48A were determined by X-ray crystallography) with
mononuclear, dinuclear, polynuclear and polymeric species generated.
The antimicrobial experiments have shown that all of the metal free dicarboxylic
acids and phosphine based ligands are relatively poor antifungals and display no
antibacterial activity. Complexes 1-11 are potent in-vitro anti-Candida agents which
display activity superior/comparable to the clinically used AgNO3 and the state-of the -art organic drug Amphothericin B. Only five of the silver dicarboxylates
(complexes 1, 4, 5, 6 and 7) displayed good antibacterial activity, although it was
significantly less than that of AgNO3. Furthermore, unlike the the activity of AgNO3
these five complexes displayed some discrimination in activity towards the Gram
positive (S. aureus /MRSA) and Gramnegative (E.coli) bacteria. Therefore, it is
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suggested that the silver dicarboxylate complexes 1-11 do not act on microbial cells in
the same way as AgNO3.
All 27 of the PPh3 complexes (12-38) exhibited significant antifungal activity against
the Candida albicans cells although their activity is, on average, over ten times less
than that of the equivalent silver dicarboxylate. Only complexes 14, 31, 33, 37 and 38
are active against the bacterial cells tested. Complexes 31, 37 and 38 are the only
complexes that display higher antibacterial activity (comparable to that of AgNO3)
than antifungal activity, a trend not previously observed. Complexes 31, 37 and 38
represent potential therapeutics that warrent further investigation as novel
antibacterial agents.
The dppm and dppe derivatives 39-60 all exhibited significant antifungal activity
against the Candida albicans cells. However, with the exception of complex 39, most
of their activities are again significantly less than that of the equivalent silver
dicarboxylate. Only complexes 39, 41 and 52 display any activity against the bacterial
cells tested. Complex 41 is interesting as it exhibits good activity against the Gram
positive MRSA but it is inactive agaist the Gramnegative E.coli. Complexes 39 and
52 display some discrimination in activity towards the Grampositive (MRSA) and
Gramnegative (E.coli) bacteria.
In conclusion this research has shown that structurally diverse, light stable silver
complexes can be synthesised easily using the aliphatic α, ω-dicarboxylic acids as
primary, and phosphines as stabilizing donor, ligands. All of the sixty complexes
generated are effective antifungal agents with a variation in the degree of activity
reflecting their structural diversity. This variation in antifungal activity and the fact
that only 13 of the complexes display antibacterial properties suggests that a mode of
action other than simple silver ion release may be responsible for their antimicrobial
properties. This class of complex represents a very interesting group of potential
antifungal agents and a number of the complexes (particularly 31, 37 and 38) may
offer significant potential as broad spectrum therapeutic antibacterial drugs.
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80 [Ag2(dda)(PPh3)4].H2O (30)
75

%T 70
65
60
3000

2000
Wavenumbers (cm-1)

1000
177

[Ag2(udda)(PPh3)3] (31)
70
%T 60
50
40
70

[Ag2(dddaH)(PPh3)3] (32)

60
%T
50
40
30
80

[Ag2(uddcaH)(PPh3)2] (33)

75
%T 70
65
60
3000

2000
Wavenumbers (cm-1)

1000
178

80 [Ag2(hxdaH)(PPh3)2].C7H8 (34)
70
%T

60
50
40
30
[Ag2(hpda)(PPh3)5].C7H8 (35)
70

%T 60
50
40
85
%T

[Ag2(oda)(PPh3)4].2C7H8 (36)

80
75
70
3000

2000
Wavenumbers (cm-1)

1000
179

80

[Ag2(udda)(PPh3)4] (37)

70
%T
60
50
40
[Ag2(uddca)(PPh3)5].C7H8 (38)
60
%T
40

20
80 [Ag2(prda)(dppm)3].C7H8 (39)
60
%T
40
20
3000

2000
Wavenumbers (cm-1)

1000
180

80 [Ag2(bda)(dppm)3].C7H8 (40)
60
%T
40
20
[Ag2(pda)(dppm)4] (41)
80
%T

70
60
[Ag2(hxda)(dppm)4] (42)
70

%T

60
50
40
3000

2000
Wavenumbers (cm-1)

1000
181

80 [Ag2(hpda)(dppm)4] (43)

%T

60

40

80

[Ag2(oda)(dppm)4] (44)

70
%T 60
50
40
[Ag2(nda)(dppm)4] (45)
60
%T
50
40
3000

2000
Wavenumbers (cm-1)

1000
182

80

[Ag(ddaH)(dppm)3].3H2O (46)

%T 70
60
80 [Ag2(udda)(dppm)4] (47)
70
%T

60
50
70 [Ag2(ddda)(dppm)4].H2O (48)
60

%T 50
40
30
3000

2000
Wavenumbers (cm-1)

1000
183

80

[Ag2(uddca)(dppm)4].2H2O (49)

70
%T

60
50
40
30
[Ag2(prda)(dppe)4].H2O (50)
80

%T 70
60

80 [Ag2(bda)(dppe)4] (51)
70
%T 60
50
40
3000

2000
Wavenumbers (cm-1)

1000

184

[Ag2(pda)(dppe)3].4H2O (52)
60
%T
40

20
[Ag2(hxda)(dppe)4] (53)
70
60
%T
50
40
30
[Ag2(hpda)(dppe)3] (54)
70
%T

60
50
40
30
3000

2000
Wavenumbers (cm-1)

1000
185

80

[Ag2(oda)(dppe)4] (55)

70
%T
60
50
40
[Ag2(nda)(dppe)4].2H2O (56)
70
%T
60
50
[Ag2(dda)(dppe)4] (57)
80
%T
70

60
3000

2000
Wavenumbers (cm-1)

1000
186

[Ag2(udda)(dppe)4].H2O (58)
60
%T
40

20
70

[Ag2(ddda)(dppe)4] (59)

60
%T 50
40
30
[Ag2(uddca)(dppe)4] (60)
70
60
%T

50
40
30
3000

2000
Wavenumbers (cm-1)

1000
187

